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Abstract.
iHeart Failure is a common clinical problem with high morbidity and mortality. 
While there are several pathological changes in cardiac failure, abnormalities of 
myocardial contraction at the cellular level are well documented. Myocyte Ca^  ^
handling which underlies excitation-contraction coupling is abnormal in heart failure 
and contributes to mechanical dysfunction. Changes in intracellular Ca^  ^during 
contraction and relaxation are mediated by both sarcolemmal Ca^  ^transport and 
sarcoplasmic reticulum (SR) Ca^  ^ release and re-uptake. Abnormalities of both 
sarcolemmal Ca^  ^transport, and SR function have been described in heart failure and 
thus the pathophysiological mechanisms of abnormal Ca^  ^handling and subsequent 
myocardial contraction need to be clarified.
In this thesis, abnormalities of Ca^  ^handling at the level of the whole myocyte are 
characterised in a coronary artery ligation model of heart failure in rabbit. Following 
this, a novel preparation for the specific study of SR function in permeabilised single, 
myocytes was developed. SR Ca^  ^content was significantly reduced in myocytes 
from failing hearts compaied to shams. Spontaneous SR Ca^  ^release occurred less 
frequently in failure myocytes and with reduced amplitude than in myocytes from 
sham hearts. SR Ca^  ^uptake was then directly measured in suspensions of single, 
permeabilised myocytes from failing rabbit hearts. SERCA 2A mediated SR Ca^  ^
uptake was significantly slower in failure cells than sham cells, and this difference 
was maintained in the presence of ruthenium red, a blocker of the SR Ca^ "" release 
chamiel. Inliibitors of specific aspects of SR function were then used to model the 
changes in SR fimction seen in heart failure. Inliibition of SR Ca^  ^uptake with 
thapsigargin in healthy permeabilised myocytes most closely modelled the heart
.
failure phenotype. Inhibition of SR Ca^  ^release at the ryanodine receptor with 
tetracaine, and stimulation of SR Ca^  ^leak with ionomycin did not accurately model 
the changes in SR function seen in heart failure.
The experimental tecliniques described in this thesis were then applied to 
human myocytes dissociated from small ventricular biopsies to ascertain whether 
similar protocols could be used in future studies to investigate SR function in human 
heai't failure.
Chapter 1 : Introduction.
1.1 Heart Failure - definition and clinical problem.
Heart failure is a syndrome which can be defined in clinical terms as a condition 
which develops as a result of cardiac disease or damage and produces recognised 
symptoms of fatigue, poor exercise tolerance, breathlessness and fluid retention 
secondary to complex circulatory and neurohormonal responses (Cowie et al. 1997).
It can also be defined as a state when cardiac output is insufficient to meet the 
requirements of metabolising tissues (Braunwald & Grossman, 1992). Heart Failure 
is a common clinical problem with high morbidity and mortality. Left ventricular 
dysfunction (LVD) is present in around 3% of all adults, and is symptomatic in #
around half of these (McDonagh el a l 1997). The prevalence of LVD rises to 5-6%
■e-v
in the elderly population (Clarke et a l 1995). The resources spent on treating heart . ;|
failure account for 1-2% of the total healthcare budget in this country (McMurray &
Davie, 1996). Mortality is high in patients with heart failure: even with optimal 
therapy patients with moderate to severe heart failure (NYHA class III-IV) have 
between 16% (Stevenson et a l 1995)and 46% (The SOLVD investigators, 1991) one 
year mortality rates.
The aetiology of cardiac failure is complex since the syndrome is the end result of
many disease processes. In the Framingham population hypertensive heart disease
.was the most frequent underlying aetiology of heart failure (Kannel & Belanger,
1991). Coronaiy artery disease has been a more common underlying pathology in 
more recent studies (McDonagh et a l 1997), but hypertension and coronary artery 
disease together underlie the vast majority of cases of heart failure in the developed
.:3::world (Cowie a/. 1997). Rheumatic valvular heart disease accounts for fewer
 c . L . 3 .   .____
cases than previously, but remains common in the developing world (Kamiel et al.
1994). There are also infective, nutritional, toxicological, endocrine and idiopathic 
aetiologies, the incidences of which vary geographically and between series.
Previous research has shown that there are several pathological changes in cardiac failure 
including myocyte loss, interstitial fibrosis and neuiohormonal activation (for review see 
(Figueredo & Camacho, 1994; Davies et al. 1996; Carter & Rubin, 1994; Gwathmey & 
Ingwall, 1995)), but the mechanical consequences of cellular contractile dysfunction are 
central to the pathophysiology of left ventricular dysflmction.
1.2 Evidence for eontractile and lusitropic dysfunction at cellular level.
Evidence for contractile dysfunction in myocytes comes from both single cell and 
multi-cellular studies. Mulieri (Mulieri et al. 1992) examined the isometric tension 
development of left ventricular' myocardial strips from patients with end stage 
idiopathic dilated cai'diomyopathy. In control tissue from non-failing hearts there was 
a positive relationship between stimulation frequency and developed twitch tension 
at frequencies of up to 3Hz. This has previously been termed the positive force 
frequency relationship and was initially described over 100 years ago (Bowditch,
1871) and has been confirmed in many mammalian species (Buckley et al. 1972). In 
Mulieri’s experiments, the positive force frequency relationship seen in control tissue 
was absent in muscle strips from failing hearts, and peak tension development was 
reduced by 80% at high fi-equency of stimulation compared to control tissue. Peak 
rate of tension development was also reduced by 75% in tissue from failing hearts.
Peak tension development and rate of tension development have also been found to 
be reduced in other human muscle human experiments (Hasenfuss et al. 1992).
These finding were extended in another study looking at the force-frequency 
relationship in papillary muscle strips from patients with both moderate (New York 
Heart Association (NYHA) class II-III) heart failuie and severe (NYHA IV) heart 
failure. In moderate heart failure the force-frequency relationship was flattened at 
low stimulation rates (0.5-2Hz) and negative at higher frequencies (2.5-3Hz), 
whereas in severe heart failure the relationship was negative tliroughout the stimulus 
range (Schmidt et al. 1994). This data are shown in fig. 1.1. Schwinger (Schwinger et 
al. 1992; Schwinger et al. 1993) found that the negative force-frequency relationship 
in papillary muscle strips from patients with terminal heart failure could be only 
partially reversed with ^-adrenergic stimulation, although full reversal was seen with 
a combination of ouabain (a cardiac glycoside) and BDF 9148 (a Na^ channel 
activator). There was no difference in developed tension at basal stimulation 
between papillary muscle strips fr om failing and non-failing hearts, but when force of 
contraction was raised approximately three-fold using inotropic stimulation, both rate 
of developed tension and rate of relaxation increased significantly more in normal 
than failing hearts. Evidence of contractile dysfunction in trabecular preparations 
also comes from a canine model of pacing-induced heart failure (Perreault et a l 
1992). Here isometric tension development in control tissue rose with increases in 
extracellular [Ca^^], but this relationship was blunted in tissue from heart failure 
animals. Taken together this evidence suggests that systolic and diastolic contractile 
abnormalities in multicellular preparations, while present at baseline in some studies 
are most marked at high stimulation frequencies and during other forms of 
physiological inotropism. This reflects the in vivo finding that cardiac function in
heart failui'e is most compromised during exercise or inotropic stimulation (Mulieri 
et al. 1992).
There are a nmiiber of theoretical problems associated with the study of myocardial 
physiology in multicellular preparations, however. In particular, it has been 
suggested that core hypoxia in multicellular preparations may affect results (Atar et 
al. 1995). In addition diffusion time within preparations may be limiting for either 
nutrients or other compounds. All of these considerations raise the possibility that 
there may be differences in function of myocardial tissue within regions of the 
preparation. For this reason, abnormalities of contraction and relaxation at the level 
of the single myocyte have been studied in both human heart failure and in animal 
models of heart failure. Most of these studies were performed by Harding’s group in 
London. In eaiiy studies there was no apparent difference in contraction amplitude or 
velocities of contraction and relaxation between cells from patients with terminal 
heart failure and control subjects (Harding et al. 1991), and maximum contraction 
amplitude in high [Ca^ ]^ media was also unchanged, although responses to 
catecholamine stimulation were reduced (Harding et al. 1992a). However in later 
studies performed at 37°C using physiological stimulation rates there was a clear 
bhmting in the positive force frequency relationship in cells from failing hearts 
compared to control cells. Time to peak contraction, and time to 50% and 90% 
relaxation were all significantly prolonged (Davies et al. 1995). Other studies have 
shown that atrial (Harding et al. 1990) and ventricular (Harding et al. 1992b) 
myocytes from failing human hearts have reduced contractile responses to 
isoprenaline, forskolin (which acts distal to p-adrenoceptors to stimulate adenyl 
cyclase) and dibutyryl cAMP (a membrane permeant analogue of cAMP) compaied
À:
to control cells. In a pacing-induced canine model of heart failure, a rate dependent
decrease in contraction amplitude has also been seen in single ventricular myocytes,
although abnormalities of relaxation were not seen (Perreault et a l 1992).
,Left ventricular hypertrophy, which often accompanies heart failure in remodelled 
myocardium, is also associated with abnormalities of myocyte contraction and 
relaxation. In a further study from Harding’s group (Del Monte et a l 1995), cells 
from patients with left ventricular hypertrophy associated with heart failure showed 
prolonged contraction and relaxation times in comparison to cells from failing hearts
without hypertrophy.
Despite some contradiction between studies, this evidence from multicellular and
single myocyte preparations shows that myocyte dysfunction does occur in heart 
failure, and that there is interaction between this dysfunction and other
pathophysiological changes seen in heart failure, for example neurohormonal
activation and left ventricular hypertrophy. Amplitude of contraction may be normal
,or reduced at low stimulus frequencies, but contractile dysfunction is increasingly 
apparent at higher frequencies. Contraction and relaxation times may also be slower, 
and these changes are more significant in hearts with ventricular hypertrophy.
Myocytes from diseased hearts do not respond normally to physiological p- 
adrenergic inotropic stimulation or to post-receptor activation of p-adrenergic 
pathways.
■f
1.3 Evidence that abnormal calcium homeostasis contributes to myocyte 
dysfunction in intact preparations.
Gwathmey was the first to note abnormal Ca^  ^homeostasis in heart failure 
(Gwathmey et a l 1987). Using aequorin, a bio luminescent Ca^  ^indicator in 
trabeculae from hearts explanted from patients with terminal heart failure, it was 
found that in tissue from myopathic hearts, the Ca^' transient was markedly 
prolonged in comparison with control tissue, and exhibited two distinct phases 
(shown in figure 1.2). This was seen in tissue from patients with both dilated 
cardiomyopathy and hypertrophic cardiomyopathy, but was more marked in 
hypertrophic tissue. This correlated with slowed relaxation when tension was 
measured simultaneously. Prolongation of Ca^  ^transients could not be totally 
blocked with either verapamil or ryanodine, suggesting that there were abnormalities 
of both sarcolemmal Ca^ ' transport and SR function. Prolongation o f Ca  ^' transients 
would be expected to cause primarily diastolic myocardial dysfunction, however at 
physiological stimulation rates, fusion o f Ca^ '*' transients occurred which was 
associated with increased diastolic tone, and reduced systolic contractile force. Later 
experiments (Gwathmey et a l 1990) confirmed that end-diastolic [Ca^ ]^ was raised 
during steady state contraction in myopathic tissue. There was no observed difference 
in peak systolic [Ca^^], despite the fact that frequency-related force potentiation was 
attenuated in myopathic tissue. Pharmacological manipulations which increased 
cytosolic [Ca^ ]^ potentiated these diastolic abnormalities, whereas drugs which 
lowered [Ca "^'] ameliorated them (Gwatlmiey et a l 1991).
In contrast, Pieske (Pieske et a l 1995) correlated reduced peak [Ca^^] levels with a 
negative force-frequency relationship in failing human trabeculae. In a pacing-
induced canine model, Perrault (Perreault et al. 1992) found a diastolic prolongation 
in Ca^  ^transients, and a reduction in peak tension development, but peak and resting 
[Ca^T levels were normal.
Studies in trabecular preparations in human heart failure and animal models 
therefore show a consistent finding of impaired diastolic Ca^  ^handling, but there is 
conflicting evidence on a reduction in peak systolic Ca^  ^availability.
Beuckelmann (Beuckelmann et al 1995; Beuckelmann et a l 1992) studied Ca^^
X
K,transients in isolated ventricular myocytes from patients with terminal ischaemic and 
dilated cardiomyopathy. Diastolic decay of Ca^ "^  transients was significantly 
prolonged and peak Ca^  ^levels were significantly depressed in heart failure. Resting
cytosolic [Ca^ '*'] was significantly raised. Smaller Ca^  ^transients have also been seen 
in isolated myocytes from an infarction model of cardiac failure in the rat (Zhang et
a l 1995), but predominantly diastolic changes were seen in a hypertensive model. ICapasso (Capasso et a l 1993) also found increased resting [Ca^^], diastolic |
Aprolongation and reduced systolic amplitude in myocytes from a post-infarction rat 
model. Peak [Ca^ ]^ has also been found to be reduced in Ca^ "^  transients in isolated 
myocytes from cardiomyopathic hamsters (Kruger et a l 1994). À
Clear evidence of altered systolic and diastolic Ca^  ^handling is therefore seen in if
isolated myocyte studies. Whether differences in findings in systolic Ca^  ^handling 
from trabeculae and single cell studies represent differences in experimental f;
prepaiation or in pathophysiology is unclear, however, since the nature of the single 
cell preparation has an effect on Ca^ "" handling. Altering load in cardiac tissue has 
been shown to qualitatively alter Ca^  ^ transients (Vahl et al. 1994). Cell 
specialisation within the ventricular wall is also known to affect electrophysiological
10
,1properties, which would in turn affect Ca^  ^handling (Drouin et al. 1995). The weight ||
of evidence, however, supports abnormalities in both systolic and diastolic Ca^  ^
handling.
1.4 Evidence that abnormal SR function contributes to altered Ca^  ^handling in 
heart failure.
Gwathmey (Gwatlmiey et al. 1987) suggested that abnormal Ca^  ^transients reflected 
both abnormal sarcolemmal Ca^  ^transport and SR dysfunction. There is conflicting ; §
evidence of abnormal sarcolemmal Ca^  ^ transport in heart failure. Several studies
S'have found reduced density of the L-type current in animal models of cardiac I
VinvA K p p n  f n i in r i  in  m \/nr*A /tA c -H
hypertrophy and failure (Ming et al. 1994; Ouadid et al. 1995; De Brito Santos et al. 
1995). In contrast no reductions in Ca^  ^current density have been found in yocytes
isolated from failing human hearts (Mewes & Ravens, 1994; Beuckelmami et al.
J1992). Both increased and reduced function of the Na"^  / Ca^  ^exchanger have been 
suggested in heart failure. Studer (Studer et al. 1994) found increased expression of 
Na”^ / Ca^  ^exchanger mRNA in patients with heart failure and coronary artery 
disease, suggesting that upregulation of the exchanger may be a compensatory
,.è:change in response to raised diastolic [Ca^^]. Flesch (Flesch et al. 1996) also found
raised levels of exchanger mRNA, and found that Na^ channel activator BDF 9148 |
was a more potent inotrope in patients with heart failure and suggested that the Na^ /
Ca^  ^exchanger may be a possible modulator of contractility in heart failure.
Enlianced Na^ / Ca^  ^exchange activity has also been reported in cardiomyopathic 
hamsters (Hatem et al. 1994). In contrast Dixon (Dixon et al. 1992) found reduced 
activity of the Na"^  / Ca^  ^exchanger in sarcolemmal preparations from rats with post I
11
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infarct cardiac failure, and Na^ / Ca exchange activity is also reduced in 
hypertrophied guinea pig hearts (Naqvi & MacLeod, 1994).
Conflicting evidence of altered sarcolemmal Ca^  ^transport in heart failure may 
reflect species differences in the relative contribution of sarcolemmal Ca^”^ currents 
and SR Ca^  ^release to the Ca^ *" transient (Tada & Kadoma, 1997). Evidence of 
abnormal SR function comes from a number of sources.
1.4.1 Altered SR protein and gene expression.
A reduction in protein levels of the SR Ca^  ^uptake protein SERCA 2A would be 
expected to cause slowed diastolic re-uptake of Ca^ ,^ consistent with findings of 
prolonged Ca^  ^transients in heart failure, and would also contribute to lower SR Ca^  ^
content which would cause reduced systolic Ca^  ^release. There is general agreement 
that mRNA for SERCA 2A is reduced in cardiac failure and hypertrophy (see (Arai 
et al. 1994) for review). SERCA 2A mRNA has been found to be reduced in human
' :
heart failure (Schwinger et al. 1995; Arai et al. 1993; Mercadier et al. 1990) and in 
animal models of heart failure (Matsui et al. 1995; Feldman et al. 1993; Boluyt et al.
1994). There is also broad agreement that levels of the SERCA 2A protein itself are 
reduced in animal models of heart failure and hypertrophy (Stein et al. 1996; Matsui
'et al. 1995; Kiss et al. 1995), although some studies have found levels to be
unchanged (Cory et al. 1994). Changes in levels of SERCA 2A in human heart 
failure remain controversial however. Schwinger (Schwinger et al. 1995) found 
unchanged levels of SERCA 2A in left ventricular' tissue from patients with dilated 
cardiomyopathy. Similar findings have been reported by Movsesian (Movsesian et 
al. 1994). In contrast Flasenfiiss (Hasenfuss et al. 1994) found reduced levels of 
SERCA 2A, which correlated with reduced twitch potentiation at high frequencies in
muscle strips from the same patients. Meyer (Meyer et a l 1995) also found reduced 
levels in human heart failure. The reason for different findings in these studies has 
not been explained. Some investigators have found a wide variation in SERCA 2A 
expression within the heart failure patient population (Lelinart et a l 1998) and 
therefore small numbers of patients in these studies may make real differences in
Iprotein levels difficult to prove due to inadequate statistical power. Given the |
reduction of mRNA expression for SERCA 2A, the expected finding would be that 
protein levels ai'e also reduced, however this assumes that rates of protein 
degradation are equivalent in failing and non-failing hearts, which remains to be 
confirmed (Movsesian et a l 1994).
Alterations in gene and protein expression for the SERCA 2A regulatory protein li:
Îphospholamban have also been studied. Since phospholamban is an inhibitory 
regulator of SERCA 2A, decreases in protein levels would have a dis-inliibitory 
effect on SR Ca^ "' uptake, antagonising the effects of reduced SERCA 2A in heart I
■p.failure. In general reduced levels o f phospholamban mRNA have been found, both in
"I-
animal models (Rockman et a l 1994; Matsui et al 1995) and in human studies (Arai 
et a l 1993; Schwinger et a l 1995).Measurements of protein levels are less uniform,
however, with studies showing decreased levels (Meyer et a l 1995; Kiss et a l 1995) S
or unchanged levels (Bohm et a l 1994; Movsesian et al. 1994; Schwinger et al. #
1995). In those studies showing a reduction in phospholamban, the degree of ■I
reduction was less than that of SERCA 2A, implying that while a reduction in 
phospholamban would have a dis-inhibitory effect on SERCA 2A, the net effect of
I;changes in SERCA 2A and phospholamban protein expression would be a reduction 
in SERCA 2A mediated SR Ca^  ^uptake. This has been confirmed in the coronary
12 ‘S
■ ‘ "ï  .................. .
artery ligation model of heart failure in the rahbit where both phospholamban and
13
SERCA 2A protein expression were found to be reduced, and SR Ca^  ^uptake in 
.vesicle experiments was reduced(Currie & Smith, 1999).
Fewer studies have examined levels of mRNA and protein for the SR Ca^  ^release 
channel (the ryanodine receptor). Arai (Arai et al. 1993) found reduced mRNA and
. :Brillantes (Brillantes et al. 1992) found reduced cDNA levels in patients with 
ischaemic but not dilated cai'diomyopathy, and Go (Go et al. 1995) found reduced 
mRNA and ryanodine binding in human failing hearts, but others have found protein 
levels to be unchanged (Meyer et al. 1995; Movsesian et al. 1994). There are also 
conflicting reports on functional changes of the ryanodine receptor in heart failure.
Nimer (Nimer et al. 1995) found differential effects of ryanodine (an inhibitor of 
Ca^  ^release through the ryanodine receptor) in SR microsomes from failing and non­
failing hearts. In contrast the properties of single ryanodine receptors under voltage 
clamp conditions have been found to be michanged in heart failure (Holmberg &
Williams, 1989).
There is general agreement that levels of protein and mRNA levels for the SR Ca^^
-
storage protein calsequestrin are unchanged in heart failure (Arai et a l 1993; Meyer
et a l 1995; Movsesian a/. 1994).
,In conclusion there is good evidence that mRNA for SERCA 2A is reduced in 
human and animal heart failure and that protein levels are lower in animal studies.
Changes in SERCA 2A expression in human heart failure remain controversial.
Reductions in mRNA and protein expression of the ryanodine receptor and 
phospholamban have been reported in some studies, but found to be unchanged in 
others. t!
S
1.4.2 Altered phosphorylation of phospholamban.
The inhibitory effect of phospholamban on SERCA 2A can be modulated by 
phosphorylation. Phosphorylation at the serine 16 and threonine 17 sites of the 
phospholamban monomer reduces phospholamban mediated inhibition of SERCA 
2A (Cornwell et al 1991; Colyer & Wang, 1991). Cuiiie (Currie & Smith, 1999) 
studied the phosphorylation status of phospholamban in a rabbit model of heart 
failure and found increased levels of phosphorylation, and increased intrinsic kinase 
activity in tissue from heai't failure animals, suggesting that phosphorylation of 
phospholamban may be an adaptive response to reduced SERCA 2A mediated SR 
Ca^  ^uptalce in failure. Bartel (Bartel et a l 1996) found reduced cAMP dependant 
phospholamban phosphorylation of trabeculae from failing human hearts, although 
phosphorylation capacity could be normalised by the addition of dibutyryl cAMP.
1.4.3 SR vesicle studies.
Ca^  ^uptake in SR vesicles has been used to study SR function in heart failure. 
Movsesian (Movsesian et a l 1989) measured Ca^  ^uptake in purified SR vesicles 
from patients with end-stage idiopathic dilated cardiomyopathy. Maximal Ca^  ^
uptake affinity constant (Kq.s,) and Hill coefficient were unchanged in failing
tissue. Olikusa (Ohkusa et a l 1997) found increased rates of Ca^  ^ uptake in SR 
vesicles in the early stages of development of pressure-induced left ventricular 
development in rats. Indices of left ventricular function were increased throughout 
the study period, but in later stages of development of ventricular hypertrophy rates 
of SR Ca  ^'■ uptake returned to normal. Other studies have found reduced Ca^ "^  uptake 
in heart failure. Schwinger (Schwinger et al. 1995) found uptake rates decreased to 
50% of control levels and reduced SERCA 2A activity in human dilated
14
cardiomyopathy, despite finding unchanged protein levels of SERCA 2A. Hasenfuss 
(Hasenfuss et al. 1994) correlated reduced Ca^  ^uptake in homogenised human 
myocardium with reduced levels of SERCA 2A in failing hearts. Ca^  ^uptake was 
reduced by 50-75% in ischaemic and dilated cardiomyopathy in a further study using 
homogenised human myocardium (O'Brien & Gwatlimey, 1995). SERCA 2A 
activity and SR Ca^  ^uptake is also reduced in left (but not right) ventricle in the post­
infarction rat model (Afzal & Dhalla, 1992), and pacing-induced canine model (Cory 
et a l 1993).
1.4.4 Measures of SR Ca^  ^content in heart failure.
Reductions in protein levels or activities of SERCA 2A would be expected to 
reduce steady state SR Ca^ "'" content. This has been measured in several ways. Denvir 
(Denvir et al. 1995) examined the amplitude of caffeine-induced contraction as a 
measure of SR Ca^ ''' content in right ventricular trabeculae from failing human hearts. 
Contraction amplitude was reduced in patients with severe heart failure compared to 
moderate failure. Using the same techniques, SR function was found to be enhanced 
in a rabbit model of heart failure (Denvir et al. 1996). Reduced caffeine-induced Ca^ "^  
release have been found in isolated myocytes from failing human hearts 
(Beuckelmaim et al. 1994), and SR Ca^  ^content was reduced in heart failure when 
measured using electron probe micro-analysis (Darvish & Moravec, 1994).
1.4.5 Genetic manipulation of SR function.
Over-expression of SERCA-2A in rat myocytes by adenoviral transfer has been 
shown to increase Ca^^-ATPase activity, shorten the Ca^  ^transient and increase and 
shorten cellular contraction (Hajjar et al. 1997a), suggesting that cellular changes 
seen in heart failme may be remediable if normal levels of SERCA 2A were present.
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Similar findings have been reported in transgenic mice over-expressing SERCA 2A 
(He et al. 1997). Over-expression of phospholamban in rats by adenoviral 
transfection mimics the changes seen in heart failure, prolonging the Ca^  ^transient 
and slowing relaxation (Hajjar et al. 1997b), and these effects can be prevented by 
maintaining relative levels of phospholamban and SECRA 2A by concomitant gene 
transfer of SERCA 2A.
There are several potentially valuable endpoints of these experiments of genetic 
manipulation of SR proteins. While treatment of human heart failure by adenoviral 
gene transfer remains a distant possibility, genetic manipulation allows hypotheses of 
causes of SR dysfunction in heart failure to be tested. This type of study can be used 
in animal models to predict whether potential pharmacological modulators of specific 
aspects of SR function will have beneficial effects without the harmful side effects 
seen with so many other treatments of heart failure.
1.5 Overview of experimental work.
As reviewed, there is a substantial amount of evidence that abnormal Ca^  ^
handling contributes to cellular contractile dysfunction in heart failure. Much of this 
work, however, relates to studies of intact tissue, where it is difficult to differentiate 
between dysfunction of sarcolemmal Ca^  ^transport and SR function. The majority of 
studies of SR function in heart failure relate to mRNA and protein expression, or to 
studies of SR function in isolated SR vesicles. The purpose of the work reported here 
was to study SR function in an animal model of heart failure in isolation from 
changes in sarcolemma function, but still in working myocardial tissue. The 
preparation chosen for these studies was the permeabilised myocyte.
16
Chapter 2 of this thesis describes preliminary studies in intact myocytes from a 
coronary artery ligation rabbit model of heart failure, to establish the presence of 
abnormal Ca^' handling at the whole cell level. Ca^  ^transients were recorded from 
electrically stimulated single myocytes at frequencies of 0.1-3Hz. The measurements 
taken from these transients were amplitude, duration, and time to peak. These were 
compared in cells from failing and sham hearts.
Chapter 3 explains the development of the permeabilised single myocyte 
preparation, which allowed the study of SR function in isolation from sarcolemmal 
Ca^  ^transport. SR Ca^  ^content was measured in myocytes from failing and sham 
hearts by application of caffeine. Spontaneous SR Ca^  ^release was stimulated in 
these cells by increasing cytosolic Ca^ "^  concentration, and the amplitude and 
frequency of spontaneous release compared in failing and sham cells.
Chapter 4 describes measurements of SR Ca^  ^uptake in suspensions of oxalate- 
loaded, permeabilised myocytes. These experiments were performed in the absence 
and presence of ruthenium red, a blocker of Ca^  ^ release at the ryanodine receptor. 
These experiments were undertaken to explore whether SR Ca^  ^content was reduced 
in heart failure due to lower SERCA 2A activity.
In chapter 5, pharmacological manipulation of SR function is described, in an 
attempt to model the abnormal SR function described in earlier chapters.
Finally, chapter 6 describes the application of these experimental methods to the 
study of SR function in human myocytes, dissociated from small ventricular biopsies 
taken at the time of cardiac surgery.
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Chapter 2. Studies in intact myocytes.
2.1 Methods.
2.1.1 Rabbit model of left ventricular dysfunction.
A coronary artery ligation model of left ventricular dysfunction was used in these 
studies as described by Pye et al(Pye et al. 1996). Experiments were undertaken in 
adult New Zealand white rabbits of either sex weighing initially 2.5 to 3 kg. Surgery 
was performed by teclinicians in the animal house at Glasgow Royal Infirmary. 
General anaesthesia was induced using Hypnorm and maintained with Halothane and 
Nitrous Oxide/Oxygen. Following induction a left thoracotomy was performed and 
the large circumflex branch of the left coronary artery was identified and occluded 
approximately midway between the left atrial appendage and the cardiac apex. This 
procedure gives rise to a large homogeneous infarct in view of the minimal collateral 
circulation in the rabbit. Intravenous Quinidine was administered to minimise 
perioperative ventricular fibrillation. Post operative analgesia was provided and 
prophylactic antibiotics were administered. Animals were monitored for signs of 
distress and were withdrawn from the experimental protocol in cases of weight loss 
greater than 20% of baseline, evidence of overt infection or severe distress. Sham 
operated animals were prepared in an identical manner, but the coronary artery was 
not tied. Following surgery, animals were allowed to recover for 8 weeks prior to 
being sacrificed for in vitro experimentation.
Prior to sacrifice all animals underwent echocardiographic examination to assess 
the degree of LVD produced by the experimental infarct. This was undertaken using 
a 5 MHz focused paediatric transducer under light sedation with Hypnorm. M-mode 
measur ements of ventricular end diastolic diameter was made and area ejection
2 0
fraction calculated from 2-D measurements of end systolic and end diastolic 
dimensions in the short axis (Pye et al. 1996).
2.1.2 Cell isolation.
Rabbits were injected via a marginal ear vein with 500U of heparin and a terminal Ioverdose of sodium pentabarbitone. Following this the heart was quickly excised and v
mounted onto a Langendorff perfusion column. The heart was retrogradely perfused 
at 37° C via the aorta with Ca free base Krebs solution buffered with 0. ImM 
Ethylene bis [oxyethylenenitrilo] tetraacetic acid (EGTA). After 5 minutes the 
perfrision solution was changed to base Krebs solution containing 80pM CaClj and 
1.5mg ml"' collagenase (type 1, Worthington Chemicals) and 0.14mg ml"' protease 
(type XIV, Sigma). The heart was perfused with this for 10-20 minutes to allow 
initial digestion of comiective tissue, judged by a softening of ventricular tissue. The 
atria and right ventricle were dissected from the heart and discarded. The left 
ventricle was then removed ft’om the aortic cannula and dissected into epicardial, 
mid-myocardial and endocardial layers. These layers were cut into small chunks and 
incubated at 37°C in further enzyme solution containing 1% bovine serum albumen 
(BSA, fraction V, Sigma) for 5 minutes before being filtered through a 250pm nylon 
mesh. Undigested material was then incubated for a further 5 minutes, while the cell 
suspension was centrifuged at 900rpm for 1 min, and the resulting cell pellet re- 
suspended in Krebs solution containing ImM CaCl2 and 1.5% BSA. When the cells 
has settled they were finally stored in Medium 199 (Gibco) with 5mM taurine, 5mM 
creatine and 0.2% BSA until use. The timing of incubation with digestive enzymes
were altered from time to time as properties of different batches of enzymes varied.
:;ii
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2.1.3 Experimental Procedure.
Changes in cytosolic [Ca^ ]^ during the cell cycle were measured using the 
fluorescent Ca^  ^indicator Fura-2 (Molecular Probes)(Kobayashi et al. 1989; Roe et 
al. 1990; Timmerman & Ashley, 1986). Cells were loaded with 5pM Fura-2 AM for 
20 minutes at 37°, before being transferred to a perfusion chamber mounted on an 
inverted Nikon Diaphot microscope. The chamber was perfused with 5ml min ' o f rat 
Ringer solution at 37° C. Single myocytes were stimulated at 0.1-3Hz using a 0.5mm 
silver-silver chloride electrode system, with one electrode placed near the cell, and a 
second electrode serving as a reference electrode at the side of the bath. Square wave 
20ms pulses were delivered to the electrodes at 80-90V using a Digitimer DS2 
stimulator. Fluorescence was stimulated 340mn and 380nm from a Xenon arc light 
source and a spimiing wheel system (Cairn Research Systems) at 60Hz. Evoked
■
fluorescence at wavelengths ahove 500nm was collected using a 500nm interference 
filter and passed tlu*ough a dichi'oic mirror to a photomultiplier. Measured 
fluorescence was restricted to the area of the microscope field containing the cell by
■
the use of a variable rectangular window on the side port of the microscope The 
output voltage from the photomultiplier was measured by a spectrophotometer 
(Cairn Research Systems), A schematic diagram of the experimental apparatus is 
shown in fig. 2.1. A ratiometric measurement of intracellular [Ca^ ]^ was calculated 
from fluorescence excited at 340 and 380nm. Data from these two wavelengths and 
their ratio was output to a chart recorder (Gould Instruments Ltd) and to videotape, 
and simultaneously digitised using the program WCP (Jolm Dempster (1993-4) and 
stored on hard disc. Ca^  ^transients from cells stimulated for 2  minutes at frequencies 
0.1, 0.3, 1, 2 and 3Hz were recorded, with a standard protocol.
2.1.4 Data Analysis.
was compared using unpaired Student t tests. Statistical significance was taken as a 
probability of <0.05.
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Data were analysed off-line. Ca transients from two minute periods of 
stimulation were averaged for the different frequencies using the program WCP.
Using this program the timecourses of the transients were analysed. Two 
measurements of timecourse were taken from each averaged Ca^ "^  transient. Time 
from the initial upstroke to half peak [Ca^ ]^ (T50) was used as a measurement of the 
rate of release of Ca^ .^ D50% was calculated as a measure of the duration of the Ca^  ^
transient, largely reflecting the time taken for Ca^  ^re-uptake by the SR and extiusion 
across the sarco lemma during the diastolic phase of the contraction cycle. D50% was 
measured as the time taken from reaching 50% of the maximum amplitude of Ca^  ^
release to reaching the same level during the relaxation / re-uptake phase.
Measurement of T50 andDgo is shown in fig. 2.2 From the chart recorder records of
4;
experiments, the mean peak and trough ratios were measured after calibration of the 
chail recorder. These values represented peak systolic and resting (diastolic)
intracellular [Ca^^.
, ■Cells which did not follow all stimulation frequencies were considered to be 
unhealthy, and were not included in the analysis. Data collected for each cell were 
myocyte length and width, time to peak Ca^ "*' release (T50), D50%, peak Fura 2 ratio 
and trough Fura 2 ratio. Mean data (± SEM) for all cells from failing and sham cells
y
2.2 Results.
2.2.1 Left ventricular function.
Mean left ventricular ejection fraction was 68.5 ± 2.7% in sham operated animals. 
LVEF was significantly reduced in experimental animals at 43.2 ± 1.9% (p<0.001).
2.2.2 Ventricular remodelling.
Since all hearts were enzymatically digested to obtain single myocytes in this
study, it was not possible to measui'e total ventricular mass in experimental and sham
hearts. Thus it was not possible to assess global remodelling changes. In a published
study from this laboratory, dry weights of both the left and right ventricle have been
found to be increased by 22.7 ± 0.5% and 50.0 ± 1.6% respectively 8 weeks post
infarction in this rabbit model (Ng et al. 1998).
Remodelling changes at the cellular level were investigated in the present study by
.measuring myocyte dimensions. Endocardial myocytes from failing hearts were 
significantly longer than those from sham hearts ( 125.2 pm + 2.9 pm, n=52 cells 
compared to 109.1 pm ± 2.6 pm, n = 32 cells, p < 0.001), but were of equivalent
24
width ( 26.8 pm ± 1 . 6  compared to 25.0 pm ± 1 . 2  pm, p = n.s.). In contrast 
epicardial myocytes from failing hearts were both longer and wider than sham cells 
(117.5 pm ± 4.5 pm, n=34 cells, vs 105.0 pm ±3.3 pm, n= 30 cells, p < 0.05, and
27.4 pm ± 2.4 pm vs 21.6 pm ±1.2 pm, p < 0.05).
2.2.3 Rate of Ca^  ^release.
T50 was measured in 52 endocardial and 34 epicardial cells at 0.1- 3 Hz from 8
experimental hearts, and in 33 endocardial and 30 epicardial cells at the same 
frequencies from 6  sham operated hearts. Mean values for these cells are shown in 
table 2.1 and fig. 2.3 and 2.4. T50 was significantly prolonged in endocardial cells at
11
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frequencies 0.1- 2 Hz compared to control cells. There was a trend towards a 
frequency dependent decrease in T50 from 0.1 - 2 Hz in experimental endocardial 
cells. Tgo was significantly lower at 1 and 2 Hz compared to 0.1 Hz (p<0.05). This 
trend was not seen in control cells. There was no difference in Tgo values between 
control and experimental epicardial cells. No frequency-dependant reduction in Tgo 
was seen in epicardial myocytes.
Expt.
(a) Endocardial cells
0.1 Hz 0.3 Hz 1 Hz 2 Hz 3Hz
Mean 67.33 62.67 58.33 57.94 58.53
SEM 4.13 2.62 0.96 0.78 0.9
P <0.05 <0.05 <0.05 <0.05 >0.05
Sham
0.1 Hz 0.3 Hz 1 Hz 2 Hz 3Hz
54.88 54.94 55.09 55.27 57.42
1.03 0.72 0.73 0.71 0.97
(b) Epicardial cells
Mean
SEM
54.45 55.81 54.77 54.94 56.32
0.82 0.73 0.64 0.53 0.63
>0.05 >0.05 >0.05 >0.05 >0.05
56.1 55.79 55.17 55 56.36
0.99 0.75 0.56 0.63 0.73
Table 2.1: Mean T^ o values for endocardial and epicardial myocytes. All times are in ms. 
Probabilities are compared to sham cells at the same frequency.
2.2.4 Duration of transients.
Dgo was measured in 56 endocardial and 33 epicardial cells at 0.1- 3 Hz fiom 8  
experimental hearts, and in 38 endocardial and 30 epicardial cells at the same 
frequencies from 6  sham operated hearts. Mean values for these cells are shown in 
table 2.2 and fig. 2.5 and 2.6. Ca^  ^transients were prolonged at all frequencies in 
endocardial cells compared to shams. Prolongation was statistically significant at
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frequencies 0 . 1 - 2  Hz. transients were prolonged in epicardial myocytes only at 
higher frequencies (1-3 Hz), and statistical significance was only reached at 3 Hz. In 
all cells there was a marked frequency-dependant shortening of transients. In 
myocytes from heart failure animals, Ca^  ^transients were longer in endocardial cells 
than epicardial cells at 0.1 and 0.3 Hz (p<0.05), but there were no differences at 
higher stimulation rates. There were no significant differences in transient length 
between endocardial and epicardial cells in sham operated animals.
In all cells there was a marked reduction in Ca^  ^transient duration with increasing 
frequency of stimulation.
Expt.
(a) Endocardial cells
Sham
Mean
SEM
0.1 Hz 0.3 Hz 1 Hz 2 Hz 3Hz
533.5 563.2 364.8 229 172.6
38.9 34 15.8 4.6 2
<0.05 <0.01 <0.01 <0.01 >0.05
0.1 Hz 0.3 Hz 1 Hz 2 Hz 3Hz
402.2 431.7 299.4 211.4 167.7 
47.8 40.6 14.9 5.3 3.7
(b) Epicardial cells
Mean 411.7 458.6 348 225.6 172.5
SEM 45.2 38 20.7 5,9 2.3
P >0.05 >0.05 >0.05 >0.05 <0.05
440.7 439.5 326.5 213.5 163.7 
41 31.7 14.3 4.7 2.8
Table 2.2 Mean Dg,, values for endocardial and epicardial myocytes. All times are in ms. 
Probabilities are compared to sham cells at the same frequency.
2.2.5 Peak systolic Fura-2 ratios.
Peak systolic Fura 2 ratios were measured in 54 endocardial and 31 epicardial 
cells at 0.1- 3 Hz from 10 experimental hearts, and in 34 endocardial and 31
26
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epicardial cells at the same frequencies from 6  sham operated hearts. Mean values 
for these cells are shown in table 2.3 and fig. 2.7 and 2.8.
Peak Ca^  ^release was strongly related to frequency in both endocardial and 
epicardial myocytes from sham animals. Increasing frequency from 0.1 to 0.3, 1, 2 
and 3 Hz, caused increases in peak Fura 2 ratios of 3.5%, 24.1%, 58.6% and 92.4% 
respectively in endocardial cells, and of 4.0%, 17.2%, 37.5% and 58.0% in 
epicardial cells. This is analogous to the positive force-frequency relationship seen in 
cellular contraction. Peak Fura-2 ratio was higher in endocardial cells at all 
frequencies studied, this difference reached statistical significance at higher 
frequencies (1-3 Hz).
The frequency related increase in peak Ca^ "^  release was blunted in both 
endocardial and epicardial myocytes from heart failure animals. Peak Fura-2 ratios 
were significantly lower at all frequencies in endocardial myocytes from failure 
hearts compared to shams. Ratios were also lower in epicardial cells, but statistical 
significance was only reached at 3 Hz. Wlien frequency - associated increases in Fura 
2 ratios were normalised to peak level at 0.1 Hz, increases with higher stimulation 
rates were still blunted at 8 .8 % (p=ns vs control), 19.0% (p=ns), 36.22% (p<0.05) 
and 49% (p=0.01) in endocai'dial cells and 6.7%, 21.2%, 40.0% and 54.5% in 
epicardial cells (all ns vs control). In cells from failing hearts, endocai'dial Fura 2 
ratios were also higher than those from epicardial cells, but these differences were 
not significant.
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(a) Endocardial cells
Expt. Sham
0.1 Hz 0.3 Hz 1 Hz 2 Hz 3Hz 0.1 Hz 0.3 Hz 1 Hz 2 Hz 3Hz
Mean 1.02 1.07 1.18 1.36 1.48 1.43 1.47 1.74 2.13 2.5
SEM 0.06 0.06 0.07 0.09 0.1 0.13 0.13 0.15 0.18 0.21
P <0.001 <0.001 <0.001 <0.001 <0.001
(b) Epicardial cells
Mean 0.94 0.99 1.09 1.24 1.35 1.15 1.18 1.33 1.57 1.78
SEM 0.08 0.08 0.08 0.09 0.09 0.12 0.12 0.13 0.17 0.19
P >0.05 >0.05 >0.05 >0.05 <0.05
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:"77,IilTable 2.3 Mean Peak Fura 2 ratios for endocardial and epicardial myocytes. Probabilities are compared to sham cells at the same frequency.
2.2.6 End diastolic Fura 2 ratios.
End diastolic Fura 2 ratios were measured in 54 endocardial and 31 epicardial
cells at 0.1- 3 Hz from 10 experimental hearts, and in 34 endocardial and 31 
epicardial cells at the same frequencies from 6  sham operated hearts. Mean values 
for these cells are shown in table 2.4 and fig. 2.7 and 2.8.
End diastolic Fura 2 ratios rose with increased frequency in both endocardial and 
epicardial myocytes from sham hearts. Normalised increases from 0.1 to 0.3, 1, 2, 
and 3Hz were 4%, 15%, 38% and 58% in endocardial cells and 4%, 14%, 28% and 
49% in epicardial cells. There were similar increases in cells from failing hearts of 
4%, 15%, 30% and 45% in endocardial myocytes and 5%, 16%, 30% and 48% in 
epicardial myocytes. Comparing end diastolic results between failure and sham cells
1;
' s 'h'i|
:
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showed no difference in epicardial cells, and endocardial cells at low frequencies, but 
levels were significantly higher in endocardial sham cells at 2 and 3 Hz.
(a) Endocardial cells
Expt. Sham
0.1 Hz 0.3 Hz 1 Hz 2 Hz 3Hz 0.1 Hz 0.3 Hz 1 Hz 2 Hz 3Hz
Mean 0.67 0.7 0.77 0.87 0.97 0.72 0.75 0.83 0.99 1.14
SEM 0.03 0.03 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.05
P >0.05 >0.05 >0.05 <0.05 <0.01
(b) Epicardial cells
Mean 0.63 0.66 0.73 0.82 0.93 0.72 0.75 0.82 0.92 1.07
SEM 0.06 0.06 0.06 0.06 0.06 0.04 0.05 0.05 0.05 0.06
P >0.05 >0.05 >0.05 >0.05 >0.05
kl
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Table 2.4 Mean end diastolic Fura 2 ratios for endocardial and epicardial myocytes. 
Probabilities are compared to sham cells at the same frequency.
2.2.7 Amplitude of transients.
Given the fact that there are differences in both systolic and diastolic Fura 2 ratios 
between cells fiom failing and sham hearts, it is important to establish whether the 
amplitude of Ca^  ^transients differs in failure and sham cells. Table 2.5 shows these 
amplitudes calculated by subtracting diastolic from systolic Fura 2 ratios in 
individual cells. All cells show a positive ampiitude-frequency relationship, but this 
is blunted in cells from failure hearts. Amplitude is significantly reduced in failure 
endocardial myocytes compared to sham cells. The reduction in amplitude seen in 
epicardial myocytes is only significant at 3 Hz. In sham cells the amplitude of Ca^ ^
29
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transients was significantly greater in endocardial than epicardial cells (p<0.05 at all 
frequencies). There was no significant difference in amplitude between Ca^  ^
transients from endocardial and epicardial regions in cells from failing hearts.
(a) Endocardial cells
Expt. Sham
0.1 Hz 0.3Hz 1 Hz 2 Hz 3Hz 0.1Hz 0.3Hz 1 Hz 2 Hz 3Hz
Mean 0.36 0.39 0.42 0.49 0.54 0.72 0.74 0.93 1.16 1.37
SEM 0.03 0.03 0.04 0.06 0.08 0.11 0.11 0.14 0.17 0.21
P <0.001 <0.001 <0.001 <0.001 <0.001
(b) Epicardial cells
Mean 0.31 0.33 0.36 0.42 0.42 0.42 0.41 0.5 0.63 0.69
SEM 0.03 0.04 0.04 0.04 0.04 0.09 0.08 0.1 0.13 0.15
P >0.05 >0.05 >0.05 >0.05 <0.05
i
I
i
Table 2.5 Mean amplitudes of Ca^  ^transients from endocardial and epicardial myocytes.
Probabilities are compared to sham cells at the same frequency.
2.3 Discussion.
Background studies in intact myocytes thus confirm abnormal Ca^  ^handling in 
this model of heart failure. Previous studies linking abnormal Ca^ "^  handling to both 
contractile and lusitropic dysfunction in heart failure suggest that the altered Ca^ ' 
handling seen in these cells contributes to the impairment of ventricular function 
documented in vivo.
30
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t2.3.1 Systolic dysfunction.
Previous studies have shown reduced peak tension development and reduced rate
'4of tension development in failing myocardium. This has been shown in both muscle 4L
strip studies (Hasenfuss et al. 1992) and single cell studies (Davies et al. 1995). Data f
(1*from intact cells in the present study support these findings. Tension development 
and rate of tension development depend upon the increase in cytosolic Ca^  ^
concentration produced from sarcolemmal transport and sarcoplasmic reticulum
I
release and the rate at which these processes occur at the onset of systole. In this Istudy peak [Ca^ ]^ and rate of rise of [Ca^ ]^ were reduced at all frequencies in f
endocardial cells and at higher frequencies in epicardial cells. (A caveat in 
acceptance of the Tgo data is that measurements are approaching the limit of the 
systems temporal capacity, given that the spinning wheel allowed sampling at 60Hz.)
Similarly several studies have shown a blunting of the positive force frequency 
relationship in heart failure (Schwinger et al. 1993; Schmidt et al. 1994). This is 
reflected in the crurent study in the blunting of the increased Ca^  ^release as 
frequency increases, notably in endocardial cells, but also in epicardial cells at high 
frequencies.
■ I -Dimensions of all cells were measured to asses whether peak Ca^ ^  release was a |
simple function of cell size. Clearly a reduction in systolic Ca^ "^  release in cells from
Iheart failure animals can not be explained in this way since heart failure cells were 
significantly larger from both endocardial and epicardial regions from heart failure
1animals. In both failure and sham animals there was no relationship between cell size f|
and peak Ca^ .^ This is shown for endocardial cells in fig. 2.9.
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The possible pathophysiological processes underlying the abnormalities of 
systolic Ca^  ^release include both abnormal sarcolemmal and SR Ca^  ^handling. At 
the sarcolemmal level, the most important effector of Ca^  ^influx is the L-type Ca 
channel. Several studies have found reduced density of the L-type Ca^  ^current in 
animal models of cardiac hypertrophy and failure (Ming et a l 1994; Ouadid et a l 
1995; De Brito Santos et a l 1995) although no reductions in Ca^  ^current density 
have been found in myocytes isolated from failing human hearts (Mewes & Ravens,
1994; Beuckelmamr et a l 1992). Since sarcolemmal Ca^  ^entry contributes a smaller 
fraction of the systolic increase in cytosolic Ca^  ^than SR release (Tada & Kadoma,
1997), it would seem unlikely, however, that a reduction in the L-type Ca^  ^current 
alone would cause the decreases seen in systolic Ca^  ^release. Since Ca^ '^ entry 
tlirough the L-type chamiel is the initiating step in the release of a larger SR store of 
Ca^  ^it is possible that a reduction in this Ca^  ^current could cause the observed 
slowed release of Ca^ .^ A fmlher explanation for this slowed release of Ca^  ^could be 
a reduction in the efficiency of the link between sarcolemmal entry and Ca^^^-induced 
Ca release. This could be explained by an increase in the spatial separation of the L-
;
type chamiel and the ryanodine receptor, or by a detuning of the gain of the signal 
.transduction process (Caimell e/a/. 1997).
A reduction in the expression of SERCA 2A as described in some previous 
studies (Currie & Smith, 1999; Hasenfuss et a l 1994; Kiss et a l 1995) could
'
contribute to reduced SR Ca^ "^  release secondary to reduced SR Ca^  ^ stores as 
measured by Darvish (Darvish & Moravec, 1994). A reduction in levels of the 
ryanodine receptor (Brillantes et a l 1992) could also explain both the reduction in 
Ca^  ^release and slowed rate of release. il
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Any of the above mechanisms causing reduced systolic Ca^  ^release would 
contribute to the blunted relationship of Ca^  ^release with frequency. Phosphorylation 
of phospholamban is also thought to contribute to the force-frequency relationship 
(Colyer & Wang, 1991). Increased phosphorylation removes the inhibitory regulation 
of phospholamban on SERCA 2A, thus increasing diastolic Ca^ "" uptake and SR Ca^ "'
I
content. This mechanism may be less effective in heart failure, if basal
. .*■
phospholamban phosphorylation is increased (Currie & Smith, 1996). This :*y;
hypothesis is consistent with previous findings that the positive inotropic action of 
isoprenaline and cAMP analogues is reduced in failing myocardium (Harding et a l
I
1992b). 4y
2.3.2 Diastolic dysfunction.
The predominant finding from these experiments in intact myocytes, is that there 
is slowed diastolic re-uptake of Ca^ "^  as indicated by prolonged Ca^ '^  transients in 
myocytes from failing myocardium. As with findings of systolic dysfunction, this is 
more marked in endocardial myocytes than in epicardial myocytes. During diastole,
Ca^  ^ is removed from the cytosol by re-uptake into the SR, effected by SERCA 2A, 
and extrusion across the sarcolemma by the sarcolemmal Ca^  ^- ATPase and the Na‘^~
Ca^  ^exchanger. As with Ca^  ^release, SR re-uptake processes are quantitatively more 
important than sarcolemmal extrusion processes in mammalian myocardium (Tada &
Kadoma, 1997).
On an individual cell basis, there was no relationship between cell area and 
duration of Ca^  ^transients. This shows that slowing of diastolic Ca^  ^re-uptake is not 
a simple function of increase in cell size during the remodelling process. This is 
shown for endocardial cells in fig 2 .1 0 .
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As discussed in the introduction, the strongest evidence from previous studies is 
that the cause of abnormal Ca^ "" handling in heart failure is abnormal function of or 
expression of SERCA 2A, and evidence for abnormal sarcolemmal extrusion of Ca^  ^
is unconvincing. Reduced SERCA 2A expression or function therefore seems the 
most likely explanation for the prolongation of Ca^  ^transients seen in this rabbit 
model of heart failure. Since a reduction in SERCA 2A activity can also explain the 
findings of abnormal systolic Ca^ "^  handling, this is a possible unifying hypothesis for 
the changes seen in these cells.
The difficulty in accepting this hypothesis, however, is the finding that diastolic 
[Ca^^] is not raised in failing cells in this study, even at high stimulation rates. Raised 
diastolic [Ca^ ]^ has been found in some previous studies (Gwatlimey et a l 1987; 
Beuckelmaim et a l 1992), though others have found normal diastolic levels 
(Perreault et a l 1992). If the sole or prime defect in Ca^ "^  handling in heart failure 
were reduced activity in SERCA 2A, causing reduced diastolic Ca^ "*" re-uptake, and a 
secondary reduction in SR Ca^ "^  content, an expected finding would be that diastolic
■Ca^  ^ levels were raised, and this would be particularly true at high stimulation
frequencies. There are several possible explanations for this discrepancy.
(i) Up-regulation of the Na^ - Ca^  ^exchanger in heart failure may be a 
compensatory mechanism. Some previous studies have found increased activity 
(Hatem et a l 1994) and increased mRNA for the exchanger (Flesch et a l 1996; 
Studer et a l 1994). In this scenario, reduced SR Ca^  ^uptake would be compensated 
for by increased sarcolemmal extrusion, and diastolic [Ca^ ]^ would not rise. In order 
to avoid SR Ca^  ^depletion or overload, there must be overall Ca^ "*" balance during
■i
7
repeated contraction - relaxation cycles. This implies that if proportionately more
is extruded across the sarcolemma during diastole, unless an equivalent amount 
of increased Ca^  ^enters the cell during systole, there will be progressive SR Ca^  ^
depletion and final contractile failure. There is no evidence for increased L-type Ca^ '*' 
current in heart failure however. It is possible that the compensatory mechanism of 
increased extrusion of Ca^  ^through the exchanger is utilised during short periods of 
increased contraction frequency, incurring an effective Ca^  ^debt which is restored 
when contraction rates return to normal, but there is no evidence to support this 
hypothesis. In these experiments 2 min stimulation protocols were used at all 
frequencies of stimulation. During this period cells appeared to be in steady state, 
with no reduction in amplitude or increase in diastolic [Ca^ ]^ towards the end of the 
stimulation period.
(ii) Reduction in the activity of SERCA 2A prolonged Ca^  ^transients, but there 
was sufficient activity to attain normal cytosolic [Ca^ ]^ by end-diastole. Those studies 
which have found increased diastolic [Ca '^ j^ have been performed in end stage heait 
failure, in heai ts explanted at the time of cardiac transplantation (Gwatlmiey et al 
1987; Beuckelmann et a l 1992). The post-infarct model of heart failure in the rabbit 
is a less severe model of heart failure, indicated by a more modest reduction in 
ejection fraction (aroimd 70% to 40%), and low mortality in rabbits which survive 
the peri-operative period (Pye et al 1996). If myocardial function is depressed less 
than in other studies, it is possible that there is a concomitantly smaller reduction in 
SERCA 2A activity, and this smaller reduction may have the observed effect o f only 
prolonging Ca^  ^transients, and not affecting end-diastolic [Ca^^j. This hypothesis is 
reasonable, but if correct means that although diastolic SR Ca^ "^  accumulation would 
be slowed, there would be no effect on total SR Ca^  ^accumulation in diastole, and
35
reduced SERCA 2A activity alone would not explain the reduction in systolic Ca^ '*' 
release.
(iii) The stimulation frequency may have been too low to cause cytosolic Ca^  ^
accumulation in diastole. The experimental protocol encompassed a wide range of 
stimulation frequencies, from 0.1 Hz to 3Hz. However, 3Hz, while physiological in 
the rabbit, does not represent peak heart rate, and it is possible that higher stimulation 
frequencies would have further limited Ca^ "" re-uptake / extrusion and caused raised 
diastolic [Ca^^]. Again the difficulty with this hypothesis is that a partial reduction in 
SERCA 2A activity at relatively low stimulus rates, causing slowed Ca^  ^transients 
but not raised end-diastolic [Ca^ ]^ would not cause reduced SR Ca^' content, and 
again could not therefore account for the systolic dysfunction seen.
(iv) SR Ca^ "*" content / storage facility is chronically reduced in failing hearts. This 
hypothesis suggests that chronically reduced activity of SERCA 2A reduces the SR 
pool of Ca^  ^available for release, and the amount of Ca^  ^cycled through the SR 
during contraction and relaxation is permanently reduced. In this new steady state, 
reduced SERCA 2A activity causes prolonged Ca^  ^transients, but since total systolic 
Ca^  ^released is smaller, slower re-uptake does not cause end-diastolic [Ca^  ^] to be 
raised. Previous findings that levels of calsequestrin are unaltered in heart failure 
argues against this hypothesis(Meyer et al. 1995; Movsesian et al. 1994).
In summary, the finding that end-diastolic [Ca^ ]^ is not raised, despite impaired 
diastolic Ca^  ^handling indicates that reduced activity of SERCA 2A is insufficient to 
explain both the diastolic and systolic dysfunction in Ca^  ^handling seen in these 
cells, and that other alterations in sarcolemmal and / or SR Ca^  ^handling must also 
be present.
36
The effects of these cellular abnormalities of diastolic handling would be to 
cause lusitropic dysfunction at the whole heart level. In vivo, diastolic dysfunction
•4
would cause decreased ventricular compliance and slowed diastolic relaxation. A 
secondary effect of diastolic dysfunction would be to reduce ventricular filling, and 1
therefore cardiac output.
2.3.3 Correlation of observed changes with left ventricular function.
If the changes observed in Ca^  ^handling in cells from failing hearts reflect
pathophysiological processes, and are not simply epiphenomena, it should be |
4
possible to correlate these changes with indices of left ventriculai' function. Fig. 2.11 
shows the relationship between ejection fraction and Ca^  ^transient duration in 
endocardial cells stimulated at IHz. Fig. 2.12 shows the relationship between peak 
Ca^  ^ release and ejection fraction in endocardial cells stimulated at 3Hz. In both cases 
there were weak ( R= -0.42 and R= 0.38 respectively) but statistically significant 
correlations ( p< 0 .0 0 1  for both).
This poor correlation between ejection fraction and cellular measurements may
1
reflect inherent difficulties in measuring ejection fraction using echocardiography,
I
where even the intra-observer error may be as high as 6 % in the rabbit (Pye et al. f
1996). Other possible explanations include cell heterogeneity within both 
experimental and sham populations, since some mid-myocardial (M) cells (which 
have different eiectrophysiological properties, and therefore possibly different Ca^  ^
handling) may have been inadvertently sampled when endoeardial and epicardial 
layers were separated during the dissociation procedure. Following infarction it is
lipossible that remodelling and cell death changes in the ventricular wall change the i||
relative thickness of the sub-endocardial, sub-epicardial and mid-myocardial layers,
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thus M cell contamination may contribute different numbers of cells in experiments 
from sham and failure hearts. Finally it is difficult to exclude differential cell 
isolation from any single cell experiment. Since there is appreciable cell death during 
the isolation procedure, it is possible that a population of relatively healthy cells are 
isolated from failing hearts, thus diluting the extent of cellular changes in the 
population available for study.
2.3.4 Differences between endocardial and epicardial myocytes.
Clear differences are evident between the abnormalities of Ca^  ^transients seen in 
endocardial and epicardial myocytes from failing heaits. In general changes are more 
marked in endocardial cells, and tend to be present at all stimulation frequencies. In 
epicardial cells, abnormalities are only present at higher stimulation frequencies. 
These patterns are similar in both Ca^  ^transient duration measurements, levels of 
systolic Ca^  ^release and Ca^  ^transient amplitude, suggesting that there are real 
differences in abnormalities of handling in heart failure in myocytes from 
different sites in the ventricular wall.
Previous studies in this model have confirmed that there is left ventricular 
remodelling post-infarction, with an increase in left ventricular mass (Ng et a l 1998). 
The finding in this study that endocardial myocytes were longer but not wider in 
failure cells than sham cells, and that epicardial myocytes were both longer and wider 
suggests that the remodelling process is not uniform throughout the ventricular wall. 
This may reflect different adaptive mechanisms in endocardial and epicardial 
regions, or adaptation to different stresses or degrees of stress. In the normal heart 
tissue systolic pressure is not uniform throughout the thickness of the ventricle.
There is an increasing pressure gradient from the epicardial surface to the
38
endocai'dium (Wong & Rautaharju, 1968; Kirk & Honig, 1964). This is reflected in 
higher systolic and diastolic cytosolic [Ca^ ]^ in endocai'dial than epicardial regions 
(Figueredo et al. 1993).It is thus possible that during ventricular remodelling and 
dilatation, increasing wall stress may affect Ca^  ^handling in endocardial cells to a 
greater extent or at an earlier stage in the remodelling process in endocardial than 
epicardial cells. It has also been shown that there is reduced sub-endocardial 
coronary blood flow reserve in the presence of left ventricular hypertrophy (Hittinger 
et al. 1995). This may be a further reason why maladaptive responses in ventricular 
remodelling might be more evident in endocardial than epicardial cells.
2.4 Summary.
Experiments in intact myocytes have therefore confirmed abnormal Ca^  ^
handling in this model of left ventricular dysfunction. These abnormalities are 
slowing of diastolic Ca^  ^re-uptake, slowed systolic Ca^  ^release and reduced 
amplitude of systolic Ca^  ^release. The consequences of these abnormalities will be in 
both diastolic and systolic contractile dysfunction. Endocardial myocytes are more 
affected than epicardial cells, probably as a result of greater wall stress during 
ventricular remodelling. The mechanisms of the observed changes in Ca^  ^handling 
are most likely to include reduced activity of SERCA 2A, although it is difficult to 
explain all of the changes seen without invoking other mechanisms.
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Chapter 3 - Studies of SR load in permeabilised myocytes.
3.1 Background.
Studies in intact myocytes have therefore demonstrated abnormal Ca^  ^handling in 
the rabbit coronary ar tery ligation model of left ventricular dysfunction at the level of 
the whole cell. These studies do not allow firm conclusions as to the mechanism of 
abnormal Ca^  ^handling to be drawn. In particular it is not possible to differentiate 
between abnormalities of sarcolemmal Ca^  ^transport and SR function using this 
experimental preparation. As discussed previously, evidence from studies in several 
species, using various experimental preparations suggests that the most likely cause 
of abnormal Ca^  ^handling in heart failure is a reduction in activity of SERCA 2A, 
the SR Ca^ "^  pump. Following the characterisation of the abnormalities of Ca^  ^
handling at the whole cell level, the next stage of this work was to investigate the 
mechanisms underlying these changes. Since SR dysfmiction was the most likely 
mechanism, it was decided to examine SR function in isolation from sarcolemmal 
function in this model of heart failrue.
Several experimental preparations have been used to study SR function in heart 
failure. Ca^ "*" uptake in isolated SR vesicles has been measmed in several studies with 
conflicting results (Ohkusa et al. 1997; Movsesian et a l 1989; Schwinger et al.
1995). Many studies have also inferred SR dysfunction from alterations in measured 
mRNA and protein expression in heart failure (Stein «/. 1996; Matsui e/'a/. 1995; 
Kiss e ta l 1995; Schwinger era/. 1995; Arai era/. 1993; Mercadier 1990). 
While useful, the disadvantage of these types of experiment is that SR function is 
studied in isolation from the excitation contraction process, and the normal anatomy 
of the SR is disrupted. An alternative preparation which has been used extensively to
;
'4%
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study SR function in both smooth and skeletal muscle is the permeabilised or skinned f
tissue preparation (Isac et a l 1988; Suko et a l 1976; Endo et a l 1982). This 
preparation has several advantages. Mechanical or chemical skinning either removes
"’j
or permeabilises the sarcolemma, without disrupting the intracellular architecture.
This allows the metabolic and ionic conditions of the cytosol next to the SR to be 
controlled, and therefore loading of the SR can be measured at precisely controlled 
pH, Ca^^concentration and other metabolic conditions. Since the intracellular 
architecture is intact, the cell retains the ability to contract and relax. Skinned 
preparations are therefore useful for studying the mechanisms of excitation- 
contraction coupling distal to the sarcolemma.
Skinned cardiac muscle has been studied using trabeculae and other multicellular
;îpreparations (eg(Steele & Smith, 1993; Smith & Steele, 1992). Denvir has studied 
SR loading in permeabilised ventricular trabeculae from rabbits with left ventricular 
dysfunction (Denvir et al 1996) and from humans with heart failure (Denvir et a l |
1995). The use of multicellular preparations, however, is hampered by limitations of 
diffusion which become significant at >50pm diameter. In effect, multicellular 
skinned preparations behave as a chemical syncytium, without the normal, rapid 
electrical coupling. In addition to this, individual cells within multicellular 
preparations can display heterogeneity of SR function and of metabolic conditions,
for example in the core of trabeculae.
■T'Permeabilised single myocytes do not suffer from these limitations. There have 
been previous reports of the use of skinned single cardiac myocytes. Fabiato 
(Fabiato, 1982) developed techniques for the mechanical skinning of single cardiac 
myocytes, but these tecliniques were difficult to apply. Bers (Hove-Madsen & Bers,
ï
%1993b; Hove-Madsen & Bers, 1993b) has studied SR Ca uptake in suspensions of f
chemically skimied myocytes. This thesis is believed, however, to be the first
54
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substantive work on chemically skinned single cardiac myocytes. |
The permeabilised single myocyte preparation is suited to the study of SR M
function in isolation from changes in sarcolemmal Ca^”^ transport. As an integrated 
subcellular preparation it is more physiological than isolated SR vesicle preparations, M
but is simpler and has fewer confounding factors than trabeculae or other 
multicellular cardiac preparations. Studies of SR function were therefore undertaken 
in permeabilised single myocytes from the rabbit model of left ventricular 
dysfunction described in chapter 2.
.Is
3.2 Methods. 
3.2.1 Dissociation of ventricular myocytes.
'.iSingle ventricular myocytes were dissociated from experimental and sham- 
operated rabbit hearts as described in section 2.1.2. Cells were isolated from all
regions of the left ventricular myocardium and not separated into endocardial,
IIepicardial and mid-myocardial fractions. Following dissociation, cells were
Issuspended in 0.1 relaxing solution (O.IR), a mock intracellular solution with Ca^  ^
concentration buffered to around 50nM with EGTA at pH 7.0 (see appendix 1 for ''ii
exact composition), and stored at room temperature until use.
'13.2.2 Pcrmcabiiisation of myocytes.
Cells were then placed in a 250pl perfusion chamber mounted on an inverted :f
-INikon Diaphot microscope as before, and perfused with 1ml min of O.IR at room 
temperature. In early experiments it was found that permeabilised cells were less
%.'15
adherent to the cover slip than intact cells, and tended to float out of the field of 
vision during perflision and particularly when caffeine was injected. To prevent this, 
cells were held in place by anchoring with a blunt, sealed micro-electrode positioned 
onto the cell with a micromanipulator (Narashige Instruments, Japan). Adhesion of 
the cell to the electrode was improved by coating the electrode in Celltak 
(Collaborative Biomedical Products). This also formed a barrier on the electrode 
which prevented leeching of Ca^  ^from the glass of the electrode. The experimental 
apparatus is shown in fig. 3.1. A micropipette was placed within the field of vision 
of the microscope close to the cell. This micropipette was attached to foui’ syringe 
drivers controlled fiom a personal computer using the program DT (Francis Burton 
1990). The first syringe contained O.IR with lOOpg ml"^  P-escin (final concentration 
90nM). P-escin is a saponin ester which permeabilises cardiac sarcolemma to low 
molecular weight molecules by removing cholesterol moieties (Itoh et al. 1991). p- 
escin has little or no effect on the membranes of intra-cellular organelles since these 
membranes contain little cholesterol and therefore permeabilised cells retain an 
active SR component (Konishi & Watanabe, 1995). Permeabilisation of the 
sarcolemma of the myocyte was achieved by rapid injection of 5-1 OpL of the p-escin 
solution close to the cell surface. In early experiments the effect of P-escin was 
monitored by pre-incubating myocytes with membrane permeant Fura-2 AM. 
Permeabilisation of the sarcolemma was confirmed in these cells by a loss of 
fluorescence. The lack of effect o f p-escin on the SR membrane was also confirmed 
in an early experiment by exposing permeabilised cells to 1% Triton-X (Sigma 
chemicals) showing an increase in fluorescence as Ca^  ^stores were released from the 
SR on exposure to Triton but not p-escin.
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3.2.3 Stimulation of SR release.
Skimied preparations allow study of SR function in isolation from sar colemmal 
frinction. Since the sarcolemma is permeabilised by the action of P-escin, the 
membrane potential is abolished, and myocytes camiot be stimulated electrically. SR 
Ca^ "^  release and hence cellular contraction can be stimulated in skinned preparations 
by exposure to millimolar concentrations of caffeine, which causes Ca^  ^release by 
increasing the open probability of the ryanodine receptor (Sitsapesan & Williams,
1990). In these experiments SR Ca^^release was stimulated by microinjecting 2-3pL 
of lOmM caffeine close to the cell via the micropipette. To avoid causing an injection 
artefact, this injectate had to have the exact composition of the perfrising solution in 
terms of Ca^  ^ and Fura-2 concentrations. Since the experimental protocol measured 
caffeine -induced SR Ca^  ^release at three different cytosolic Ca^  ^concentrations, it 
was necessary to use three syringe drivers coimected to the same micropipette with a 
very small terminal deadspace, so that different solutions could be injected through 
the same pipette with minimal mixing.
3.2.4 Experimental protocol.
Throughout all experiments cells were superfused at 1ml min"  ^with O.IR
containing lOpM Fura-2. Ca^  ^concentration was varied during the experiment by the
jf
addition of 10 mM CaClj (0-4 pi ml"^  - giving solutions of 50-250 nM Ca^ '^ ’•
concentration, referred to as solutions 0,1,2,3,and 4). Fluorescence was measured 
using a spectrophotometer at 30 Hz as described in section 2.1.3 and recorded on 
VHS videotape and chart recorder. The signal was digitised and recorded to disc 
using the program New Tape (Francis Burton 1990). Video image of cell contr action 
was simultaneously monitored on screen and recorded to videotape.
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Myocytes with clear cross striations and minimal membrane blebbing were 
selected for study. The field of view of the microscope was constrained to the area of
the cell being studied by a diaphragm on the output port of the microscope. The I
■,i:jcontribution to the signal of the bulk solution above the cell did not appear to depend 
on the depth of the bath, probably because the cell was in the focal plane of the 
microscope. Following anchoring, each cell was superfused for 2 minutes with
solution 1 (lOOnM [Ca^^) before being permeabilised by brief exposure to (3-escin. A ï
IItest injection of lOmM caffeine confirmed successful permeabilisation if cellular i
contraction was accompanied by a Ca^  ^transient, since Fura 2 does not cross the 
sarcolemma of intact cells. SR Ca^  ^release and cellular contraction were then 
stimulated at 2 min intervals by injection of 2-3 pi 10 mM caffeine via the 
micropipette described above. This protocol continued until reproducible caffeine- 
induced Ca^  ^transients were elicited. Caffeine-induced Ca^  ^transients were then 
measured in solution 0 (50nM [Ca^^ ) and then solution 2 (150nM [Ca^^) again at 2 
minute intervals until reproducible transients were obtained. Ca^  ^concentration in the 
injected caffeine solution was always equal to that in the perfusate to avoid injection
Iartefact. Thus caffeine-stimulated SR Ca^ "" release was measured at cytosolic Ca^  ^ #
concentrations from 50-150 nM. At higher cytosolic Ca^ "'" concentration, spontaneous 
SR Ca^  ^release occurred, and caffeine stimulation was umiecessary. Spontaneous 
Ca^  ^transients were then recorded for 2 mins during perfusion with solutions 3 and 4 
(200iiM and 250nM [Ca^^). Spontaneous Ca^  ^transients were therefore measured at 
200-250 nM cytosolic Ca^  ^concentration, but in most cells spontaneous Ca^  ^release
t
IIfirst occurred at cytosolic Ca^  ^concentrations of 100-150nM. Thus for many cells
results were available to compare caffeine-induced and spontaneous Ca release at I
5
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the same cytosolic Ca^  ^concentrations in solutions 1 and 2. A representative 
experimental trace showing caffeine-induced and spontaneous Ca^  ^transients is 
shown in fig. 3.2.
3.2.5 Calibration of cytosolic Ca  ^ concentration
Use of Fura 2 acid in permeabilised cells allows precise measurement of 
Ca^^concentration, since calibration curves can be plotted of Fura 2 ratio against 
Ca^^concentration. The relationship of Ca^^concentration to Fura 2 ratio is sigmoid, 
and is described by the equation:
R-R
C a ^ + =  K g x
I^max ■ ^
[1]
where R is the measured Fura 2 ratio, R„,i„ is the ratio in Ca^^-ffee solution, is the 
ratio at saturating Ca^^concentration, and K is constant (Grynkiewicz et al. 1985).
A calibration curve of Fma 2 ratios against Ca^^concentration was plotted. 
Ca^^concentration was varied by combining different ratios of 10 mM EGTA and 10 
mM CaEGTA. Ca^^concentration in these solutions was calculated using the program 
React (Godfrey Smith 1990). A curve was then fitted to the data points using the 
equation:
( t )IT ■ '  \  —max —mm
l+XxK„ p]
(from (Grynkiewicz et al. 1985)). Here Y (Fura 2 ratio) is a function of X
(Ca^^concentration) dependant on the constants R„,;„ and K g . The cuiwe was
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fitted by iterative variation of these constants until the best fit was found. This was 
done using the program Origin (Microcal Software). Using the constants calculated 
from this curve fitting, Ca^^concentration could then be calculated from any given 
Fura 2 ratio using equation [1]. The calibration curve is shown in fig. 3.3. The 
constants given by this curve were:
Rmm 0.531 
Rmax 9.068 
Kg 1.517 X 10 "
3.3 Results.
3.3.1 Measurement of background Ca concentration.
UEGTA was used in all solutions at a concentration of 0.1 mM to buffer ICa^^concentration to very low levels. Free Ca^^concentration in these experiments Iwas designed to range from sub-diastolic levels (around 50nM) to levels approaching 
those seen during systole (200-300nM). Using the program REACT the theoretical 
free Ca^^concentration of O.IR with no added Ca^  ^was calculated to be of the order 1of 50nM. Adding 1 pi mb' 1 OmM CaCl^ was calculated to raise free 
Ca^^concentration by around 50nM, giving a range of free Ca^^concentration for the
Iexperiment from 50-250nM by adding 0-4 pi ml lOmM CaClj. (For the pui'poses of 7
these calculations, the contaminant Ca^^concentration of de-ionised water in this '
laboratory has previously been measured using a pH metric technique (Moisescu &
Pusch, 1975) to be 5.6 ± 0.35pM and using similar techniques the purity of EGTA '
■t:
has been measured to be 97%. Free [Mg^^] for these experiments was ImM).
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Using the Fura-2 Ca^^concentration calibration curve described above, 
Ca^^concentration in all experimental solutions was measured. The mean results for 
solutions used for ligation and sham experiments are shown in table 3.1.
Ligation Sham
Calcium Mean SEM Mean SEM P
0 16.0nM 5.7nM 16.6nM 6.7nM 0.47
1 50.1nM 6.8nM 50.6nM 9.9nM 0.48
2 86.0nM 9.3nM 74.2nM 15.2nM 0.25
3 154.6nM 15.9nM 129.1nM 28.1 nM 0.2
4 217.0nM 19.8nM 195.4nM 38.4nM 0.29
Tab 3.1: Mean Ca^*concentration measured by Fura-2 fluorescence for solutions used in 
skinned cell experiments. Calcium is added in aliquots o f 0-4 p i mC o f lOmM CaClz.
As can be seen from table 3.1, Fura-2 measui'ements of Ca^^concentration 
consistently underestimated theoretical calculated Ca^^concentration, however there 
were no significant differences between the mean Ca^ '*' concentration of solutions 
used for ligation and sham experiments. The differences between measured Ca^  ^and 
theoretical calculated Ca^  ^may reflect buffering of Ca^  ^ by cells themselves (which 
were not present in calibration solutions), or small changes in solution composition 
due to cellular metabolites.
3.3.2. Caffeine-induced Ca^  ^transients.
Peak Ca^^concentration following caffeine injection was measured for all cells in 
solutions containing 0,1 and 2 pi ml'^ lOmM CaClj. These will be referred to as
6 0
solution 0,1 and 2 respectively. The amplitude of the Ca^  ^transient produced by 
caffeine injection was calculated as the rise in measured Ca^^concentration. This 
measurement rather than an integral of Ca^  ^release throughout the transient was used 
since the duration of the Ca^  ^transient produced by caffeine injection depended upon 
the length of time the cell was exposed to caffeine. Exposure time of the cell to 
caffeine depended upon the rate at which caffeine diffused away from the cell 
following injection. This varied between experiments and depended upon the depth 
of the bath and the exact placement of the injection cannula with respect to the cell. 
These factors could not be standardised between experiments, but should not have 
affected the amplitude of the Ca^ "^  transient, in particular, small movements of the 
injection cannula did not qualitatively affect peak Ca^  ^release. For these reasons, and 
because some SR Ca^  ^re-uptalce can occur even in the presence of caffeine (Smith & 
Steele, 1998), measurement of the peak Ca^  ^release rather than the integral of Ca^  ^
release was used as a surrogate measure of SR load. Experiments were first 
undertaken in stock animals to investigate the validity of this approach. Figure 3.4 
shows that within free Ca^  ^concentrations studied in these experiments, there is an 
approximately linear relationship between cytosolic Ca^'^concentration and the 
amplitude of caffeine-induced Ca^ '*' transients, suggesting that amplitude of Ca^  ^
release is a reasonable measure of SR load.
3.3.3 Caffeine response in heart failure and sham cells.
Experiments were undertaken in 37 cells from 11 experimental hearts, and in 38 
cells from 13 sham hearts. In 8 cells (21.6%) from experimental hearts caffeine- 
induced Ca^  ^transients could not be elicited at any of the three cytosolic 
Ca^^concentrations studied. This was the case in only one cell (2.6%) from sham
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operated hearts. Successful permeabilisation was confirmed in all o f these cells by 
observing spontaneous cell contraction with associated Ca^  ^transients in higher 
Ca^  ^concentration solutions. Failure of these cells to respond to caffeine may 
therefore have reflected poor placement of the caffeine-injection camiula, although in 
all but one experiment, other cells produced adequate transients with the same 
placement of the cannula. There was therefore a significantly higher percentage of 
cells from experimental hearts which failed to respond to caffeine (p<0.01). This 
difference did not remain significant if the experiment where no cells from one heart 
responded to caffeine was removed from the analysis (p=0.06).
In addition to the cells which did not respond to caffeine at any cytosolic 
Ca^^concentration, there were a number of cells from both failure and sham hearts 
that did not respond to caffeine at all cytosolic Ca^  ^concentrations. Cells were most 
likely to respond to caffeine in higher Ca^^concentration solutions. Excluding cells 
which did not respond to caffeine at any Ca^^concentration, 62.1% of cells from 
ligation hearts responded to caffeine in solution 0. A significantly greater fraction of 
cells from sham operated hearts responded to caffeine in solution 0 (83.8% p<0.05). 
For solutions 1 and 2, similar numbers of cells from experimental and sham hearts 
responded to caffeine (96.6% vs 91.9% for solution 1 and 96.6% vs 97.3% for 
solution 2).
There are two possible explanations for cells which did not respond to caffeine 
at low cytosolic Ca^^'concentration. The first explanation is that this represents a true 
failure to respond to caffeine, reflecting low SR Ca^ "^  load. It is difficult, however, to 
discount the possibility that the amplitude of Ca^  ^transients elicited by caffeine- 
injection in these cells was too low to be detected above the background noise.
62
Visual inspection of these cells for contraction was difficult as during caffeine 
injection there was a small movement artefact of the cell, and so small contractions 
could also be missed.
3.3.4 Amplitude of caffeine-induced transients.
The amplitude of caffeine-induced Ca^  ^transients for experimental and sham 
cells for solutions 0, 1 and 2 are shown in table 3.2. Data shown are mean ± SEM for 
37 cells from 11 experimental hearts and from 38 cells from 13 sham operated hearts. 
Mean amplitudes of caffeine-induced Ca^ "^  transients were significantly greater in 
cells from sham hearts at all tlrree cytosolic calcium concentrations. As with 
preliminary results from stock animals, in sham cells there was a positive 
relationship between cytosolic Ca^^concentration and the amplitude of caffeine- 
induced Ca^  ^transients. This relationship was blunted in cells from experimental 
hearts. This is also shown in fig. 3.5.
Ligation Sham
Calcium Mean SEM Mean SEM P
0 22.3nM 3.4nM 34.1 nM 3.8nM <0.05
1 35.5nM e.OnM 56.5nM 6.5nM <0.05
2 39.3nM 6.3nM 61.4nM 9.5nM <0.05
Table 3.2: mean amplitude o f caffeine-induced Ca^  ^transients 
in cells from ligation and sham hearts.
3.3.5 Spontaneous activity.
Again data were available from 37 cells from 11 experimental hearts and from 
38 cells from 13 sham operated hearts. Any cells which did not respond to caffeine
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and did not show any spontaneous activity were discarded and not included in any 
analysis. Spontaneous contraction with associated Ca^^transients was not seen in any t |
cells in solution 0. No spontaneous activity was seen in 9 cells from sham hearts 
(23.7%) at any cytosolic Ca^^concentration. Similarly there was no spontaneous 
activity at any Ca^^concentration in 10 cells from experimental hearts (27.0%, p =
U .S .). The integrity of the contractile response in these cells and their successful 
permeabilisation was confirmed by the presence of contraction with associated 
transients during caffeine injection.
Spontaneous activity was observed in increasing number of cells from both
failing hearts and sham operated hearts as cytosolic Ca^^concentration increased. #
Excluding cells with no spontaneous activity at any Ca^^concentration, 48.3% of
'I
sham cells were spontaneously active in solution 1 compared to 14.8% of %
experimental cells (p<0.01). Figures for solution 2 were 75.9% and 44.4% (p<0.01).
There was no difference between sham and experimental cells in solution 3 (93.1% 
vs 88.9%, p = U .S .) or solution 4 (93.1% vs 96.3%, p = n.s.).
3.3.6 Frequency of spontaneous activity.
The mean frequency of spontaneous Ca^  ^release and contraction for cells from T
experimental and sham operated hearts is compared in table 3.3 and shown in fig. |
3.6. Frequency increases with increasing cytosolic Ca^^concentration in cells from 
both experimental and sham hearts. At low eytosolic Ca^^^concentration frequency of 
spontaneous Ca^  ^release is significantly greater in cells from sham hearts. This
II Idifference is not apparent at higher cytosolic Ca^^concentration (solutions 3 and 4). |
i
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and did not show any spontaneous activity were discarded and not included in any 
analysis. Spontaneous contraction with associated Ca^  ^transients was not seen in any 
cells in solution 0. No spontaneous activity was seen in 9 cells from sham hearts 
(23.7%) at any cytosolic Ca^^^concentration. Similarly there was no spontaneous 
activity at any Ca^^concentration in 10 cells from experimental hearts (27.0%, p = 
n.s.). The integrity of the contractile response in these cells and their successful 
permeabilisation was confirmed by the presence of contraction with associated Ca^  ^
transients during caffeine injection.
Spontaneous activity was observed in increasing number of cells frrom both 
failing hearts and sham operated hearts as cytosolic Ca^^concentration increased.
Excluding cells with no spontaneous activity at any Ca^^concentration, 48.3% of 
sham cells were spontaneously active in solution 1 compared to 14.8% of 
experimental cells (p<0.01). Figures for solution 2 were 75.9% and 44.4% (p<0.01).
There was no difference between sham and experimental cells in solution 3 (93.1 % 
vs 88.9%, p = n.s.) or solution 4 (93.1% vs 96.3%, p = n.s.).
3.3.6 Frequency of spontaneous activity.
The mean frequency of spontaneous Ca^  ^release and contraction for cells from 
experimental and sham operated hearts is compared in table 3.3 and shovm in fig.
i:;'
3.6. Frequency increases with increasing cytosolic Ca^^^concentration in cells from
.both experimental and sham hearts. At low cytosolic Ca^^concentration frequency of 
spontaneous Ca^  ^release is significantly greater in cells from sham hearts. This 
difference is not apparent at higher cytosolic Ca^^concentration (solutions 3 and 4).
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Ligation Sham
Calcium Mean SEM Mean SEM P
1 0.011hz 0.006 0.034hz 0.007 <0.05
2 0.031 hx 0.009 0.056hz 0.009 <0.05
3 O.OShz 0.014 0.094hz 0.013 >0.05
4 0.135hz 0.023 0.139hz 0.019 >0.05
Table 3.3: frequency o f spontaneous Ca^  ^release in cells from  
experimental and sham hearts.
3.3.7 Amplitude of spontaneous transients.
The amplitudes of spontaneous Ca^  ^transients for experimental and sham cells 
for solutions 1,2,3 and 4 are shown in table 3.4. Mean amplitude ± SEM was 
calculated only from cells which were spontaneously active at the given cytosolic 
Ca^^concentration. The number o f cells active and therefore used for calculation 
purposes is shown in the table. Mean amplitudes of transients were greater at all 
cytosolic Ca^^concentration in cells from sham hearts than from experimental hearts. 
This reached statistical significance for solutions 2, 3 and 4. As with caffeine- 
induced Ca^  ^transients, in sham cells there was a positive relationship between 
cytosolic Ca^^concentration and the amplitude of spontaneous Ca^  ^transients. This 
relationship was blunted in cells from experimental hearts This is shown in fig. 3.7, 
and amplitude of spontaneous Ca^  ^release is compared to that for caffeine-induced 
release in fig. 3.8.
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Ligation. Sham.
Calcium Mean SEM N Mean SEM N P
1 27.2nM 7.2nM 4 49.4nM 7.4nM 14 >0.05
2 37.5nM 4.3nM 12 68.4nM 9.2nM 22 <0.05
3 48.7nM 4.1 nM 25 73.4nM 10.4nM 27 <0.05
4 65.6nM 6.3nM 28 106.7nM 14.1nM 28 <0.01
Table 3,4 mean amplitude o f spontaneous Ca^  ^transients in cells 
from experimental and sham hearts.
3.4 Discussion.
3.4.1 Experimental preparation.
Experiments in intact myocytes confirmed the presence of abnormal Ca^”^ handling 
in this coronary artery ligation model of heart failure. The experiments described in 
this chapter were designed to provide more specific information on the site or 
mechanism of abnormal Ca^  ^handling. The permeabilised myocyte preparation 
allowed the investigation of SR function in isolation from any possible changes in 
sarcolemmal Ca^  ^transport.
While permeabilisation of the sarcolemma allowed specific study of SR function, 
this also led to the main drawback of this preparation, the inability to electrically 
stimulate the preparation. This meant that experiments in permeabilised cells could 
not be directly analogous to those in intact cells. In intact cells the effect of 
increasing the frequency of stimulation was studied, and showed that in normal cells 
increasing stimulation frequency caused an increase in the amplitude of Ca^ "^
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transients, analogous to the positive force-frequency relationship which has 
previously been correlated to increasing systolic Ca^  ^release (Pieske et al. 1995).
In permeabilised cells the effect of increasing stimulation frequency can not be 
directly assessed. In the current experiments what is investigated is the ability of the 
SR to load at different cytosolic Ca^  ^concentrations. These experiments show that as 
cytosolic Ca^  ^concentration increases, the amplitude of Ca^  ^release rises, and there 
is an increased frequency of spontaneous Ca^  ^release. This is relevant to the positive 
force frequency relationship as one of the mechanisms of increased contractile force 
at higher stimulation frequencies is a rise in diastolic Ca^  ^which promotes a rise in 
SR Ca^ '*^  content (reviewed in (Bers, 1991)). Diastolic Ca^  ^rises since increased 
stimulation frequency increases Ca^  ^influx through L-type Ca^  ^chamiels. There is a 
proportional reduction in the time spent in diastole and therefore reduced Ca^ "" 
efflux. From this it follows that the force frequency relationship depends upon the 
integrity of function o f the SR Ca^  ^pump, SERCA 2 A. If abnormal function of this 
pump underlies the abnormal Ca^  ^handling seen in heaif failure as seems most likely 
from the studies in intact cells described above and from evidence discussed in the 
introduction to this thesis, then investigation of the ability of the SR to load under 
different conditions of cytosolic Ca^^concentration is reasonable.
The natur e of the permeabilised myocyte preparation also means that the 
duration of Ca^  ^transients which was seen to be abnormal in intact cells could not be 
investigated in these experiments. In intact cells the decay of the Ca^  ^transient is 
effected by both SERCA 2A and Na^-Ca^^ exchange. In permeabilised cells, 
however, the decay depends upon both SR Ca^  ^uptake mediated by SERCA 2A and
a;'
diffusion of Ca^  ^away from the cell studied. Since the fraction of the decay mediated
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by diffusion cannot be quantified and this fraction will vary between experiments due 
to alterations in bath kinetics, it was not possible to make comparisons of the 
duration of Ca^  ^transients between cells using this preparation.
An additional benefit of this preparation however, was the opportunity to study 
spontaneous SR Ca^  ^release. Spontaneous SR Ca  ^ release is thought to reflect SR 
Ca^  ^overload (Lakatta, 1992), and may cause ventricular arrhytlimias by the 
production of delayed afterdepolarisations (Marban et a l 1986). Arrhythmias 
produced by this mechanism may be particularly important in heart failure 
(Vermeulen et al. 1994). Since cytosolic Ca^^concentration can be controlled directly 
in the permeabilised myocyte preparation, SR Ca  ^overload and spontaneous SR
Ca^  ^release can be readily produced. This preparation therefore allowed the 1relationship between SR Ca^  ^load and spontaneous SR activity to be compared in m
normal and failing tissue.
3.4.2 Loading characteristics of the SR in heart failure.
Caffeine-induced contracture of myocytes and trabeculae have been used 
previously to assay the Ca^  ^content of the SR (Bers, 1987). Implicit in these 
measurements is the assumption that caffeine causes the release of a high fraction of 
stored Ca^  ^and that this fraction is reproducibly released. Given the good agreement 71
between caffeine-induced Ca^  ^release and rapid cooling induced contracture results 
(Bers, 1987), these assumptions appear reasonable. In the current experiments the 
amplitude of the caffeine-induced Ca^  ^transient has been used as a measure of SR *|
Ca^  ^load or content. The alternative measure would have been to integrate the area ■'7
beneath the Ca^  ^transient, but this method cannot be used since this area is critically
=';idependent on bath flow, the characteristics of which vary between experiments. The T
I
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?linear relationship between cytosolic Ca^^concentration and Ca^  ^transient amplitude ÿ
as a measure of SR load shown in fig. 3.4 suggests that this is a valid approach. Thus
'ialthough SR Ca^  ^content can not be directly measured using these techniques, since 
amplitude of caffeine-induced transients depends upon SR Ca^  ^content, it can be 
used to compare SR Ca^  ^content in different cells under the same loading conditions.
Fig. 3.8 shows that at the same loading conditions caffeine-induced Ca^  ^transients Y
are generally larger than spontaneous transients, indicating that a greater proportion
of SR Ca^  ^is released during caffeine-stimulation than during spontaneous release.
ftThese differences are not significant, however, and mean amplitude of spontaneous
Irelease is also a valid comparative measure of SR load.
:Figs 3.5 and 3.7 show that imder the same loading conditions, spontaneous and
caffeine-induced Ca^  ^transients have significantly greater amplitude in sham cells y|
ft7compared to cells from failing hearts. The ratio of sham transient amplitudes to
failure amplitudes remains fairly constant across all loading conditions as shown in -7
table 3.5. ift
ft'ift..'fti
Ca2+ soin: ratio (sham : falling)
0 (caff) 1.529
1 (caff) 1.593
1 (spent) 1.817
2 (caff) 1.561
2 (spent) 1.825
3 (spent) 1.508
4 (spent) 1.626
mean 1.577 ± 0.050
Table 3.5 Ratios o f mean amplitude ofCa^^ release in cells from sham 
and failing hearts in different Ca^  ^solutions.
Amplitude of release is therefore in the order of 50-60% greater at all loading 
conditions in sham cells compared to failing cells. As discussed above, the 
implication of this is that SR Ca^ "^  content is greater by the same magnitude in sham 
cells than failing cells. The only alternative explanation of this would be that the 
fractional release of SR Ca^ "^  stores during caffeine stimulation or during spontaneous 
oscillation was different in heart failure.
Is it possible to differentiate between these two possibilities? A reduction in the 
fractional release of Ca^  ^during contraction could be mediated by a reduction in the 
numbers of SR Ca^  ^release channels. As discussed in chapter 1, there is 
contradictory evidence for such a reduction with some studies finding a reduction in 
mRNA (Go et al 1995; Arai et a l 1993) and cDNA (Brillantes et a l 1992) for the 
ryanodine receptor with others finding unchanged protein levels (Meyer et a l 1995;
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Movsesian et al. 1994). Since the amplitude of Ca^  ^release is approximately 60% 
higher in sham cells, it is possible to estimate the change in fractional Ca^  ^release in 
heart failure needed to explain this. If  SR Ca^  ^content is equivalent in heart failure 
and sham cells, and it is assumed that caffeine causes an 80% release of stored Ca^ '*’ 
in normal tissue, this figure must be reduced to 50% in heart failure to account for the 
reduced Ca^  ^release seen. Similarly if it is assumed that 70% of stored Ca  ^*^ is :g
released duiing a spontaneous contraction in normal cells, 43.8% would be released 
in failing cells. Brillantes (Brillantes et al. 1992) reported a 28% reduction in cDNA 7
for the ryanodine receptor in heart failure, which is of the order necessary to account
for the reduction in fractional Ca^  ^release that would be necessary to explain the
• l i 'smaller Ca^ "^  transients observed here. This seems unlikely, however, since studies
measuring actual ryanodine receptor protein levels have reported no change (Meyer
..ftîet a l 1995; Movsesian et al. 1994). However, studies in ferret myocytes have shown
::|that fractional release of stored Ca^  ^from the SR depends upon SR Ca^ *^  content, and 
that the fraction of Ca^  ^released rises as stored Ca^  ^increases (Bassani et al 1995). I
This suggests that if  SR Ca^  ^content was reduced in heart failure, there might be an 
additive effect on Ca^  ^release since a smaller fraction of the SR Ca^  ^store would be
'I:
released.
A reduction in the fraction of SR Ca^  ^released as a single explanation for the 
observed reduction in amplitude of Ca^ "^  transients seems unlikely when considered 
with the findings in this study with regard to spontaneous SR activity, however. T;
Denvir found that spontaneous SR Ca^'*'release was seen in skinned trabeculae I;
following long loading periods at high loading Ca^Toncentration, suggesting that 
spontaneous activity depended upon SR Ca^ '^  overload (Denvir et a l 1995). In the I
SERCA 2A. Evidence for a reduction in protein expression of SERCA 2A is strong.
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current experiments, heart failure cells were significantly less likely to be 
spontaneously active than control cells, and in cells which were spontaneously active 
frequency of oscillation was significantly lower in heaif failure cells at low 
Ca^fooncentration, and equivalent at higher Ca^fooncentration (as shown in fig. 3.6).
If heai't failure cells had equivalent SR Ca^  ^content but released less Ca^ "^  per 
oscillation, the time required for the SR to accumulate sufficient Ca^  ^to cause 
overload would be less than in control cells. Thus if the main determinant of 
spontaneous Ca^  ^release was SR Ca^ "^  overload, heart failure cells would be expected 
to have higher frequencies of spontaneous oscillation. The fact that this is not the 
case argues against the hypothesis that Ca^ "^  transient amplitude is lower in heart
ft
failure due to a reduced fraction of SR Ca^  ^load being released.
It therefore seems probable that the reduction in systolic Ca^  ^release in heart 
failure cells is caused by a lower SR Ca^ "^  content in these cells. Since previous 
studies have found no difference in levels of the SR Ca^  ^ storage protein 
calsequestrin (Arai et al. 1993; Meyer et al. 1995; Movsesian et al. 1994), it seems
"ft:
I
imlikely that this reduction in SR Ca ‘ content depends upon reduced ability of the
SR to store Ca^ "^ . Furthermore, if the assumption that caffeine stimulation causes the 
release of most of the stored Ca^  ^from the SR is correct, it follows that there must be 
abnormal SR Ca^  ^uptake, whether there is a defect in SR Ca^  ^storage ability or not.
The working hypothesis suggested both by the weight of previous investigation 
and the results of experiments on intact cells was that the abnormal Ca^ '^  handling 
seen in heart failure resulted from a reduction in the activity of the SR Ca^  ^pump,
I '
particularly in animal models of heart failure (Stein et al. 1996; Matsui et al. 1995;
i
Kiss et al. 1995), and as discussed in chapter 2, the most likely explanation for the 
prolongation of Ca^  ^ transients and the reduction in systolic release of Ca^ ""' in intact 
myocytes was a reduction in the activity of SERCA 2A. The present data from 
permeabilised myocytes support this hypothesis. A reduction in the activity of 
SERCA 2A is consistent with the findings of reduced SR Ca^ "* release during 
caffeine-induced or spontaneous contractions. This reduction in activity of SERCA 
2A would cause a reduction in SR Ca^  ^content, and reduced Ca^ "^  release on 
stimulation. Since SR Ca^  ^uptake would be slower, if SR volume or storage capacity 
was unchanged, SR Ca^  ^overload would take longer and the frequency of 
spontaneous SR Ca^  ^release would be lower.
A reduction in the activity of SERCA 2A could be caused by a reduction in the 
expression of SERCA 2A as suggested by previous measurements of this protein in 
heart failure (Stein et al. 1996; Matsui et al. 1995; Kiss et al. 1995). The same result 
would be achieved by an increase in activity of phospholamban, the inhibitory 
regulator of SERCA 2A, but this seems unlikely, as previous measurements of this 
protein have found that levels are reduced in heart failure (Meyer et al. 1995; Kiss et 
al. 1995) or unchanged (Bohm et al. 1994; Movsesian et al. 1994; Schwinger et al. 
1995), and phosphorylation levels of phospholamban are increased in heart failure 
(Currie & Smith, 1996).
Finally, an apparent reduction in SR Ca^  ^uptake could be caused by an increased 
Ca^  ^leak from the SR in the presence of normal activity of SERCA 2A. Bassani and 
Bers have measured low rates of SR Ca^  ^leak from intact myocytes during diastole 
or rest which they attributed to occasional openings of the ryanodine receptor 
(Bassani & Bers, 1995). The Ca^ "^  flux due to these elemental openings or Ca^  ^sparks
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is low compared to other transmembrane Ca^  ^currents or SR Ca^ '*' fluxes, but may be 
more significant when integrated over a longer timecourse as in the current 
experiments when cells may be quiescent for long periods of time (i.e. up to two 
minutes during this protocol). Thus if the rate of Ca^ "" leak via this pathway was 
larger in heart failure cells than control cells it is conceivable that this would have the 
effect of reducing SR Ca^  ^content in heart failure cells. The theoretical basis for a 
possible increase in Ca^  ^leak through this pathway is that p-adrenergic stimulation 
has been shown to cause phosphorylation of the ryanodine receptor (Yoshida et al. 
1992). Since phosphorylation may increase the open probability of the ryanodine 
receptor (Hain et al. 1995) (although one study has found the opposite (Lokuta et al. 
1995b)), and sympathetic overdrive occur s as a consequence of heart failure (Homey 
et al. 1991), this seems a reasonable hypothesis although there is no hard evidence to 
support it. However, since background leak in normal SR has been measured to be 
0.15-0.33% of peak SR Ca^  ^uptake (Bassani & Bers, 1995), any increase in heart 
failure would have to be around 1 to 2 orders of magnitude to have an effect of 
reducing SR Ca^  ^content to the degree seen in these studies. An effect of increased 
leak may, however, when integrated over longer timecourses, have some effect on 
SR Ca^  ^content, particularly at high SR Ca^  ^load, when SERCA 2 activity will be 
reduced.
In summary, the results of SR loading experiments in permeabilised myocytes 
have shown that there is significantly less Ca  ^*’ release in response to caffeine and 
during spontaneous SR activity in cells from ligation hearts than control hearts. 
Taking into account the results of studies described in chapter 2 in intact myocytes, 
and earlier studies reviewed in the introduction to this thesis, the most satisfactory
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explanation for this is that the SR Ca^ "^  content is reduced in heart failure, rather than 
that a reduced fraction of SR Ca^  ^content is released during each contraction. The 
most likely explanation of this reduced SR Ca^  ^content is a reduction in the activity 
of the SR Ca^^pump, SERCA 2A, rather than an increased leak of Ca^  ^from the SR. 
Whilst these results are best explained by a reduction in the activity of SERCA 2A, it 
is not possible from these experiments to exclude smaller contributions from the 
other mechanisms discussed to the SR dysfunction seen in this model of heart 
failure. In support of this is the finding in fen et myocytes that the degree of 
fractional release of stored Ca^  ^from the SR depends upon SR Ca^  ^content, and that 
the fraction of Ca^  ^released rises as stored Ca^ "^  increases (Bassani et a l 1995). In 
this heart failure model, therefore, with reduced SR Ca^  ^content secondar y to 
reduced activity of SERCA 2A, the amplitude of systolic Ca^  ^release would be 
reduced secondary to reduced SR Ca^  ^content, and further reduced compared to 
control since a reduced fraction of these SR Ca^ "*" stores would be released per 
contraction.
3.4.3 Implications of reduced SR Ca load in heart failure.
Eisner (Eisner et a l 1998) has recently reviewed mechanisms for the control of 
Ca^  ^release from the SR, concluding that changes in myocardial force of contraction 
are largely mediated via changes in systolic Ca^  ^release, and that the predominant 
mechanism for increasing systolic Ca^  ^release is increasing SR Ca^' content. SR Ca^  ^
content may be increased by increasing frequency of stimulation which results in 
cellular gain of Ca^  ^due to greater influx of Ca^  ^through L-type Ca^ '" channels in 
systole than Ca^  ^efflux tlirough Na' -^Ca '^  ^exchange during diastole. SR Ca^ "*" content 
may also be increased by adrenergic stimulation which results in phosphorylation of
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phospholamban which reduces inhibition of SERCA 2A, as well as increasing Ca^ "^  
influx via L-type Ca^  ^ chamiel phosphorylation.
Thus two important mechanisms for increasing force of myocardial contraction, 
(the force-frequency relationship and adrenergic stimulation) rely upon the ability of 
the SR to increase Ca^ "^  load. Several investigators have noted the absence of a 
positive force-frequency relationship in heart failure (Davies et al. 1995; Schwinger 
et al. 1993; Mulieri et a l 1992) and blunted responses to adrenergic stimulation 
(Schwinger et al. 1993; Harding et a l 1990). Whilst there may be several 
pathophysiological mechanisms for contractile dysfunction in heart failure, the 
reduced ability of the SR to load Ca^ "^  seen in this model of heart failure is consistent 
with these findings, and suggests that SR dysfunction is an important mediator in the 
development of contractile dysfunction.
3.4.4 Implications of spontaneous SR activity to arrhythmogenesis in heart 
failure.
Spontaneous SR Ca^  ^release has been described as defining feature of SR Ca^ "^  
overload (Stern et al. 1988). As SR Ca^  ^load increases, the gain function of Ca^^- 
induced Ca^  ^release increases (Janczewski et al 1995), and therefore unitary releases 
of Ca^  ^from single ryanodine receptors (“calcium sparks”) are more likely to 
propagate and produce generalised SR Ca^  ^release and cellular contraction. 
Fm'thermore it is likely that sparks themselves occur more frequently as SR Ca^  ^
load increases. Spontaneous SR Ca^  ^release therefore occurs as a function of 
increasing cytosolic Ca^  ^concentration and increasing time intervals between 
stimulation. There are species differences in the occurrence of spontaneous SR Ca^  ^
release, and these differences depend upon factors such as the gain of Ca^^-induced
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release (Stern et a l 1988). Spontaneous Ca^ "^  release is more common in rats 
and relatively less common in rabbits and humans, but seems to occur in all species 
studied to some extent (Stern et a l 1988).
It is interesting in the present studies that increasing cytosolic Ca^  ^concentration 
caused an increase not only in the frequency of spontaneous release, but also in the 
amplitude. It might be expected from the above discussion that once a threshold SR 
Ca^  ^content was reached spontaneous release would occur, and this would preclude 
further SR Ca^ "^  loading. This hypothesis is supported by experiments in intact rat 
myocytes where it was found that increases in cytosolic Ca^fooncentration affected 
frequency but not amplitude of spontaneous Ca^  ^release (Diaz et a l 1997). It is 
possible that these opposite results reflect species differences between rat and rabbit 
cells, since the gain function of the ryanodine receptor is higher in rat SR than rabbit 
(Stern et a l 1988). It is also possible that small increases in SR load may produce 
larger increases in Ca^  ^release as fractional Ca^  ^release increases with increasing SR 
load (Bassani et a l 1995).
Spontaneous SR Ca^ "*" release has been suggested to be arrhythmogenic due to 
the production of delayed after depolarisations (Vermeulen et a l 1994; Marban et a l 
1986). Other suggested consequences have been an increase in diastolic tone due to 
myofilament activation, and reduced systolic Ca^  ^release due to SR Ca^  ^depletion 
(Stern et a l 1988). Denvir found increased frequencies of spontaneous Ca^  ^release in 
trabeculae from the coronary aifery ligation model of heart failure in the rabbit 
(Denvir et a l 1996) and suggested that spontaneous Ca^  ^release may underlie some 
of the increased incidence of arrhytlimias in heart failure. In human tissue the same 
group found that spontaneous SR Ca^  ^release was more common in hearts from
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patients with ischaemic rather than dilated cardiomyopathy, and in moderate rather 
than severe heart failure (Denvir et a l 1995).
The results from this current study are in contradiction to those found in 
Denvir’s earlier study in the same rabbit model of heart failure (Denvir et a l 1996). 
Spontaneous SR Ca^’^ release was less likely to occur in cells from heart failure 
animals than shams, and when it did occur, frequency of release was lower. At high 
cytosolic Ca^fooncentration these differences were less marked, but at no 
Ca^^concentration was spontaneous activity more likely to occur in heart failure cells.
Given the mechanism for the production of spontaneous SR Ca^  ^release, this finding 5 |
liis not surprising. At all cytosolic Ca^fooncentrations studied in these experiments, f
cells fr om heart failure animals showed reduced SR Ca^  ^content. If spontaneous SR 
Ca^  ^release stems from SR Ca^  ^overload, it would be expected that spontaneous 
activity would be less common in heart failme cells with lower SR Ca^ "* content.
Although Denvir’s study was in the same model of heart failure used in this #7
study, the experimental preparation studied was skinned ventricular trabeculae, and 
Ca^  ^release was not measured directly, but inferred from changes in tension 
production. Spontaneous SR Ca^  ^release has been reported previously in
ft
I
ftft:
multicellular preparations (Stern et a l 1988), but has been described as a “chaotic 7
'Isquirming motion” of “asynchr onous subcellular waves of contraction”. Denvir 
describes “spontaneous tension oscillations”. In skinned preparations spontaneous 
SR Ca^ "^  release must propagate from the site of initiation by chemical diffusion,
’I
since membrane potential is abolished. In single cells rate of propagation has been
;Sestimated at 100pm s'^  (Stern et a l 1988) and in multicellular preparations such as 
trabeculae with diameters of 100-200 pm and lengths of 2-3mm, diffusion rates will
ft::'
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clearly affect the behaviour of the preparation as a whole during spontaneous 
activity. It seems unlikely therefore that spontaneous activity in these preparations 
would be synchronous. However Denvir’s findings that spontaneous activity was 
more common in heart failure was consistent with the proposed mechanism of 
generation of spontaneous SR Ca^  ^release, since in his experiments, heart failure 7
rabbits showed entranced SR loading, and in these circumstances increased 
spontaneous activity would be expected.
There is no clear explanation for the fact that Denvir found enhanced SR loading 
in trabeculae from the same model of heart failure when the experiments reported 7
■i*
here conclude that SR loading is significantly impaired in heart failure. Evidence
i
from many different sources discussed in the introduction to this thesis suggests that 
there is impaired SR function in heart failure, Denvir argued that the enhanced SR 
function seen in his experiments may have reflected early adaptive responses to 
impaired ventricular fimction, for example phospholamban phosphorylation in
ft
response to chronic adrenergic stimulation. Whilst the coronary artery ligation model ftft
of heart failure in the rabbit is not a severe model, and represents compensated left ■g;
ventricular dysfunction rather than terminal heart failure, there is no corroborating 
evidence from other studies to support the hypothesis of enhanced SR function in 
early heart failure, and Ca^  ^uptake studies in SR vesicles from this same model also 
suggest significantly reduced SR function (Cunie & Smith, 1997). One possible
explanation of the differences reported in this thesis and those reported by Denvir, is
7
that trabeculae are derived almost exclusively from endocardial myocytes, and the
experiments described here were performed on myocytes from the full thickness of
yï;
the left: ventricle and would contain endocardial, epicardial and mid-myocardial 
myocytes.
The reduction in frequency and incidence of spontaneous SR Ca^  ^release in cells
from ligation hearts seen in these experiments seems to argue against a major role for
this mechanism of arrhythmia production in heart failure. It is interesting, however,
that at higher cytosolic Ca^  ^concentrations the frequency of spontaneous release in
heart failure cells approaches that seen in control cells. Since spontaneous Ca^^
transients have lower amplitude in heart failure cells with the implication that SR
Ca^  ^content is lower in these cells, this may suggest that there is reduced SR volume
in these cells, or that spontaneous Ca^' release is more likely at a given SR Ca^^
■content in heart failure. Circumstances likely to produce high cytosolic Ca ^
.
concentration in vivo, for example digitalis treatment and ischaemia, are more 
common in heart failure than in health. It therefore remains possible that despite the 
fact that at a given cytosolic Ca^  ^concentration spontaneous SR Ca^  ^release occurs 
less frequently in heart failure cells than in control cells, since high cytosolic 
Ca^^'concentration is reached more commonly in heart failure, paradoxically, 
spontaneous SR Ca^  ^release may still be more common in heart failure.
■'1 
I3,5 Summary.
Following the findings of reduced systolic Ca^ "^  release and prolongation of Ca^ "^  
transients in intact myocytes in heart failure, studies in permeabilised cells were
■■
undertaken to clarify whether SR dysfunction was responsible for these 
abnormalities. In these experiments, there was a significant reduction in the 
amplitude of caffeine-induced and spontaneous SR Ca^  ^release. The most likely
I
I
I
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explanation for these findings is a reduction in SR Ca^  ^content in heart failure, 
reflecting reduced activity of the SR Ca^ '*' pump. These findings are in keeping with 
previous observations of a negative force frequency relationship and blunted 
responses to adrenergic stimulation in heart failure.
The incidence and frequency of spontaneous SR Ca^  ^release was found to be 
reduced in cells from heart failure animals. This is in keeping with findings of 
decreased SR Ca^  ^content, and may argue against, but not necessarily exclude a 
major role for this mechanism of arrhythmia generation in heart failure.
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Chapter 4 - Studies of SR uptake in cuvette-based experiments.
4.1 Background.
Following the studies described in chapter 2 confirming abnormal Ca^  ^handling 
in the coronary artery ligation model of heart failure in the rabbit, and the 
experiments in single permeabilised myocytes described in chapter 3 suggesting that 
this abnormal Ca^ "^  handling was caused at least in part by SR dysfunction, studies 
were designed to look specifically at SR Ca^  ^uptake. In chapter 3, studies on single 
permeabilised myocytes were described, and the chief finding was that SR Ca^  ^
release was reduced in heart failuie cells at all loading Ca^  ^concentrations studied. 
The implication of this result was that SR Ca  ^*' loading was impaired in these heart 
failure cells, and the likeliest cause of this was reduced SR Ca^  ^uptake, although as 
discussed it was not possible to exclude an increase in SR Ca^  ^leak.
The experimental preparation chosen in investigate SR Ca^  ^uptake was again the 
permeabilised myocyte, but in the studies to be described in this chapter, suspensions 
of isolated myocytes rather than single cells were used. This followed similar 
descriptions of the measurement of SR Ca^  ^uptake in this preparation in normal 
tissue by Hove-Madsen and Bers (Hove-Madsen & Bers, 1993b; Hove-Madsen & 
Bers, 1993b). Briefly, a standardised concentration of myocytes is suspended in a 
cuvette and permeabilised using |3-escin. Ca^  ^concentration within the SR is 
maintained at a low level by loading with oxalate and cytosolic Ca^  ^concentration is 
raised by the addition of CaClj to the cuvette. Cytosolic Ca^  ^concentration is 
monitored using Fura-2, and SR Ca^^uptake is stimulated by adding ATP. Following 
addition of CaClj the rate of SR Ca^  ^uptake is measured from the decay in cytosolic 
Ca^ "^  concentration.
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Measm-ement of SR Ca^  ^uptake in this preparation is analogous to experiments in 
SR vesicle preparations described in the introduction to this thesis eg(Ohkusa et a l 
1997; Movsesian et a l 1989), but this preparation has the advantage that the 
intracellular architecture is preseiwed, and there is also no confusion over “sidedness” 
o f the SR component. The advantage of this preparation over the single 
permeabilised myocyte experiments described in chapter 3 is that SR Ca^  ^uptake can 
be directly measured rather than inferred from SR Ca^  ^release, and since SR uptake 
is measured in a large number of myocytes simultaneously, individual variations in 
cell function have less effect on results. Finally, in this preparation, SR Ca^  ^leak can 
be blocked without affecting measurement of SR Ca^  ^uptake, and therefore 
differences in both SERCA 2A function and SR Ca^  ^leak can be differentiated in 
heart failure and control cells.
J
a
;=i
#
4.2 Methods.
4.2.1 Overview
In these experiments the rate of SR Ca^  ^uptake in suspensions of myocytes was
measured. Myocyte concentration was standardised to allow comparisons of the rate 
of SR Ca^  ^uptake in heart failure and control cells. The range of Ca^ "^  concentrations 
over which uptake was measured was also standardised.
■
The rate of SR Ca uptake in this preparation would have been expected to be
limited by Ca^  ^concentration within the SR. For this reason all experiments were
done in the presence of oxalate, which acts as a Ca^^-precipitating anion within the 
SR, and prevents Ca^  ^concentrations within the SR rising to levels which would 
inhibit SR Ca^  ^uptake. In the presence o f oxalate, therefore the rate of SR
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uptake is determined by free Ca^  ^concentration outside the SR (Hove-Madsen &
Bers, 1993b). In the absence of oxalate, Ca^  ^uptake was very slow. ■il.
Measures of the rate of SR Ca^  ^uptake in this preparation depended upon the 
activity of the SR Ca^  ^pump (SERCA 2A), but also depended upon the rate of Ca^ "^  
leak from the SR thr ough the ryanodine receptor. The magnitude of the Ca^  ^leak 
through the ryanodine receptor would be a non-linear function of extra-SR Ca^  ^
concentration due to Ca^^-induced Ca^  ^release and hence would be expected to affect
I
both the steady state Ca^  ^concentration outside the SR and the net rate of SR Ca^  ^ §
uptake. For this reason SR Ca^’*' uptake was measured in all experiments in the 
absence and presence of ruthenium red, a high affinity blocker of this leak pathway 
(Ma, 1993).
4.2.2 Myocyte isolation.
Myocytes were isolated from coronary artery ligated and sham rabbit hearts as 
described in section 2.1.2. Since maximum numbers of functioning myocytes were ïi
required for the experimental protocol, myocytes were taken from the full thickness 
of the left ventricle, and not divided into endocardial, epicardial and mid-myocardial
' Ifractions. Following isolation myocytes were suspended in 0.05 relaxing solution
(0.05R), a mock intracellular solution with Ca^  ^concentration buffered to low levels 
with 50pM EOT A at pH 7.0 (see appendix 1 for exact composition), and stored at Iroom temperature until use.
4.2.3 Myocyte counting.
In order to make comparative measurements of SR Ca^  ^uptake rates in myocytes
from heart failure and control hearts, it was necessary to standardise the prepar ation
; |
since myocyte yield varied between dissociations. Measurement of Ca^  ^uptake in SR 1
■I
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vesicle preparations has previously been standardised by weight of the SR 
component (Movsesian et a l 1989). In the cuiTcnt experiments it was decided to 
standardise the concentration of rod shaped myocytes within the cuvette. This was 
done by counting the number of dissociated rod shaped cells in a given volume 
following dissociation in a cytometer, the Improved Neubauer cytometer (Weber, 
England). This method of standardisation relies on the assumption that SR Ca^  ^
uptake is mediated solely or principally by rod shaped myocytes. However, 
dissociation of single myocytes produces both rod shaped myocytes and cells which 
are morphologically balled-up. As will be discussed later, the mechanism by which 
these cells become contracted is uncertain, but may reflect Ca^  ^overload and 
hypercontracture due to membrane damage during dissociation. However, since it 
was not clear whether these cells contained any functioning SR material the number 
of these myocytes was also counted. Since the number of rod shaped cells and 
contracted cells varied independently, it was not possible to standardise 
concentrations of both types of cell. Following counting of myocytes, the suspension 
was then either concentrated by centrifugation or diluted to give a solution containing
2.5 X 10^  rod shaped myocytes ml"' and then comiting was repeated to confirm 
myocyte concentration.
4.2.4 Experim ental protocol.
Following counting, myocytes were transfeiTed to 2ml cuvettes containing 
1 OmM oxalate, and stirred continuously with a magnetic stirrer to prevent settling. 
The rate of stirring was not changed between experiments. The experimental 
apparatus is shown in fig. 4.1.
;
concentration in the cuvette (and outside the SR) was measured by addition 
of lOpM Fura-2. Fluorescence evoked at 340mn and 380nm was measured using a 
Cairn spectrophotometer as described in section 2.1.3, and a ratiometric measurement 
of free Ca^ "^  concentration was made and recorded to disc using the program New 
Tape (Francis Burton 1990) and to chart recorder.
Following a 2 min equilibration period 10-20pL of lOmM CaCl2 was added to 
the cuvette, raising the free Ca^  ^concentration to 1-2 pM. There was some variation 
between experiments in the amount of CaCl2 required to raise Ca^  ^concentration to 
this level. This varied with the buffering power of the solution which in turn 
depended on the total concentration of myocytes (live and dead) within the solution. 
The volume of CaCl2 required to raise free Ca^  ^therefore varied between 
experiments, and had to be assessed by trial and error at the start of each experiment. 
Once the volume required was ascertained, it remained fixed for the duration of the 
experiment. Fura-2 ratio was then measured as free Ca^  ^concentration decayed to 
resting levels. Myocytes were then permeabilised by the addition of 90nM |3-escin, 
and a repeat free Ca^ '*' decay curve was recorded after the addition o f the previous 
volume of CaClg.
This protocol allowed measurement of SR Ca^  ^uptake rates over a range of free 
Ca^  ^concentrations from around 1-2 pM to around 50-1 OOnM. Since Ca^^-induced 
Ca^  ^release would be expected to occur at Ca^  ^concentrations much less than the 
maximum fi’ee concentrations in this range, SR Ca^  ^uptake was then measured in the 
presence of ruthenium red (3OmM) which blocks SR Ca^  ^release from the i-yanodine 
receptor, with a of order of < IpM  (Ma, 1993). Ruthenium red blocked both Ca^ '*'-
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induced release and SR Ca^  ^leak which is thought to be caused by occasional 
spontaneous openings of the ryanodine receptor (Bassani & Bers, 1995),
Experiments were performed in suspensions of myocytes from both ligation and 
control hearts. Thus SR Ca^  ^uptake could be compared in both intact and 
permeabilised myocytes from failing and normal heails, and SR Ca^  ^uptake could be 
compared in the presence and absence of SR Ca^  ^leak. A typical experimental trace 
showing SR Ca^  ^uptake in myocytes before and after permeabilisation and then 
following the addition of ruthenium red is shown in fig. 4.2.
4.2.5 Data analysis and curve fitting.
The relationship of the ratio of Fura-2 fluorescence at 340nm and 380nm to Ca^  ^
concentration was described in section 3.2.5. Essentially the relationship is sigmoid 
and depends on the constants R,„i„ and K .^ These constants vary depending upon 
several properties of the system in use, in particular, the optical properties of the 
system and the presence of other chemicals within the solution. For these reasons it 
was necessary to plot a calibration curve for these experiments. This was done as 
previously described by combining different ratios of lOmM EOT A and lOmM 
CaEGTA to create a range of Ca^  ^concentrations, and measuring the ratio of 
fluorescence at 340 and 380nM stimulation. Free Ca^  ^concentration was calculated 
for these solutions using the program React (Godfrey Smith 1990). As shown in fig. 
4.3, the addition of ruthenium red to the solution significantly affected the à
fluorescence properties of Fura-2. Ruthenium red had a quenching effect shown by a 
reduction in fluorescence at both wavelengths which was not completely 'I
symmetrical. For this reason calibration curves were plotted in the presence and 
absence of ruthenium red.
The values calculated from these calibration curves were: 
ruthenium red: No ruthenium red:
R.„in 0.83 0.94
13.55 13.19
-7Kj 1.51x10"' 8.37x10
Raw data were plotted in real time on chart paper, and the output voltage from the 
spectrophotometer for individual wavelengths and ratio was stored on hard disc. All 
analysis of Ca^  ^decay cui'ves was performed on personal computer. Areas of interest 
within data sets were selected using the program QA (Francis Burton 1990) and 
ratiometric measurements were then converted into Ca^  ^concentrations. Following 
conversion, each Ca^ "^  decay curve was then plotted using the program Origin 
(Microcal software) and a bi-exponential curve was fitted to the portion of the decay 
curve below 600nM Ca^ "^  concentration. From this plot, 2 time constants for each 
decay curve were calculated, reflecting a fast and slow phase of Ca^ "" uptake. The fast 
time constant reflected Ca^  ^uptake at higher cytosolic Ca^  ^concentrations, and was 
more a more consistent measure of the rate of Ca^  ^uptake, and comparisons of Ca^  ^
uptake between heart failure and control preparations were therefore made using this 
measurement. Other methods of analysis were possible, for example plotting the 
differential of changes in free Ca^ ,^ but this method was chosen for simplicity. An 
example of this curve fitting is shown in figure 4.4.
4.3 Results.
Ca^  ^uptake measurements were made in cell suspensions from 7 ligation hearts 
and 8 control hearts. Time constants from bi-exponentially fitted decay curves were 
therefore available for Ca^  ^uptake in intact cells (prior to the addition of (3-escin),
95
sham ceils and 0.81 in failure cells (p=0.09) The ratio of mean time constants of
cells (p=0.04). These results are shown in fig. 4.6.
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skinned cells, and in skinned cells following the blocking of Ca^ '" leak with ruthenium ; j
red. Representative decay curves for a heart failure preparation and a sham 
preparation are shown together in fig. 4.5. It can be seen that the rate of Ca^  ^uptake 
was slower in heart failure preparations.
Table 4.1 shows the mean time constants for heart failure and sham preparations.
It can be seen that the rate of Ca^  ^uptake is reduced in heart failure cells, although 
the difference between mean time constants was only statistically significant for «
skinned cells before the addition of ruthenium red. In sham cells, the time constant 
for Ca^ '^ uptake was significantly less in skinned than intact cells (p=0.03), and in 
ruthenium red treated cells than skinned cells (p=0.01). In failure cells there was no 
significant difference in the time constant in intact and skinned cells (p=0.3) but time 
constants were significantly shorter when SR Ca^  ^leak was blocked with ruthenium
if..ïéS
red (p=0.01). The ratio of mean time constants of skinned to intact cells was 0.78 in
I
ruthenium red treated cells to skiimed cells was 0.77 in sham cells and 0.56 in failure
3
.. 3:
%,3.
3''3
  _
Sham Expt
1 S RR 1 S RR
mean (s) 54.72 42.43 32.55 90.64 74.04 41.81
SD (s) 27.54 13.81 13.07 46.41 29.02 11.57
SEWI (s) 8.71 4.37 4.13 13.99 8.75 3.49
P 0.052 0.009 0.086
Table 4.1 Mean time constants fo r Ca^  ^uptake in suspensions o f heart failure 
and sham cells. (I = intact, S  = skinned, RR = ruthenium red).
The analysis of these results was based on the premise that SR Ca^  ^uptake was 
mediated principally by cells that remained rod shaped following the isolation 
procedure, and numbers of these cells were standardised between experiments. 
Numbers of cells which had undergone hypercontracture and appeared balled up 
could not be standardised at the same time as rod shaped cells since the yield of the 
two types of cells varied in each experiment. This is shown in table 4.2. As can be 
seen, although there was no difference in the total yield between experimental and 
sham hearts, there was a significantly higher yield of rod shaped myocytes from 
sham hearts. Since the experimental protocol standardised the number of rod shaped 
myocytes between experiments, this means that the total number of all myocytes (rod 
shaped and contracted) was lower in sham experiments than heart failure 
experiments.
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Sham
balls total Date
Failure
totalExpt. Date rods rods balls
1 3.6.97 6.3 17.4 23.7 19.6.97 5 23.1 28.1
2 12.6.97 7.7 13.3 21 26.6.97 4.6 21.7 26.3
3 24.6.97 6.3 21.1 27.4 31.7.97 4 12.5 16.5
4 29.7.97 5.4 22 27.4 21.8.97 3.6 10.9 14.5
5 7.8.97 3.6 5.6 9.2 3.7.97 3.6 28.1 31.7
6 28.8.97 5.7 15.3 21 17.7.97 6.9 15.2 22.1
7 9.9.97 8.3 23 31.3 5.8.97 3.4 13 16.4
8 19.8.97 6 12.6 18.6
mean 6.16 16.29 22.44 mean 4.44 17.79 22.23
SEIM 0.43 1.76 2.05 SEIM 0.37 1.97 2.01
P 0.014 0.323 0.476
Table 4.2. Numbers of rod shaped and hyper contracted myocytes following isolated.
Statistical tests compare sham and heart failure experiments. All numbers are xlOl
Given the results described in the previous chapter it was surprising that the 
differences in the rate of Ca^  ^uptake in the cuvette preparation were so small. This 
raised the question of whether the original premise that Ca^ '^  uptake was mediated 
totally or principally by rod shaped myocytes. This question was being investigated 
independently at this time by Lorraine Bruce (PhD student under supervision of 
Professor Smith). Data from experiments in control tissue showed that rates of Ca^“^
• 1
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uptake were predicted better by the total number of cells in the prepar ation, and that 
there was a poor correlation between uptake rate and concentration of rod shaped 
myocytes The best correlation with uptake rate was with total protein concentration 
within the cuvette, although total cell concentration was more accurate in predicting 
uptake rate than rod shaped myocyte concentration. This suggested that SR material 
in contracted cells contributed to Ca^  ^uptake, and that cell counting was less 
discriminating in estimating the amount of functioning SR in the preparation than 
protein measurement.
Protein measurement had not been undertaken in these experiments, but it was 
possible to re-analyse the data standardised to the time constant for decay per 1x1 O' 
total cells. These data aie shown in table 4.3 and fig 4.7.
Sham Expt.
Ic Sc RRc Ic Sc RRc
mean 496.59 382.56 287.32 1161.42 1031.41 552.51
SEIM 96.57 50.15 35.36 218.16 214.07 92.33
P 0.023 0.013 0.02
Table 4.3. Time constants for Ca^  ^uptake corrected to 1x10  ^total cells in intact (Ic), 
permeabilised (Pc) and ruthenium red (RRc) cells. Statistical comparisons are between heart 
failure and sham experiments.
Comparisons of time constants for Ca^  ^uptake in intact, skinned and ruthenium 
red treated cells in this analysis shows that in sham cells, the time constant for Ca^^
I
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uptake was significantly shorter in skinned than intact cells (p=0.03), and in 
ruthenium red treated cells than skinned cells (p=0.02). In failure cells there was no 
significant difference in the time constant in intact and skinned cells (p=0.4) but time 
constants were significantly shorter when SR Ca^  ^leak was blocked with ruthenium 
red than in skiimed cells (p=0.02). The ratio of mean time constants of skinned to 
intact cells was 0.77 in sham cells and 0.88 in failure cells (p=0.09) The ratio of 
mean time constants of ruthenium red treated cells to skimred cells was 0.75 in sham 
cells and 0.54 in failure cells (p=0.04).
In summary then, the results presented in this chapter show;
(i) When data are analysed normalised to rod shaped myocyte numbers, there 
is a general small, non-significant trend towards lower time constants for 
Ca^  ^uptalce in sham compared to failure cells.
(ii) This difference is significant in intact, skinned and ruthenium red treated 
cells when the data are normalised to total cell numbers rather than rod 
shaped myocyte numbers.
(iii) In sham cells there is a significant increase in the rate of Ca^  ^uptake 
when myocytes are skinned, and again when SR Ca^  ^leak is blocked with 
ruthenium red. In failure cells the difference between intact and skinned 
cells does not reach significance.
(iv) The relative increase in Ca^  ^uptake with the addition of ruthenium red is 
greater in failure cells than in sham cells.
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4.4 Discussion.
The purpose of the experiments described in this chapter was to directly measure 
SR Ca^ *" uptake and identify whether this was slowed in heart failure cells compared 
to control cells. Studies in single permeabilised myocytes described in chapter 3 
suggested that SR Ca^  ^load was reduced in heart failure cells, and the most obvious 
cause of this was a reduction in SERCA 2A mediated Ca^ "^  uptake. It was not 
possible to exclude changes in SR Ca^  ^release or storage as a cause of the apparent 
decrease in SR load, however. These problems were overcome in these studies by 
directly measuring SR Ca^  ^uptake in large numbers of myocytes.
4.4.1 Normalisation of results.
As discussed earlier, in plamiing these experiments, it was assumed that the SR 
component of hypercontracted cells was not active, and therefore, SR Ca^ "^  uptake 
would be mediated by rod shaped myocytes. For this reason, myocyte concentration 
in cuvettes was standardised to numbers of rod shaped myocytes. This assumption 
was critical, since there was a significant difference in the relative yields of rod and 
contracted myocytes from failing and control hearts. Subsequent experiments from 
this laboratory contradict this assumption, and for this reason data were re-analysed, 
and normalised to the total number of cells within each preparation. This analysis did 
not change the trend of the results in intact, skinned or ruthenium red treated cells, 
but affected the magnitude and significance of the differences in failing and control 
cells. Further refinement of these results would have been possible if rates of Ca^  ^
uptake could have been normalised to total protein content. Information on the 
predictive value of protein estimation came from control tissue, however, and it is 
possible that protein levels in heart failure cells would differ from those in control
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cells, and may not therefore have been the most appropriate measure of cell 
concentration in these studies. Normalising Ca^ "^  uptake to total cell numbers seems 
therefore to be the best practical solution.
It is possible that this is an oversimplification, however, since this analysis 
assumes that SR activity in contracted cells is equivalent to that in rod shaped 
myocytes. It is possible that there is at least a degree of SR damage in these cells, and 
there would be a range in activity of SR function. The mechanism of cellular damage 
is important in this context, since hypercontracture may be generated by both 
hypoxia causing a depletion of high energy metabolites, or by direct damage to the 
sarcolemma in the dissociation process. In the former case, SR activity may be 
restored by the availability of ATP and creatine phosphate in the bathing solution.
These questions could only be fully assessed by measuring SR Ca^  ^uptake in pure 
suspensions of rod shaped and contracted myocytes, but at present there is no method 
for separating these two fractions. It remains possible, therefore, that normalisation 
of SR Ca^”^ uptake to total cell number is an overcorrection, which artificially f
increases the difference in SR uptake in failure and control cells. If this were the 
case, the true difference would lie somewhere between the corrected and uncorrected
102
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data.
a .
4.4.2 Uptake in intact myocytes.
Uptake was first measured in all experiments in intact myocytes. In these 
circumstances free Ca^  ^was measured in the extracellular space, since Fura 2 is not ;
membrane permeant. SR Ca uptake in these experiments depended on both |
sarcolemmal Ca^ "*^  uptake (principally via the Na-Ca^ *^  exchanger following a 
concentration gradient) and thereafter SR uptake mediated by SERCA 2A. There are
a number of theoretical problems in the analysis of these results. Firstly enzymatic 
dissociation of myocytes is thought to damage the sarcolemma in some cells, causing 
increased membrane permeance. These cells undergo hypercontracture due to Ca^  ^
overload from extracellular sources, and appear balled up on light microscopy. It has 
already been suggested, however, that these cells retain an active SR component, and 
thus SR Ca^  ^uptake measurements in intact cells probably constitute an element of 
uptalce in both intact and leaky (or permeable) cells. Since the relative yield of rod 
and ball shaped myocytes varied between experiments, and there was a significantly 
greater proportion of rod shaped cells from sham hearts, there is an inherent bias in 
the analysis. However, it would be expected that the presence of a higher fraction of 
permeable cells in failure experiments would tend to increase the rate of Ca^  ^uptake, 
since in these cells Ca^  ^uptake would be a single step process, and trans- 
sarcolemmal Ca^  ^transport would be bypassed. These arguments tend to strengthen 
the finding that in intact myocytes Ca^  ^uptake is slower in heart failure cells.
In control cells there was a significant decrease in the time constant for Ca^  ^
uptake between intact and skinned cells. This difference was not significant in failure 
cells, and the ratios of 0.77 (control cells normalised to total cell numbers) and 0.88 
(failure cells) were significantly different. This may reflect the different numbers of 
permeable cells in the preparations, since if higher numbers of cells were already 
permeable in the failure group it would be expected that there would be smaller 
increase in the rate of Ca^  ^uptake following chemical permeabilisation. An 
alternative explanation is that sarcolemma! Ca^ "^  transport was less of a bamer to SR 
Ca^  ^uptake in heart failure cells due to an upregulation of Na-Ca^^ exchange, which 
has been suggested earlier. It is not possible to separate these two hypotheses.
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A further problem in intact myocyte studies, is the site of oxalate mediated Ca^ "^  
buffering. Control experiments in the absence of cellular material showed that 
following addition of Ca^  ^boluses, Ca^  ^concentration did not decay, suggesting that 
Ca^  ^concentration was not sufficiently high in the extracellular compartment to 
precipitate with oxalate. It is also imlikely that cytosolic Ca^  ^concentration would be
high enough to cause precipitation, although this cannot be excluded. The fact that 
Ca^ '*' uptake was consistently higher in skinned cells, however, argues against this 
happening to any major extent.
4.4.3 Uptake in skinned myocytes.
The difficulties in interpreting results in the studies described above are less 
problematic in permeabilised cells. Following permeabilisation, the cytosol becomes
‘-ï'i
a single compartment with the extracellular space, and control studies have not
-
shown any significant Ca^  ^oxalate precipitation here. Similarly, the theoretical 
problem of contracted cells having a permeable sarcolemma is also irrelevant 
following chemical permeabilisation. As would be expected, in control cells, SR Ca^  ^
uptake is significantly faster in permeabilised cells than in intact cells. The 
magnitude of this increase in rate of uptake is around 25%, suggesting that
sarcolemmal Ca^  ^transport is a less significant barrier to SR Ca^  ^uptake than
SERCA 2A mediated uptake in itself. This seems lower than might have been 
expected, since there will be a tenfold maximum trans-sarcolemmal Ca^  ^gradient in 
these experiments (»lpM  [extracellular]: wlOOnM [cytosolic]). If this is compai'cd 
with the concentration gradient seen if vivo, with ionised Ca^  ^in the millimolar range 
in extracellular fluid it can be seen that Na-Ca^"  ^exchange has a substantially lower 
driving gradient in these experiments.
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The main conclusion from measurements of SR Ca^  ^uptake in skimied cells is 
that uptake is significantly faster in control compared to failure cells. These 
experiments are analogous to results in intact and skinned single cells, in that they 
allow the conclusion to be made that the abnormal Ca^  ^handling in this model stems 
from SR dysfunction rather than changes in Na-Ca^^ exchange, although additional 
changes in Na-Ca '^^ exchange are not excluded. The difference is that in these 
experiments SR Ca^  ^uptake is measured directly rather than inferred from 
measurements of Ca^  ^release.
Ca^  ^uptake was 43% faster in skinned cells from control compared to failure 
hearts. This figures rises to 63% when the data are normalised to total cell numbers. 
This compares well with the findings in single cells described in chapter 3 that SR 
load was 50-60% greater in control than failure cells.
4.4.4 Blocking release at the ryanodine receptor.
While this experimental protocol measures SR Ca^  ^uptake in permeabilised cells, 
net Ca^ "^  uptake represents a balance between Ca^  ^uptake and release at the ryanodine 
receptor. Since cytosolic Ca^  ^concentration at the beginning of uptake experiments is 
high (l-2pM), Ca^'^-induced Ca^  ^release occurs, and may significantly reduce the 
rate of net Ca^  ^uptake. There are several reasons why the rate of SR Ca^  ^leak may 
not be equivalent in failure and control preparations. Evidence for differences in 
protein expression of the ryanodine receptor in heail failure was discussed in chapter 
1, but briefly, some investigators have found reduced mRNA expression (Arai et al. 
1993) and ryanodine binding (Go et al. 1995). Sensitivity of the ryanodine receptor 
is also modulated by phosphorylation (Lokuta et al. 1995a). Little is known of the 
state of ryanodine receptor phosphorylation in heait failure although alterations are
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possible since phosphorylation may be dependant on p-adrenergic stimulation 
(Yoshida et al. 1992), and other p-adrenergic dependent modulations are altered in 
heart failure (Harding et al. 1990). There is also evidence for a ryanodine- 
independent SR Ca^  ^leak (Smith et al. 1998), although nothing is known as whether 
this leak is altered in heart failure.
The presence of oxalate within the SR will, however, reduce the amplitude o f both 
ryanodine-dependent and independent SR Ca^  ^leak, since free Ca^  ^concentration in 
the SR will be in the order of IpM, approximately one hundred times lower than 
normal. In control tissue, however, Ca^  ^uptake is significantly faster following the 
addition of ruthenium red, signifying that there is an appreciable SR Ca^  ^leak despite 
the presence of oxalate. |
The ratio for the time constant for Ca^  ^uptalce in control tissue following addition 
of ruthenium red to uptake in skinned myocytes was 0.77, and when normalised to
"S'!total cell number this ratio was virtually unchanged at 0.75. This increase in rate of
' Iuptalce following blocking of the ryanodine-dependent leak was therefore equivalent
'
to the change seen following skinning of myocytes. This confirms that SR Ca^  ^leak i |j;,l
has a significant effect on the rate on net SR Ca^  ^accumulation. This underestimates 
the true effect of SR Ca^  ^leak, since the magnitude of the ryanodine-independent #
leak has not been quantified.
In failure cells, the effect of ruthenium red is still more pronounced. Here the ratio
kof time constants for Ca^  ^uptake following ruthenium red was 0.56. This was 
significantly lower than in control cells (p = 0.04), indicating that ryanodine 
dependent Ca^ "^  leak has a greater effect on net Ca^ "^  accumulation in heart failure
■f
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cells. Results are similar in the normalised analysis, with the ratio in heart failure 
being 0.54, again significantly lower than in control cells (p = 0.04).
Since the fractional increase in rate of Ca^  ^uptake following ruthenium red is 
greater in heart failure than control cells, it follows that the magnitude of the 
ryanodine-dependent leak is greater in heait failure. This is an important finding, as 
this is the first result in this series of experiments to indicate that abnormalities of 
Ca^  ^handling in heart failure camiot be explained purely by a reduction in the 
activity of SERCA 2A.
The mechanism of this increased SR Ca^  ^leak must depend on a modulation of 
the ryanodine receptor in heart failure, since all evidence of protein expression, 
mRNA expression and ryanodine binding suggests that levels of the ryanodine 
receptor are either unchanged or reduced in heart failuie. The increased leak at the 
ryanodine receptor camiot be a function dependent on intraluminal Ca^  ^
concentration, since studies in skinned single myocytes described in chapter 3 show 
that SR Ca^ "^  load is decreased in heart failure, and the sensitivity of the ryanodine 
receptor is increased by higher rather than lower SR Ca^  ^load (Janczewski et al. 
1995). It is also not possible to explain the increased leak in terms of raised cytosolic 
Ca^  ^concentration in heart failure, since in the skinned cell preparation, cytosolic 
Ca^  ^concentration is controlled by the bathing medium, rather than any function of 
cell Ca^ "^  handling. It therefore follows that the mechanism of the increased Ca^  ^leak 
must depend either on a functional alteration of the ryanodine receptor itself, or 
modulation of the receptor by external control mechanisms (eg phosphorylation). 
These changes must cause either an increase in the inlierent leak characteristics of the 
ryanodine receptor, or increase its sensitivity to Ca^  ^induced Ca^  ^release. An
107
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increase in the sensitivity of Ca^^-induced Ca^ "^  release could be a secondary, 
compensatory change following either a reduction in the numbers of ryanodine 
receptors, or reduced SERCA 2A mediated SR Ca^  ^ loading.
The finding of an increased SR Ca^ "^  leak, possibly secondaiy to a compensatory 
increase in the sensitivity of Ca^^-induced Ca^  ^release may seem to be at variance 
with the finding of reduced spontaneous SR Ca release in skimied single cells
:described in the previous chapter. Spontaneous SR Ca^  ^ release was measured, 
however, at the whole cell level. It is likely that an increased SR Ca^  ^leak would 
manifest as an increased frequency of Ca^ '^  sparks, but for this to be seen at the whole 
cell level, spark propagation would need to occur thr oughout the cell. A reduction in 
SR Ca^  ^load would decrease the likelihood of spark propagation, even in 
circumstances where spark frequency was increased. In support of this, a number of 
cells were recorded from heart failure experiments where local contractions were 
seen at high cytosolic Ca^  ^concentrations, but co-ordinated cell contractions were 
absent, and changes in fluorescence were not large enough to constitute Ca^ "^  
transients. This could only be fully investigated if confocal microscopy were 
available to record the frequency and propagation of Ca^ "^  sparks in heart failure and 
control cells.
The second important conclusion from uptake experiments in the presence of 
ruthenium red is that the absolute rate of uptake is reduced in heart failure cells. The 
mean time constant for uptake was 22% lower in sham than failme cells (p = 0.09).
This difference was significant following normalisation of results (52%, p = 0.02).
Since the ryanodine-dependent Ca^  ^leak is abolished in these experiments, 
measurement of net Ca^  ^uptake largely reflects SERCA 2A activity. The small,
fi:
ryanodine-independent leak is a possible confounding factor, but there is no evidence 
that this leak is altered in heart failure. The mechanism of this leak is imcertain, 
although it is possible that it reflects reverse activity of SERCA 2A in a proportion 
of Ca^  ^pumps (Smith et a l 1998). Since the suggested cause of decreased SERCA 
2A activity in heart failme is a reduction in the expression of SERCA 2A eg. (Kiss et 
al 1995), it might be expected that there would be a concomitant decrease in both 
forward and reverse activity of SERCA 2A in these circumstances, and a consequent 
reduction of the ryanodine-independent leak. This hypothesis would serve to 
strengthen the results presented in this chapter. Finally, if the cause of the ryanodine- 
independent leak was reverse activity of SERCA 2A, and this leak were increased in 
heart failure, it could be argued that this in itself constitutes a reduction in the net 
activity of SERCA 2A.
It is therefore reasonable to conclude that in this heart failure model, there is a 
reduction in the activity of SERCA 2A of the order of 50%. This again is consistent 
with the findings in skinned single cells of a reduction in the SR Ca^ '*' load of 50-60% 
in heart failure.
4.5 Summary.
The main findings from these experiments measuring Ca^ "^  uptake in suspensions 
of permeabilised myocytes are that there is a reduction in the activity of SERCA 2A and 
an increased ryanodine-dependent SR Ca^  ^leak in heart failure. This second finding 
may be a compensatory change. These findings are entirely consistent with earlier 
results in intact and skimied myocytes, but allow firm conclusions as to the mechanism 
of abnormal Ca^  ^handling and SR dysfunction in heart failure. For the first time.
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however, it has been shown that the changes in Ca^  ^handling seen in this model are not 
purely explicable in terms of a reduction in the activity (or expression) of SERCA 2A.
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Chapter 5: Pharmacological modelling of SR dysfunction seen in heart failure.
5.1 Introduction.
Pharmacological modelling of the changes in SR function described in the
previous chapters is attractive for a number of reasons. Since heart failure is a
complex syndrome, with many pathophysiological features, the finding of a single
physiological abnormality does not necessarily imply that this mechanism plays a
causative role in the pathogenesis of heart failure. In addition, any abnormalities
found may be compensatory mechanisms acting to offset other known or unknown
changes. If a drug whose pharmacological action is known can be shown to produce
the phenotypic abnormality seen in heart failure, this can be considered as a positive
control experiment. If the action of such a drug does not produce the required
phenotype, this is strong evidence against the proposed pathophysiological 
.mechanism. If the drug produces a phenotype which resembles that seen in heart 
failure, but changes are different in quality or degree, this suggests that the proposed 
mechanism is over simplistic.
Several compounds are known to have specific actions on SR Ca^  ^uptake and 
release processes. Unlike the clinical picture of heart failure, where there may be 
multiple perturbations of myocyte function, the action of these compounds can be 
relatively specific in their effect on SR Ca^  ^handling. Thus modelling of SR 
dysfimction in normal myocytes may be able to dissect out the effects of 
abnormalities of these functions, without directly affecting other control mechanisms.
By studying the effects of compounds which alter SR functions, the potential 
benefits of pharmacological therapy to offset changes in SR function in heart failure 
can also be addressed. :
V-!
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Possible sites for disruption of SR Ca^’*' handling processes are shown in fig. 5.1. 
The compounds which were studied in this group of experiments were:
(i) Tetracaine.
(ii) Caffeine.
(hi) Thapsigargin.
(iv) lonomycin.
5.1.1 Tetracaine.
Tetracaine, like other local anaesthetics blocks fast Na"^  channels in excitable 
tissue. It is membrane permeant, however, and has been found to inhibit Ca^  ^
release tlnough the ryanodine receptor in skeletal muscle (Xu gf arZ. 1993) and 
cardiac muscle (Gyorke et al. 1997a). Evidence that there was reduced expression of 
the ryanodine receptor in heart failui'e (eg (Brillantes et a l 1992; Aral et al. 1993)) 
suggested that abnormal Ca^  ^release tlirough the ryanodine receptor may contribute 
to the altered Ca^  ^handling seen in heart failure. Although this hypothesis does not 
seem to explain the abnormalities of diastolic Ca^ "^  re-uptake seen in many studies (eg 
(Gwathmey et a l 1987)), it is possible that reduced Ca^  ^release contributed to the 
small Ca^  ^transients seen in both intact and permeabilised myocytes described in 
earlier chapters of this thesis. Tetracaine was thus chosen to test the hypothesis that 
inhibition of Ca^  ^release at the ryanodine receptor would model the abnormalities of 
hequency and amplitude of spontaneous Ca^  ^ release seen in permeabilised myocytes 
from failing hearts.
The mechanism of action of tetracaine on SR Ca^ "^  release has been studied in 
purified ryanodine preparations in lipid bilayers from rabbit skeletal muscle (Volpe et
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al. 1983; Xu et al. 1993) and in spontaneously active rat myocytes (Overend et al. 
1997; Studer et a l 1994). The effects of other local anaesthetics including procaine 
has been studied in these prepaiations and in sheep cardiac SR (Tinker & Williams, 
1993). Possible mechanisms of action of tetracaine include reducing single chamrel 
conductance of the ryanodine receptor, reducing the open probability of the receptor, 
decreasing the sensitivity of the receptor to cytosolic Ca^  ^(decreased sensitivity of 
Ca^^- induced Ca^  ^release) or reducing the sensitivity of the ryanodine receptor to 
lumenal Ca^  ^(i.e. reduced sensitivity to increasing SR Ca^^load). (The presence of a 
mechanism sensing SR Ca^' load and promoting Ca^  ^release through the ryanodine 
receptor is suggested by the finding that the gain function of Ca^  ^-induced Ca^  ^
release is linearly related to SR Ca^  ^load (Janczewski et al. 1995)). These possible 
mechanisms may not he mutually exclusive.
In bilayer experiments from rabbit skeletal muscle, 150 pM tetracaine reduced the 
open probability of ryanodine receptors by around 50% (Xu et al. 1993). A Hill 
coefficient of 2 suggested that tetracaine bound at 2 or more co-operative sites.
Single channel recordings showed that tetracaine (up to 500pM) did not affect 
channel conductance unless lumenal [Ca^^ was above lOmM. Tetracaine had the 
same action when applied to both the cytoplasmic or SR lumenal side of the bilayer. 
The authors suggested that the action of tetracaine depended on binding to two or 
more regulatory sites near or within the SR membrane resulting in allosteric 
modification of the ryanodine receptor, with the possibility of a further low affinity 
binding site within the channel causing direct blockade. Despite tetracaine acting 
when placed on either the cytosolic or lumenal phase of the SR membrane, evidence 
for a time dependence on the action of local anaesthetics depending on membrane
120
121
'
a
permeability suggests that the site of the putative regulatory binding sites is either 
within the membrane or on the lumenal side (Volpe et a l 1983). In contrast, 
experiments in sheep cardiac muscle showed that local anaesthetics procaine, QX314 
and QX222 acted to reduce Ca^  ^release by reducing open probability, but only when 
present at the cytosolic face of the SR membrane (Tinker & Williams, 1993). This 
contradiction in the effect of local anaesthetics on the lumenal face of the SR 
membrane is important, since it is less likely that the mechanism of action of 
tetracaine is via an intra-SR Ca^ "^  sensing pathway if the tetracaine binding site is 
outside the SR.
The action of tetracaine has been investigated at the level of the whole cell in 
spontaneously contracting rat cardiac myocytes (Overend et a l 1997). Application of 
25-200pM tetracaine decreased the frequency of spontaneous SR Ca^  ^release, but 
increased the amplitude of release events. This was associated with an increase in SR 
Ca^  ^content, which is readily understandable since in the presence of tetracaine Ca^ "^  
will continue to load into the SR, but the threshold SR Ca^  ^content necessary to 
initiate Ca release will be higher. It is interesting that the amplitude of each release 
also increased, despite inhibition by tetracaine. This finding is consistent with the 
previous result that tetracaine reduces the open probability of the ryanodine receptor
but does not reduce channel conductance (Overend et a l 1997). Using confocal 
microscopy, tetracaine has been shown to initially reduce the frequency and 
magnitude of Ca^  ^spai'ks in rat cardiac myocytes, but in these experiments this was 
followed by a delayed potentiatory phase where spark frequency, amplitude and 
duration were all increased (Gyorke et a l 1997b). The action of tetracaine was again 
associated with an increase in SR Ca^  ^content. In lipid bilayer experiments the
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application of high concentrations of Ca^  ^overcame the inhibition of channel activity 
induced by tetracaine. In these experiments the dose of tetracaine was significantly 
higher, 0.25-1.25 mM.
In summary, sub-millimolar doses of tetracaine have been shown to inhibit Ca^ "^  
release through the ryanodine receptor, although the mechanism underlying this and 
the site of action of tetracaine remain unproved.
5.1.2 Caffeine.
Caffeine is thought to bind to a specific site on the ryanodine receptor and 
increases the open probability of the channel without affecting the duration of 
opening events (Sitsapesan & Williams, 1990). Caffeine thus acts to potentiate Ca^  ^
-induced Ca^  ^release (Trafford et al. 1998). Since studies described in the preceding 
chapters of this thesis have shown a reduction in the systolic release of Ca^  ^in heart 
failure, caffeine was used to test the hypothesis that by sensitising Ca^  ^-induced Ca^  ^
release, opposite changes in SR function to those seen in heart failure could be 
produced. Such a result would raise the possibility that drugs such as caffeine could 
be used to reverse the abnormalities of SR function seen in heart failure.
At millimolar doses caffeine is thought to cause complete release of SR Ca^  ^
stores, and has therefore been used to assay SR Ca^  ^content (Varro et a l 1993; Bers, 
1987). The effect of caffeine is dose dependent in this range, however. Sustained 
application of caffeine causes a concentration dependent release of Ca^  ^from the 
ryanodine receptor, and the ability of the SR to re-accumulate Ca^  ^is inversely 
dependent on the concentration of caffeine applied in the range 5 - 40mM (Smith & 
Steele, 1998). At high concentrations, caffeine therefore has the effect of causing SR
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depletion, since the rate of SR Ca^  ^release is greater than the maximum rate of 
SERCA 2A mediated SR Ca^  ^re-uptake.
Since the effects of caffeine are dose dependent, however, it remains possible that 
low doses of sustained caffeine application may stimulate Ca^  ^release without 
jeopardising the ability of the SR to re-accumulate Ca  ^'' during the diastolic or rest 
interval, particularly as reduced SR lumenal Ca^  ^concentration is known to stimulate 
SERCA 2A mediated SR Ca^  ^uptake (Inesi & de Meis, 1989). It is therefore possible 
that caffeine could cause a sustained increase in SR Ca^  ^cycling and hence force 
development during myocyte contraction and relaxation. In intact rat myocytes 100- 
200pM caffeine caused only a transient increase the amplitude of the Ca^  ^transient 
(Trafford et a l 1998). This was accompanied by an increase in Na^-Ca^^ exchange 
current, and a decrease in SR Ca^ "^  content. In steady state the amplitude of the Ca^ "*" 
transient returned to control levels despite the reduced SR Ca^  ^content. This data 
confirms that low dose caffeine has a sustained effect on SR function, since the 
predicted effect of reduced SR Ca^  ^content would be a reduction in amplitude of the 
Ca^  ^transient. Since the reduction in SR Ca^  ^content was secondary to increased 
cellular efflux of Ca^ "^  via the Na' -^Ca '^  ^exchanger, the effect of caffeine in 
permeabilised cells without the compounding influence of the Na^-Ca^^ would be to 
increase both SR Ca^  ^release and uptake.
5.1.3 Thapsigargin,
Thapsigargin is a naturally occurring sesquiterpine lactone which interferes with 
intracellular Ca^  ^ control in many cell types. In car diac and skeletal muscle 
thapsigargin reduces systolic SR Ca^  ^release and contraction without directly 
affecting sarcolemmal Ca^  ^currents (Kirby et al 1992). In permeabilised myocytes
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and SR vesicles, thapsigargin blocks oxalate-supported SR Ca^  ^uptake at 
concentrations of-lO nM  (Sagara & Inesi, 1991; Kirby et al. 1992). No effect on 
Ca^^-induced Ca^  ^release in ryanodine receptor enriched SR vesicles is seen with 
thapsigargin (Kirhy et al. 1992).
Thapsigargin acts in cardiac muscle by inliibiting the SR Ca^  ^ATPase SERCA 
2A. Ion transport with SERCA 2A is accomplished hy Ca^  ^binding when the 
enzyme is in a high affinity state (Ej state) and release with the enzyme in a low 
affinity state (Ej state). The shift in state from E, to £ 3  is caused by hydrolysis of 
ATP via the formation of a phosphorylated intermediate (EP). Thapsigargin acts to 
inhibit the £3  form of the enzyme (Kijima et al. 1991). The sensitivity of the Ca^  ^
ATPase to thapsigargin is lower in cardiac muscle than skeletal muscle, but 
sensitivity in cardiac muscle is increased by phosphorylation. Since phospholamban 
also binds to the £ 3  form of SERCA 2A, and phospholamban is modulated by 
phosphorylation, it has been suggested that the binding sites of thapsigargin and 
phospholamban may be close to each other (Kijima et al. 1991).
The central hypothesis of this thesis has heen that abnormal Ca^  ^handling in heart 
failure results from SR dysfunction, which in turns stems from a reduction in the 
activity of SERCA 2A. As discussed in the introduction to this thesis, there is 
substantial evidence that there is a reduction in expression of SERCA 2A in heart 
failure. In addition, the findings in intact and permeabilised myocytes presented in 
eaiiier chapters that there is a reduction in SR Ca^”^ release and SR Ca^  ^load are most 
readily explained by a reduction in SERCA 2A activity. For these reasons, the effect 
of thapsigargin in modelling the changes in SR function seen in heart failure was 
crucial to the support of this hypothesis.
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5.1.4 lonomycin.
lonomycin is a carboxylic acid ionophore which is relatively miselective for the 
transport of several divalent and trivalent cations (Wang et al. 1998; Liu &
Hermann, 1978). One calcium ion is transported across membranes complexed to 
one ionomycin molecule, and each calcium ion is exchanged for 2  protons so that 
the process is electroneutral. The driving force for transport is therefore a 
transmembrane Ca^ "^  or proton gradient (Erdahl et a l 1995).
Little experimental work has been published on the effect of ionomycin on cai'diac 
myocytes. In vascular smooth muscle low doses of ionomycin cause release of Ca^”^ 
from the SR, an effect which is abolished if the SR is depleted prior to addition of 
ionomycin (Smith et a l 1989). Higher doses of ionomycin increase cytosolic Ca^  ^by 
increasing sar colemmal Ca^  ^influx. The basis for the selectivity of action of 
ionomycin at low doses is probably the relatively low affinity of ionomycin for Ca^ ;^ 
higher Ca^  ^concentration within the SR compared to extracellular concentrations 
means that the predominant effect of ionomycin is to transport Ca^  ^across SR 
membranes rather than the sarcolemma.
In other tissues, the effect seems more complex. In myometrium, ionomycin 
induces phasic contractions which can be attenuated by inliibiting the production of 
inositol 1,4,5-triphosphate (IP3), by inhibiting Ca^^-induced Ca^  ^release or by 
blocking sarcolemmal Ca^  ^channels (Phillippe et al 1995). The induction of phasic 
contractions was associated with an increased production of both inositol 1 - 
monophosphate (IPJ and IP3.It is therefore difficult to explain the action of 
ionomycin in this system piuely in terms of a release effect on SR Ca^  ^stores, and it
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is possible that in addition to its action as a Ca  ^^  ionophore, ionomycin acted directly
i '
or indirectly on the phosphotidylinositol signalling pathway.
For the purposes of the studies described in this thesis, the action of ionomycin I
was initially assumed to be simply that of a Ca^  ^ionophore. It seemed likely that the 
action of ionomycin in cardiac myocytes would resemble that in vascular smooth 
muscle, rather than the more complex action described in myometrium. If this
assumption was correct ionomycin would increase SR Ca^  ^leak through a ryanodine-
insensitive pathway. This would reduce SR Ca^ "^  content through a mechanism other 
than the inhibition of SERCA 2A. This pharmacological manipulation was necessary 
since results in permeabilised myocytes described in chapter 3 suggested that SR 
Ca^  ^content was lower in heart failure cells. Since some authors had found
unchanged levels of SERCA 2A in heart failure (eg (Schwinger et al. 1995; Cory et 
al. 1994)), it was important to explore other potential mechanisms for producing the 
heart failure phenotype. While there is no evidence currently available that SR Ca^  ^
leak is increased in heart failure, and studies of SR Ca^  ^uptake and leak in oxalate- 
loaded myocytes described in chapter 4 suggested that in fact the ryanodine 
insensitive SR Ca^  ^leak was reduced in heart failure, these experiments seemed 
worthwhile for completeness.
5.2 Methods.
All experiments in this section were performed on cells from healthy animals 
which had not undergone coronary artery ligation or sham operation. Left ventricular 
function was not measured, but was assumed to be normal. Ventricular myocytes
were dissociated from stock New Zealand White rabbits as described in chapter 2, 
They were then stored as previously at room temperature until experimentation. Two
1 7
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types of experiment were performed. In single cell experiments rate and amplitude of 
spontaneous oscillation and SR Ca^  ^load assayed by Ca^  ^release stimulated by high 
dose caffeine were compared before and after perfusion with the compound under 
study. In a second set of experiments, SR Ca^ "^  uptake was measured in oxalate- 
loaded suspensions of myocytes to confirm the mechanism of action of some of the 
compounds.
5.2.1 Single cell experiments.
Single ventricular myocytes were perfused with O.IR (see appendix for 
composition) at I ml min'^ in a perfusion chamber on an inverted Nikon microscope. 
Cells were anchored using a blunt, sealed microelectrode coated in Celltak to 
improve adhesion. The initial perfusate contained Ipl m f‘ lOmmol CaClj, with 
lOpM Fura-2. Permeabilisation was achieved by briefly exposing the cell to lOOpg 
ml'^ p-escin (final concentration 90nM). Ca^ "^  concentration in the perfusate was then 
raised to a solution containing 3.5 Ipl ml’^  lOmmol CaCl2. This concentration was 
chosen since at this concentration, most cells in the previous experiments had been 
spontaneously active, while above this concentration, the signal to noise ratio 
deteriorated. Permeabilisation was confirmed when Ca^ "^  transients were recorded 
from spontaneously active cells, showing that cytosolic Ca^  ^concentration had risen, 
and that the sarcolemma was permeable to Fura-2. In those cells where spontaneous 
activity was absent after 2 mins in the high Ca^  ^solution, or cells that were active but 
Ca^  ^transients were not seen, a further exposure to p-escin was tried. Cells which 
continued not to respond were discarded. Fluorescence was measured using a Cairn 
spimiing wheel spectrophotometer operating at 30Hz. Previous calibration values for 
R,nnx, Rinii., ^U d K q WCl'C USed.
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The rate and amplitude of spontaneous activity were measured for a period of two 
minutes once a steady state for amplitude and frequency of oscillation had been 
reached. In tetracaine and caffeine experiments, SR Ca^  ^ content was measured after 
this two minute period by microinjecting a solution of lOmmol caffeine which 
contained the same concentration of Ca^  ^and Fura-2 to avoid injection artefact. SR 
Ca^  ^load was measured on 3-4 occasions at 2min intervals until reproducible Ca^ '*' 1
transients were obtained. The perfusate was then changed to one containing the 
compound for study. Rate and amplitude of spontaneous Ca^ "" release was measured 
as the mean of all releases for 30s bins following the change of solution. The 
experiment proceeded until a new steady state was reached, either of cessation of 
spontaneous activity, or for new steady values for amplitude and frequency were 
achieved. Experiments continued for at least 10 mins if no changes in frequency or 
amplitude were apparent. In tetracaine and caffeine experiments, measurement of SR 
load using high dose caffeine injection were performed at 2 min intervals once steady 
state had been achieved. Dose ranging studies were performed for all compounds by 
starting at relatively high concentrations and reducing until no effect was seen. The 
dose ranges used were:
(i) Tetracaine: 50 - lOOpM
(ii) Caffeine: lOOpM
(hi) Thapsigai’gin: lOOnM - lOOpM 
(iv) lonomycin: 15pM - 15nM
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5.2.2 Oxalate-supported Ca^  ^uptake measurements.
Oxalate-supported Ca^ "" uptake was measured in the presence of tetracaine. As 
before myocytes resuspended in 0.05R (see appendix for details) containing lOmM 
oxalate to buffer intra-SR Ca^ "' concentration. They were then counted, and the 
concentration adjusted to give a final concentration of 2.5 10^  m f’ rod shaped 
myocytes. Myocytes were transferred to 2ml cuvettes and lOpM Fura-2 and 90nM p- 
escin added. Fluorescence was measured using a Cairn spinning wheel 
spectrophotometer at 30 Hz. Following a 2min incubation, 10-20 pi of lOmM CaCl^ 
was added to raise cytosolic Ca^  ^concentration to approximately l-2pM. Ca^  ^decay 
curves were then recorded as Ca^  ^ concentration fell due to SR uptake mediated by 
SERCA 2A.
In the case of tetracaine experiments, SR Ca  ^^  uptake was then measured 
following addition of 75pM tetracaine, and then again in the presence of tetracaine 
plus 30pM ruthenium red. The protocol was then repeated in a new batch of cells and 
Ca^  ^uptalce was measured again in the absence of both tetracaine and ruthenium red. 
Ca^  ^uptalce was then measured in the presence of ruthenium red, and finally in the 
presence of both tetracaine and ruthenium red. This allowed any ruthenium red- 
independent action of tetracaine to be measured, since at this concentration, 
ruthenium red can be considered a total blocker of Ca^  ^release at the ryanodine 
receptor. In ionomycin experiments, uptake was measured following the sequential 
addition of ruthenium red and ionomycin. The concentrations of ionomycin and 
tetracaine were chosen from experiments in single cells to be in the range where the 
compound studied had a noticeable steady state effect, but did not cause complete 
inhibition of spontaneous SR Ca^  ^release.
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Results were analysed as previously. 2"^  order exponential decay curves were 
fitted to the data, and time constants calculated from these curves. In the case of 
ionomycin experiments, further analysis of SR Ca^  ^ leak was performed.
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5.3 Results.
5.3.1 Effect on tetracaine on spontaneous Ca^  ^release in single cells.
The effect of tetracaine on permeabilised single cells was measured at doses of 
50pM, 75 pM and lOOpM. In total, experiments were done on 34 cells from 10 
rabbits. A typical experimental record in a spontaneously active cell is shown in fig.
5.2. Here 75pM tetracaine was added to the perfusate of a spontaneously active 
single cell in steady state. Prior to the addition of tetracaine, SR Ca^  ^content was 
assayed by rapid injection of lOmM caffeine. The trace shows that after addition of
■tetracaine, there is a decrease in frequency of spontaneous Ca^  ^release. This is 
associated with a rise in the amplitude of spontaneous Ca^  ^release. The reason for 
the rise in amplitude is shown by the increase in the amplitude of the caffeine 
induced Ca^  ^transient, indieating increased SR Ca^  ^content. Following the removal 
of tetracaine, there is a transient burst of high frequency spontaneous Ca^  ^release, 
before the cell returns to control activity.
The effect of lOOpM tetracaine on frequency of spontaneous release in 14 cells 
from 7 rabbit hearts is shown in table 5.1. The was a reduction in the mean frequency 
of spontaneous SR Ca^  ^release from 0.149 ± 0.012 Hz to 0.028 ± 0.010 Hz, a 
reduction of 77.5 ± 8.1% (p = 9.5 xlO'*^ ) on addition of tetracaine. lOOpM tetracaine 
abolished spontaneous activity in 50% of all cells. The mean frequency of 
spontaneous release in those cells where tetracaine abolished spontaneous release
V
was non-signifîcantly higher than in the other cells (0.176 ±0.013 Hz, p > 0.05). If 
the analysis is restricted to the cells in which there was ongoing spontaneous SR Ca^  ^
release, the effect of tetracaine was to reduce ftequency by 55 ± 7.6%.
Expt. No. Cell no. Control Tetracaine Normalised
Frequency (Hz) Frequency (Hz) Frequency (%)
1 1 0.2 0 0
2 0.13 0.025 19.2
2 3 0.1 0 0
3 4 0.2 0 0
5 0.15 0 0
4 6 0.217 0 0
7 0.233 0 0
5 8 0.1 0.05 50
6 9 0.15 0.058 38.9
10 0.125 0.033 26.7
11 0.108 0.017 15.4
7 12 0.12 0.106 88
13 0.13 0.1 76.9
14 0.129 0 0
mean 0.149 0.028 22.5
SD 0.045 0.037 30.2
SEM 0.012 0.01 8.1
P 9.52 X 10-6
Table 5.1: Effect o f 100jaM tetracaine on the frequency o f spontaneous Ca^  ^release. 
P value shown is calculated from a paired t-test o f control and tetracaine frequency.
The effect of 75pM tetracaine on frequency of spontaneous release in 7 cells from 
3 rabbit hearts is shown in table 5.2. The was a reduction in the mean frequency of 
spontaneous SR Ca^  ^release from 0.250 ± 0.022 Hz to 0.114 ± 0.033 Hz, a reduction 
of 55.2 ± 12.2% (p = 0.002) on addition of tetracaine. 75pM tetracaine abolished 
spontaneous activity in only 1 of 7 cells. In the cells which remained spontaneously 
active the effect of tetracaine was to reduce frequency by 47.7 ± 10.6%.
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Expt. No. Cell no. Control 
frequency (Hz)
Tetracaine 
frequency (Hz)
Normalised 
frequency (%)
1 1 0.2 0.005 2.5
2 0.18 0.1 55.6
2 3 0.23 0.2 87
3 4 0.23 0.13 56.5
5 0.35 0.23 65.7
6 0.28 0 0
7 0.28 0.13 46.4
mean 0.25 0.114 44.8
SD 0.058 0.088 32.3
SEM 0.022 0.033 12.2
P 0.002
Table 5.2: Effect o f 75/.tM tetracaine on the frequency o f spontaneous Ca^ * release. P value shown is 
calculated from a paired t-test of control and tetracaine frequency.
The effect of 50pM tetracaine on frequency of spontaneous release in 13 cells 
from 5 rabbit hearts is shown in table 5.3. There was a reduction in the mean 
frequency of spontaneous SR Ca^  ^release from 0.169 ± 0.018 Hz to 0.137 
+ 0.018 Hz, a reduction of 20.1 + 2.9% (p = 2.23 x 10' )^ on addition of tetracaine. 
This dose of tetracaine did not abolish spontaneous activity in any of the cells 
studied.
Tetracaine thus reduced the frequency of spontaneous SR Ca^  ^release in a dose 
dependent manner. At high doses, spontaneous activity was abolished in 50% of cells 
and markedly reduced in all others. At lower doses the effect was reduced. 
Spontaneous activity was not abolished, and frequency was reduced by ai*oimd 20%. 
The dose dependence of the effect of tetracaine is shown in figure 5.3.
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Expt. No. Cell No. Control 
frequency (Hz)
Tetracaine 
frequency (Hz)
Normalised 
frequency (Hz)
1 1 0.23 0.2 87
2 0.23 0.2 87
2 3 0.258 0.233 90.3
4 0.3 0.267 88.9
3 5 0.142 0.083 58.8
6 0.083 0.075 90
7 0.17 0.117 68.6
4 8 0.108 0.085 78.5
9 0.15 0.114 76.2
10 0.107 0.077 72.1
5 11 0.167 0.133 80
12 0.117 0.108 92.9
13 0.133 0.092 68.8
mean
SD
SEM
0.169
0.066
0.018
0.137
0.065
0.018
79.9 
10.5
2.9
P 2.22x10-6
I
ï
Table 5.3: Effect o f 50pM  tetracaine on the frequency o f spontaneous Ca^  ^release. P  value shown is 
calculated from a paired t-test o f control and tetracaine frequency. Ï
Table 5.4 shows the effect of lOOpM tetracaine on the amplitude of spontaneous 
SR Ca^ "^  release in 6 cells in which spontaneous SR Ca^ "*^  release was not abolished. 
There was a significant increase in the amplitude of release in these cells from 35.4 
±3.1 iiM to 39.2 ±3.2  (p=0.0013). This represented an increase of 11.2 ± 2.2%. The 
amplitude of spontaneous Ca^ '*' release in those cells where this dose of tetracaine 
abolished spontaneous activity was 38.0 ± 5.1 iiM.
■I:
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Expt. No. Cell No. Control 
frequency (Hz)
Tetracaine 
frequency (Hz)
Normalised 
frequency (Hz)
1 1 33.6 40 118.81
2 2 32.4 34.2 105.62
3 31.6 35.8 113.31
4 49.6 54 108.78
3 5 28 32.3 115.39
6 36.9 38.9 105.44
mean 35.4 39.2 111.22
SD 7.6 7.8 5.48
SEM 3.1 3.2 2.24
P 0.0013
Table 5.4: Effect o f lOOpM tetracaine on the amplitude o f spontaneous Ca^  ^release.
P value shown is calculated from a paired t-test o f control and tetracaine amplitudes.
Table 5.5 shows the effect of 75pM tetracaine on the amplitude of spontaneous 
SR Ca^  ^release in the 5 cells in which spontaneous SR Ca^ '*' release was not 
abolished. There was a non-significant increase in the amplitude of release in these 
cells from 62.4 ± 8.4 iiM to 65.2 ± 8.2 (p=0.220). This represented an increase of 6.2 
± 6,3%.
Expt. No. Cell No. Control 
frequency (Hz)
Tetracaine 
frequency (Hz)
Normalised 
frequency (Hz)
1 1 42 48.7 115.82
2 45.5 54.6 120.01
2 3 84.9 86.9 102.33
3 4 62.6 52.6 84.1
5 77 83.8 108.86
mean 62.4 65.3 106.2
SD 18.8 18.4 14.1
SEM 8.4 8.2 6.3
P 0.22
Table 5.5: Effect o f 75pM  tetracaine on the amplitude o f spontaneous Ca^  ^release. 
P value shown is calculated from a paired t~test of control and tetracaine amplitudes.
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Table 5.6 shows the effect of 50pM tetracaine on the amplitude of spontaneous 
SR Ca^  ^release in the 13 cells from 5 experiments. There was a highly significant 
increase in the amplitude of release in these cells from 36.6 ± 2.6 nM to 40.2 ± 2.9 (p 
= 6.58 X 10'^). This represented an increase of 10.1 ± 2.6%.
Expt. No. Cell No. Control 
frequency (Hz)
Tetracaine 
frequency (Hz)
Normalised 
frequency (Hz)
1 1 29.3 31.6 107.85
2 34.4 36.9 107.45
2 3 52 59 113.48
4 57.9 60.3 104.01
3 5 38.1 46.4 121.78
6 35.1 39.5 112.5
7 33.6 37.6 112.04
4 8 30.2 34.4 113.97
9 36.8 36.7 99.72
10 23.6 25.8 109.25
5 11 30.2 32.2 106.69
12 33.7 35.7 105.9
13 40.5 47.2 116.51
mean 36.6 40.2 110.09
SD 9.3 10.3 5.78
SEM 2.6 2.9 1.6
P 6.58E-05
Table 5.6: Effect of 50pM  tetracaine on the amplitude of spontaneous Ca^ '^  release.
P value shown is calculatedfrom a paired t-test o f control and tetracaine amplitudes.
In contrast to the effect of tetracaine on frequency of spontaneous SR Ca^ "*" release, 
the effect on amplitude of spontaneous release was therefore not shown to be dose 
dependent. This is shown in fig. 5.4. 4
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The cause of increased amplitude of spontaneous SR Ca^  ^release was investigated 
by measuring the effect of tetracaine on SR Ca^  ^content. This was done by 
measiuing caffeine-induced SR Ca^  ^release in a subgroup of cells for concentrations 
of tetracaine of 100 pM and 75 pM. In 4 cells from 3 experiments 100 pM tetracaine 
increased the amplitude of caffeine induced Ca^  ^transients in 75% of cells. The mean 
amplitude rose from 53.4 ± 3.7 nM to 61.2 ± 8.5 nM, an increase of 13.3 ± 11.9 % (p 
== 0.2). A clearer effect was seen with 75 pM tetracaine. In experiments on 5 cells 
from 3 rabbit hearts, tetracaine increased the amplitude of caffeine-induced Ca^  ^
transients in all cells. Mean amplitude rose from 63.9 ± 8.8 nM to 82.0 ± 11.4 nM, an 
increase of 28.4 ± 2.5 % (p = 0.002). While numbers in these experiments were 
small, and no experiments looked at the effect of 50 pM tetracaine, as with the 
amplitude of spontaneous SR Ca^  ^release, the effect of tetracaine did not appear to 
be dose dependent.
5.3.2 Effect on tetracaine on SR Ca^  ^uptake and leak in cuvette experiments.
The mid-range dose of 75pM tetracaine was chosen for these experiments. The 
effect of tetracaine on SR Ca^  ^uptake in oxalate-loaded myocytes was measured in 4 
experiments. Representative traces showing the effect on tetracaine prior to the 
addition and following the addition of ruthenium red are shown in figure 5.5. These 
traces show that compared to control conditions, tetracaine caused an increase in the 
rate of Ca^' uptake in these myocytes. Ruthenium red caused a similar increase in the 
rate of Ca^  ^uptake. These traces also show that tetracaine had an small additive 
action to ruthenium red, and that ruthenium red had a similar additive action to 
tetracaine.
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Table 5.7 shows the action of tetracaine and ruthenium red on mean time 
constants and rate constants for Ca^  ^uptake. In the absence of ruthenium red, 
tetracaine increased the rate constant for Ca^^uptake by 81.6 ± 19.4% (p = 0.02). 
Addition of ruthenium red increased the rate constant by a fuidher 53.0 ± 15.7% (p = 
0.03). Similarly, in the absence of tetracaine, ruthenium red increased the rate 
constant for Ca^  ^uptake by 164.7 ± 34.2% (p = 0.01) and addition of tetracaine 
increased the rate constant by a further 7.9 ± 2.4% (p = 0.02).
Both tetracaine and ruthenium red significantly increased the rate of SR Ca^  ^
uptake in oxalate loaded permeabilised myocytes. The effect of 30nM ruthenium red 
was greater than that of 75pM tetracaine. Both compounds had an additive effect to 
each other, and again the addition effect of ruthenium red was greater than the 
additional effect of tetracaine. This is shown in fig. 5.6. In this figure, panel A(i) 
shows the effect of tetracaine normalised to control rate constants. Panel A(ii) shows 
the additional effect of ruthenium red normalised to the rate constants in the presence 
of tetracaine. Panel B shows the reverse effects of the addition of ruthenium red to 
control and then of tetracaine to ruthenium red.
a
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(a) Time constants (s).
Expt. Control Tetracaine Tet. + RR Control RR RR + Tet.
1 48.7 25.7 19.59 47.2 18.2 16.6
2 70.3 31.3 20.4 63.4 16.8 15.9
3 43.9 22.7 11.5 23.1 11.5 11.2
4 127 106.9 82.2 139.6 63.1 55.5
mean 72.48 46.65 33.42 68.33 27.4 24.8
SD 33.01 34.92 28.38 43.58 20.76 17.85
SEIM 16.51 17.46 14.19 21.79 10.38 8.92
(b) Normalised time constants (%).
Expt. Control Tetracaine Tet. + RR Control RR RR + Tet.
1 100 52.77 40.23 100 38.56 35.17
2 100 44.52 29.02 100 26.5 25.08
3 100 51.71 26.2 100 49.78 48.48
4 100 84.17 64.72 100 45.2 39.76
mean 100 58.29 40.04 100 40.01 37.12
SD 15.27 15.19 8.76 8.44
SEIM 7.64 7.59 4.38 4.22
P 0.009 0.0037 0.0006 0.0299
(c) Rate constants (s-1 ).
Expt. Control Tet. Tet. + RR Control RR RR + Tet.
1 0.021 0.039 0.051 0.021 0.055 0.06
2 0.014 0.032 0.049 0.016 0.06 0.063
3 0.023 0.044 0.087 0.043 0.087 0.089
4 0.008 0.009 0.012 0.007 0.016 0.018
mean 0.016 0.031 0.05 0.022 0.054 0.058
SD 0.006 0.013 0.026 0.013 0.025 0.026
SEIM 0.003 0.007 0.013 0.007 0.013 0.013
(d) Normalised rate constants (%).
Expt. Control Tet. Tet. + RR Control RR RR + Tet.
1 100 189.49 248.6 100 259.34 284.34
2 100 224.6 344.61 100 377.38 398.74
3 100 193.39 381.74 100 200.87 206.25
4 100 118.8 154.5 100 221.24 251.53
mean 100 181.57 282.36 100 264.71 285.22
SD 38.71 88.37 68.35 71.17
SEIM 19.36 44.19 34.18 35.58
P 0.0177 0.03 0.0125 0.0158
Table 5.7: effect o f tetracaine (Tet>) and ruthenium red (RR) on time and rate constants for Ca^  ^
uptake in permeabilised myocytes.
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5.3.3. Effect of caffeine on spontaneous SR Ca^  ^release.
The effect of 1 OOpM caffeine on spontaneous SR Ca^  ^release was tested on 13 
cells from 8 rabbit hearts. Following addition of caffeine the mean frequency of 
spontaneous SR Ca^  ^release fell from 0.21 ± 0.02 Hz to 0.20 ± 0.03 Hz. This 
represented a reduction of 5.2 ± 7.45%. This effect was non-significant. There was a 
small accompanying reduction in the amplitude of spontaneous release from 61.0 
± 5.8nM to 52.6 ± 5.5nM, a reduction of 13.6 ± 8.9% (p = 0.049).
5.3.4. Effect of thapsigargin on spontaneous SR Ca^  ^release.
The effect of thapsigargin at concentrations ranging from lOOnM to 15nM was 
measured. Fig 5.7 shows a typical experimental trace of the effect of 30nM 
thapsigai'gin on a spontaneously active single myocyte. In this experiment 
thapsigargin reduced both the frequency and amplitude of spontaneous SR Ca^  ^
release.
(1) Effect on frequency of spontaneous release.
Thapsigargin had a slow onset of action at low concentrations. For this reason 
recordings from spontaneously active cells were made for significantly longer 
periods (up to 30mins) than for experiments using other drugs. It was necessary 
therefore in these experiments to study a control population of cells to ascertain 
whether there was a natural run down of spontaneous activity over the course of this 
time period in the absence of any pharmacological manipulation.
Spontaneous activity was recorded in 13 control cells from 6 rabbit hearts. 
Spontaneous activity ceased within 15mins in only 1 of 13 cells. 11 of 13 cells 
remained spontaneously active after 20mins. The mean frequency of spontaneous 
activity after 15 mins was 72.8 ± 7.2% of control value after 15mins and 58.6 ± 6.4%
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after 21 mins. In cells in which recording was continued for 30 mins, final frequency 
of spontaneous release was 52.2 ± 16.4% of control value. There was therefore some 
diminution of activity, but in the majority of cells activity was relatively stable over 
the course of 15-20 mins.
High concentrations of thapsigai’gin had the effect of abolishing spontaneous SR 
Ca^  ^release. Thus lOOnM thapsigargin abolished spontaneous activity in all cells 
after 15mins, and 50nM thapsigargin abolished spontaneous activity in 50% of cells 
over the same timescale. In contrast all cells exposed to 30nM or lower 
concentrations of thapsigargin remained spontaneously active beyond 15mins. The 
effect of lOOnM - lOOpM thapsigargin at 15mins is shown in fig 5.8. Compared to 
the change in frequency in control cells at 15mins, there was a significant reduction 
in frequency of spontaneous Ca^  ^release in lOOnM (100%, p < 0.001), 50nM (95,0 ± 
5.0%, p < 0.01), 30nM (67.8 ± 7.8%, p< 0.001) and lOnM (43.6 ± 5.6%, p < 0.05) 
thapsigargin. Reductions in frequency caused by InM and lOOpM were not 
significant.
The change in frequency of spontaneous SR Ca^  ^release over time compared to 
control cells for all concentrations of thapsigargin is shown in fig. 5,9. Differences in 
frequencies of spontaneous activity are apparent for different concentrations of 
thapsigargin after 3mins of exposure suggesting that the rate of onset of action of 
thapsigargin is rapid. The ciu'ves continue to diverge for different concentrations of 
thapsigargin, but after 9 minutes the rate of decay in frequency of spontaneous 
release appears similar for all concentrations, suggesting that the action of 
thapsigargin is maximum at this point. Further reductions in frequency beyond 9
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minutes are of the order of those seen in control cells and therefore seem to represent 
the natural tendency for the frequency to decline over time.
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Thapsigargin concentration 0 lOOnIM 50nlM 30nlM lOnlM InIM lOOplM
No of experiments 
No of cells
6
13
1
3
1
2
7
9
5
9
2
5
2
4
Control frequency (Hz) 
(+/-) SEIM
0.21
0.03
0.15
0.04
0.09
0.03
0.19
0.02
0.15
0.02
0.18
0.03
0.17
0.02
3min frequency (% control) 
(+/-) SEIM
98.2
5.2
73.9
5.8
82.3
2.3
88.6
2.6
95,5
1.9
92.2
5.3
83.3
3.5
6min frequency (% control) 
(+/-) SEIM
91.2
6.5
24.2
15.1
50.6
4.4
71.7
5.7
88.8
3
85.3
4.9
68.7
4.9
9min frequency (% control) 
(+/-) SEIM
83.7
7.8
9.1
8
22.7
7.3
58.7
5.3
76.5
3.4
75
7
59.5
8.1
12min frequency (% control) 
(+/-) SEIM
70.7
8.3
2.8
2.8
10
10
42.1
8.1
62.9
4.9
66.2
8.2
57.3
7.2
15min frequency (% control) 
(+/-) SEIM
72.8
7.2
0 12.5
12.5
32.2
8.8
56.4
5.6
55
8.2
50.5
12
18min frequency (% control) 
(+/-) SEIM
64.6
8
0 5
5
39.2
8.9
60.6
5.8
41.4
10
46.9
11.8
21min frequency (% control) 
(+/-) SEIM
58.6
6.4
0 2.5
2.5
30.5
13.4
40.4
3.3
30
8.5
44.7
17.4
Table 5.8 Effect o f lOOnM- lOOpM thapsigargin on frequency o f spontaneous SR Ca^  ^release.
(ii) Effect on amplitude of spontaneous release.
Given the slow onset of action of thapsigargin, the effect was again compared to a 
control group of cells where no pharmacological manipulation was made. This group 
of cells was studied to ascertain whether there was any natural diminution in the 
amplitude of spontaneous SR Ca^  ^release over the timecourse of the experiment. The 
amplitude of spontaneous Ca^  ^release in this group of cells was 108.6 ± 3.4% of the
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initial value at 15 mins, and 102.6 ± 6.9% at 21 mins. In contrast to the reduction in 
frequency of spontaneous release over time, there was therefore no reduction in the -i
amplitude of spontaneous SR Ca^  ^release over 20 mins in this group of cells in the 
absence of thapsigargin. Any reduction in amplitude seen in the experimental group 
could therefore be attributed to the action of thapsigai'gin.
The effect of thapsigargin at concentrations from lOOiiM to lOOpM is shown in 
table 5.9. At high concentration thapsigargin abolished spontaneous SR Ca^  ^release.
At lOOnM, thapsigargin abolished spontaneous activity in all cells within 15 mins.
50nM thapsigargin abolished activity in all but one cell within the same timescale.
As can be seen from table 5.9, lower concentrations of thapsigargin caused a dose
jdependent steady state reduction in the amplitude of spontaneous SR Ca^  ^release.
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Thus at 15 mins the percentage of control amplitude for 30nM, lOnM, InM and 
lOOpM thapsigargin was 63.1 ± 5.2 % (p = 0.001), 82.1 ± 8.2 % (p = 0.02), 97.3 ±
i f '7.8% (p = ns) and 100.2 ± 9.9% (p = ns). The dose dependency of the effect of 
thapsigargin is shown in figiu'e 5.10.
• i rI I
Thapsigargin concentration 0 lOOnM 50nM 30nM lOnM InM lOOpM
No of experiments 
No of ceiis
6
13
1
3
1
2
7
9
5
9
2
5
2
4
Controi amplitude (nM) 
(+/-) SEWI
39.8
6.8
53.6
6.9
33.1
3.2
53.7
6.1
42.8
4.4
31.7
4.7
47.1
8.7
3min ampiitude (% controi) 
(+/-) SEM
107
2.3
81.3
11.1
93.4
0.4
93.9
1.5
97.7
5
109.7
5.2
95.6
4.8
6min ampiitude (% control) 
(+/-) SEM
106.4
2.1
70.2 77.5
1.2
84.6
2.7
96.2
5.9
106.7
7.5
85.8
4.4
9mln ampiitude (% controi) 
(+/-) SEM
106.2
2
51.3 61.6
3
75
5.1
93.4
5.9
103.4
10.7
87.6
5.8
12min ampiitude (% controi) 
{+/-) SEM
104.8
2.6
40.3 57.5 68.5
6
89.6
7.1
103.3
8.6
91.4
7.7
15min ampiitude (% controi) 
{+/-) SEM
108.6
3.4
0 35.9 63.1
5.2
82.1
8.2
97.3
7.8
100.2
9.9
18min ampiitude (% controi) 
{+/-) SEM
109.1
5
0 35.8 61
6.9
73.2
9.2
84.4
5.3
90.7
13.9
21min ampiitude (% controi) 
(+/-) SEM
102.6
6.9
0 35.8 71.3
2.5
46.8
4.6
89.4
10.4
92.3
9.4
Table 5.9 Effect o f lOOnM - lOOpM thapsigargin on amplitude of spontaneous SR Ca^ * release.
5.3.5. Effect of ionomycin on spontaneous SR release.
The effect of ionomycin at concentrations ranging from 1.5mM to 15nM was 
measm-ed. Fig 5.11 shows a typical experimental trace of the effect of 15nM 
ionomycin on a spontaneously active single myocyte. In this experiment ionomycin 
reduced the frequency of spontaneous SR Ca^  ^release, but had no apparent action on 
the amplitude of Ca^  ^release.
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(i) Effect on frequency of spontaneous release.
Ionomycin had a significant effect on the frequency of spontaneous SR Ca^  ^
release. This is shown in table 5.10. At higher concentrations of 1.5pM and 150nM, 
ionomycin abolished spontaneous SR Ca^  ^release within 4 mins in all cells studied. 
The action of ionomycin was rapid in these cells, and a significant reduction in 
frequency was observed 2 mins after the addition of ionomycin before total cessation 
of spontaneous activity within 4 mins. The effect of 15nM ionomycin, the lowest 
concentration studied was to abolish spontaneous activity in some cells, and reduce 
the frequency of spontaneous release in the group. Thus spontaneous activity ceased 
by 10 mins in 1 of 6 cells, and by 12 mins in 3 of 6 cells. In contrast a significant 
reduction in frequency was apparent 4 mins after addition of ionomycin, although no 
effect was apparent after 2 mins. These data are also shown in fig. 5.12.
I
Ionomycin Expts Cells Controi 2 min 4 min 6 min 8 min 10 min 12 min
cont. Freq. (Hz) (%) (%) (%) (%) (%) (%)
1.5mM 3 5 mean
SEM
P
0.165
0.019
35.2
7.5
<0.0001
0
0
<0.0001
150nM 4 5 mean
SEM
P
0.093
0.023
47.5
18.8
<0.05
0
0
<0.01
15nM 3 6 mean 0.092 96.9 70.3 65.4 50.1 36 17,3
SEM 0.017 5.9 3.5 8.2 4.2 9.1 9.6
P >0.05 0.001 0.01 0.002 0.001 <0.05
Table 5.10: Effect o f ionomycin on frequency on spontaneous SR Ca^ '^  release. (Frequencies shown 
normalised to control, p  values calculated from paired t tests on absolute frequencies compared to 
control).
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seem to be any steady state reduction in amplitude of spontaneous SR Ca^  ^release;
1
Ionomycin thus had a concentration dependent effect on the frequency of §
spontaneous SR Ca^  ^release. At high concentrations the effect was rapid and 
abolished activity within 4mins. At lower concentration, the effect was also rapid: 
there was a significant reduction in fr equency of spontaneous release within 2 mins 
compar ed to control. The magnitude of this effect increased over the course of 10 
mins.
(ii) Effect on amplitude of spontaneous release.
Ionomycin at concentrations of 1.5p,M and 150nM abolished spontaneous SR Ca^  ^
release within 4 mins in all cells, and so no steady state effect on amplitude of 
spontaneous release could be assessed. At 15nM ionomycin spontaneous activity was
?..
abolished in only 1 cell of 6 from 3 hearts, but in the other cells there was no change Iin amplitude within 10 mins. This is shown in table 5.11. In summary, there did not
spontaneous activity was either abolished or continued at the same amplitude despite If
,S;
a reduction in frequency of release.
. ' I iI,
Ï
II
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ionomycin Expts Ceiis Controi 2 min 4 min 6 min 8 min 10 min
cone amp. (nM) (%) (%) (%) (%) (%)
1.5 mM 3 5 mean
SEM
P
38.6
3.5
93.8
2.8 
<0.05
0 0 0 0
150 nM 4 5 mean
SEM
P
30.8
6.5
93.9
5.1
>0.05
0 0 0 0
15 nM 3 6 mean
SEM
P
35
3
101.8
3.5
>0.05
100
5
>0.05
99.7
3.4
>0.05
99.2
5.2 
>0.05
99.9
4.2
>0.05
Table 5.11 Effect of 15 n M - 1.5 p M  ionomycin on the amplitude o f spontaneous SR Ca^ '^  release over 
a lOmin timecourse.
5.4 Discussion.
The primaiy purpose of the studies described in this chapter was to attempt to 
model the changes in SR function seen in heart failure by pharmacological 
manipulation of SR function. Further information on normal SR function may also be 
gained from this type of study, however, as well as insight into the action of the four 
compounds under study.
5.4.1 Modelling heart failure.
The characteristics of spontaneous SR Ca^  ^release in permeabilised myocytes 
from failing and normal hearts were described in chapter 3. Essentially, both the 
frequency and amplitude of spontaneous SR Ca^  ^release were reduced in cells from 
failing hearts. The direction of the effect of the four compounds studied on amplitude 
and frequency of spontaneous SR Ca^ "" release is compared to the changes seen in 
heart failure in table 5.12. In terms of direction of change thapsigargin was the only
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1
'i:
compound to model the decrease in both amplitude and frequency seen in heart 
failure.
Mechanism of 
action:
Effect on 
Amplitude
Effect on 
Frequency
Heart Failure ? U U
Tetracaine -ve RyR Û h
Caffeine +ve RyR Jf izj.
Thapsigargin -ve SERCA u h
Ionomycin +ve leak h
Table 5.12 Comparison o f the major effects o f tetracaine, caffeine, thapsigargin and ionomycin 
on the amplitude andfrequency o f spontaneous SR Ca^  ^release, in relation to the changes in these 
parameters in heart failure. (RyR: ryanodine receptor, SERCA: SR Ca^ * ATPase).
A bipolar plot of the percentage change in amplitude and frequency for heart 
failure (compared to sham) and the four compounds is shown in figure 5.13. In 
heart failure cells there was a reduction in frequency of spontaneous SR Ca^  ^release 
of 44.6 ± 16.1% for Ca^  ^solution 2 (see section 3.2.4 for details) and 14.9 ± 14.0% 
for Ca^  ^solution 3, giving a mean reduction in frequency of 29.8 ± 15%. There was a 
reduction in amplitude of 45.3 ± 6.3% and 33.7 ± 5.6% for the same solutions giving 
a mean reduction of 39.4 ± 5.9%. These figures can be compared with thapsigargin, 
the only compound to significantly reduce both amplitude and frequency of
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spontaneous release. Direct compar ison is difficult given the range of effects of 
thapsigargin at different doses and the fact that the magnitude of effect of 
thapsigargin increases with time of exposure, but if a moderate dose of thapsigargin 
is chosen and a median time point is examined (i.e. 30 pM at 12 mins) the reduction 
in frequency of 57.9 + 8.1% and amplitude of 31.5 ± 6.0% approximates to the 
changes seen in heart failure, although there may be a slightly greater effect on 
amplitude compared to frequency in heart failure, with the reverse seen with 
thapsigargin. As can be seen from fig 5.13, the changes induced with the other 
compounds modelled the changes in heart failure poorly.
Close modelling of the changes in SR function seen in heart failure by 
thapsigargin supports the hypothesis that abnormal Ca^  ^handling in heart failure 
results from a reduction in the activity of SERCA 2A. However possible 
explanations as to why thapsigargin did not produce the exact changes seen in heart 
failure need to be considered. There are three possible explanations for this:
(i) SR dysfunction in heart failure results from multiple alterations in the 
function of SR components.
(ii) The extent of changes in SR function modelled by thapsigargin was 
within the bounds of experimental error in comparison to the changes 
in heart failure.
(iii) Mechanisms other than those considered above result in SR 
dysfunction in heart failure, and the close modelling of these changes 
by thapsigargin is coincidental.
These explanations are not mutually exclusive.
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Perhaps the weakness of this pharmacological approach to studying SR 
dysfunction is that it is assumed that changes in SR function result from a single 
mechanism. In fact, given the cyclical nature of the processes of SR Ca^  ^uptake and 
release, it would be surprising if one component of SR function could be altered 
without a concomitant change in other processes. It is possible from the data above 
to postulate the effects of multiple pharmacological manipulations. However the 
necessary effect to add to that of thapsigargin would be one that reduced amplitude of 
spontaneous release without altering frequency. In this way a smaller thapsigargin 
effect with this postulated second effect would more accurately model heart failure. 
The difficulty of this is that no other compound had this effect, and so with the 
current data, the effect of thapsigai'gin could not be better matched to heart failm'e. 
Since other possible modulations of SR function are possible and have not been 
tested, however, this approach remains possible.
The possibility remains that these experiments were not accuiate enough to 
reliably distinguish the effects of heart failure and thapsigargin. As has been 
discussed, the actions of thapsigargin at different concentrations and time points were 
measured, and changes in the effect of thapsigargin were seen, making comparisons 
difficult. However, any changes in frequency and amplitude of spontaneous Ca^  ^
release induced by thapsigargin tended to vary in a parallel mamier, and no 
concentration or time point chosen would have given relatively different magnitudes 
of effect on amplitude compared to frequency. This contrasts, however, with the 
findings in heart failure cells, described in chapter 3. The amplitude of Ca^  ^release 
in heart failure cells was reduced to a similar extent compared to sham cells at all 
cytosolic Ca^  ^concentrations, there was a non-linear relationship between cytosolic
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concentration and the difference between frequency of Ca^  ^release in heart 
failure and sham cells.
The possibility that there are other theoretical modulations of SR function that 
have not been considered here can also not be discounted, but this is a hypothesis that 
can never be tested by this type of experiment. The corollary of this argument is that 
for the a reduction in the activity of SERCA 2A not to be the underlying cause of SR 
dysfunction in heart faihne, it is necessary to invoke hypothetical changes in SR 
function which are not based upon currently understood physiology.
5.4.2 Insights into SR function.
The simplest paradigm of spontaneous SR Ca^  ^release is a system where Ca^ '*' is 
taken up into the SR by SERCA 2A until SR Ca^  ^overload occurs and spontaneous 
release causes emptying of stored Ca^ "^ . The effects of ionomycin, tetracaine and 
thapsigargin, as well as the observed changes in heart failure confirm that this is an 
oversimplification of the system.
The theoretical effect of reducing the activity of SERCA 2A, and hence the rate 
of SR Ca^ ^  accumulation would be to reduce the frequency of spontaneous SR Ca^ "' 
release, since the length of time taken for the intraluminal Ca^  ^concentration to reach 
tlu'eshold for spontaneous release would be longer. In this simple system there is no 
mechanism for the alteration in amplitude of Ca^  ^release that is observed both in 
heart failure and with thapsigargin. Here there is a concomitant decrease in both 
frequency and amplitude of Ca^ "^  release. In control cells the reverse of this occurs; as 
cytosolic Ca^  ^concentration is raised both amplitude and frequency increase. The 
unifying feature in these circumstances is that the amplitude of Ca^  ^release seems to 
depend upon the rate of SR Ca^ "*^  accumulation.
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The effect of ionomycin complicates the system further. By increasing the SR 
Ca^ "" leak, ionomycin should have the saiue theoretical effect as thapsigargin, in that 
the rate of SR Ca^  ^accumulation will be reduced, although the mechanism of this 
reduction is different. In the presence of ionomycin, however, there is a reduction in 
frequency of SR Ca^  ^release as expected, but amplitude is unaffected. This suggests 
that modulation of the amplitude of spontaneous Ca^  ^release is not absolutely 
dependent of the rate of SR Ca  ^'' accumulation. An attractive hypothesis is that the 
modulation of amplitude of Ca^  ^release depends not on the simple rate of SR Ca^ '^  
accumulation, but on SERCA 2A activity. This suggests a link between SR Ca^  ^
uptake and release.
The effect of tetracaine is also interesting. Tetracaine acts to inhibit SR Ca^  ^
release at the ryanodine receptor. As discussed earlier, possible mechanisms of 
action of tetracaine include reducing single channel conductance of the ryanodine 
receptor, reducing the open probability of the receptor, decreasing the sensitivity of 
the receptor to cytosolic Ca^  ^or reducing the sensitivity of the ryanodine receptor to 
lumenal Ca^ .^ In this experimental system, tetracaine reduced the frequency of 
spontaneous Ca^  ^release, but increased the amplitude. If it is assumed that tetracaine 
has no action on SERCA 2A, then a reduction in frequency of spontaneous SR Ca^  ^
release means that lumenal Ca^  ^concentration is higher in the presence of tetracaine 
prior to release, and this increased lumenal Ca^  ^overcomes the action of tetracaine. 
Wlien SR Ca^  ^release occurs the amplitude of this release reflects the increased SR 
load. This suggests that tetracaine is not acting to reduce single chamiel 
conductance, since the effect is on the likelihood of release rather than the degree of 
release.
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A possible paradigm of spontaneous SR Ca  ^^ release is as follows. In the presence 
of high cytosolic Ca^  ^concentration in unstimulated cells, lumenal Ca^  ^
concentration rises due to SERCA 2A mediated SR Ca^  ^uptake. At low lumenal Ca^  ^
concentration the open probability of the ryanodine receptor is low, and therefore 
unitary Ca^  ^release episodes are infrequent. These infrequent unitary releases of Ca^  ^
are insufficient to trigger Ca^^-induced Ca^  ^release. As lumenal Ca^ "^  concentration 
rises the open probability of the ryanodine receptor increases. Greater frequency of 
unitary Ca^  ^ release occurs, and there is a greater likelihood that sufficient unitary 
release events occur to trigger Ca^^-induced Ca^  ^release. In this paradigm tetracaine 
could act in any of the three ways not yet discounted. Tetracaine could reduce open 
probability, reduce the sensitivity of open probability to lumenal Ca^ '*' concentration, 
or reduce the sensitivity of Ca^^-induced Ca^  ^release. In any of these cases an 
increase in lumenal Ca^  ^concentration would overcome the effect of tetracaine and 
the present data therefore cannot separate these possibilities.
As was discussed previously, the effect of thapsigargin on both frequency and 
amplitude of SR Ca^  ^release suggested that there may be a functional link between 
SR Ca^  ^uptake and release beyond that mediated by lumenal Ca^  ^concentration. In 
the experiments with tetracaine, while there is no evidence that inhibition of Ca^ '*' 
release at the ryanodine receptor has an inhibitory effect on SR Ca^  ^uptake, such an 
effect camiot be excluded. In uptake experiments the effect of inhibiting Ca^  ^release 
with tetracaine was to increase the rate of net SR Ca^  ^accumulation. This does not, 
however give any direct information on possible changes in SERCA 2A activity 
brought about by inliibiting Ca^  ^release. The fact that tetracaine caused an additional
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iIincrease in the rate of SR Ca^  ^accumulation independently of the action of ruthenium | |
red may suggest that tetracaine has a direct stimulatory action on SERCA 2A.
5.5 Summary.
In smnmary, inliibition of SERCA 2A mediated SR Ca^  ^uptake most closely 
mimicked the changes on amplitude and frequency of spontaneous SR Ca^  ^release II
seen in heart failure. This suggests that a reduction in the activity of SERCA 2A 
underlies abnormal SR function in heart failure, rather than changes in Ca^  ^release 
characteristics of the ryanodine receptor.
Differences in the actions of thapsigargin and ionomycin suggest that there are 
processes in the SR which regulate Ca^  ^release independently of lumenal Ca^  ^ #
concentration. These regulatory processes may link the activity of SERCA 2A to the 
Ca  ^*^ release characteristics of the ryanodine receptor. Whether there is a bi­
directional effect can neither be confirmed or excluded. Tetracaine may have a direct 
action on SERCA 2A.
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Chapter 6: Studies in human myocytes.
6.1 Background.
The use of animal models of human disease is a powerful tool in the investigation 
of the pathophysiological processes of disease. Animal models have several clear 
advantages for scientists, including tissue availability, the absence of co-morbidity or 
disease modifying treatment, and the ability to produce a relatively homogenous 
disease population. In contrast, the study of disease processes in human cardiac tissue 
is made difficult by the frequent co-existence of morbid conditions such as 
hypertension, diabetes, myocardial ischaemia, pulmonary disease and many others. 
The untreated patient population is also virtually non-existent, and common 
cardiological treatments may all have significant effects on the disease process. Thus 
few patients with significant heart failure will not be treated with combinations of 13- 
blockers, ACE inhibitors, diuretics, Ca^  ^antagonists and cardiac glycosides. Given 
the multifactorial aetiology of heart failure, and the pathophysiological interplay 
between the p-adrenergic system, the renin-angiotensin system, cellular remodelling 
and E-C coupling, it is clear that pharmacological treatment might confound 
pathological changes in cellular function.
In addition to these problems, the investigation of human heart failme is further 
hampered by the difficulty in obtaining human tissue. Since functional study is not 
possible on post-mortem cardiac specimens, tissue can only be obtained from living 
donors under special conditions of cardiac surgery or transplantation. Clearly only 
small tissue samples can be removed from hearts other than at transplantation.
Despite these difficulties, if there is to be any therapeutic gain from this type of 
research, the study of human tissue is necessary. This reseai'ch must delineate any
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species differences, and establish whether the presence of co-morbidity and medical 
therapies significantly alter the pathophysiological process. The study of human 
tissue in heart failure research is therefore an important challenge.
6.1.1 Difficulties in obtaining human myocardial tissue.
Most previous studies have obtained myocardial tissue from explanted hearts 
taken duiing cardiac transplantation. In most cases, the pathology in these hearts 
comprises ischaemic and idiopathic dilated cardiomyopathy, with rarer cases of 
valvular heart disease and viral myocarditis. Explanted hearts have provided tissue 
for prepar ations including isolated myocytes(Harding et a l 1992b), 
trabeculae(Denvir et a l 1995), papillary muscles(Schwlnger et a l 1992) and 
ventricular muscle strips(Hasenfuss et a l 1994). For many of these studies the only 
control tissue available has come from occasional donor hearts which could not be 
implanted for teclmical reasons. In addition to the rarity of this control tissue, donor 
hearts have frequently been exposed to high doses of inotropic drugs during the
I
period prior to harvesting, which may have significant effects on myocardial 
physiology. A further problem with the use of explanted heaids is that all 
experimental tissue comes from patients with end stage heart failure. There is 
therefore no opportunity to study the pathophysiological process early in the disease 
process, where therapeutic interventions may be more successful, and in all cases, 
patients will be on multiple medical therapies.
These problems have led investigators to develop methods for obtaining 
myocardial tissue from patients undergoing routine cardiac surgery, in most cases 
coronary artery bypass grafting or valvular surgery. This does not allow tissue to be 
taken from non-diseased hearts, but provides tissue from patients with normal
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ventricular function, and varying degrees of left ventricular dysfunction. This allows 
the study of heart failure in the early stages of the disease process and during its 
progression to terminal stages, as well as providing reasonable control tissue. It is not 
possible to obtain papillary muscle or trabeculae preparations from routine cardiac 
surgery, but methods for dissociating single myocytes from small atrial and
Jventricular biopsies have been developed(Peeters et a l 1995), and small epicardial
ventricular muscle strips can be dissected safely(Hasenfuss et a l 1990). Left
ventricular volume reduction surgery (the Batista procedure(Batista et a l 1996))
.provides larger amounts of myocardial tissue for either dissociation of myocytes or %
.dissection of trabeculae, although this procedure is only undertaken in patients with 
severe heart failine, and myocardium removed is often scarred.
6.1.2 Conflicts between animal and human studies.
In general, studies of force development and shortening in human myocytes and |
multicellular preparations are in keeping with animal studies. There is a negative 
fbrce-ffequency relationship in papillary muscle preparations (Schwinger et a l 1992; if
Schwinger et al 1993), and this correlates with the degree of left ventricular 
dysfunction (Schmidt et a l 1994). Differences in contractile force are difficult to 
detect at basal stimulation rates, but are more apparent at higher frequencies and 
during inotropic stimulation. Similarly, single cell studies have shown a clear 
blunting in the positive force frequency relationship in cells from failing hearts with 
significant increases in time to peak contraction, and time to 50% and 90% |
relaxation (Davies et a l 1995), although changes in cell contraction during basal 
stimulation were difficult to detect (Harding et a l 1991).
.1"
Changes in the Ca^ "^  transient in human heart failure are also broadly in keeping 
with animal studies. Gwathmey noted that Ca^  ^transients in human trabeculae were 
prolonged (Gwathmey et a l 1987), although peak systolic Ca^  ^levels were 
unchanged. In general, most studies in human myocytes and trabeculae 
(Beuckelmann et al 1995; Beuckelmann et a l 1992; Pieske et a l 1995) have shown 
a reduction in peak Ca^  ^availability. While there is general agreement from animal 
studies that the Ca^  ^transient is prolonged, the effect of left ventricular dysfunction 
on systolic Ca^  ^release is less clear. Studies in a canine pacing-induced induced 
model (Perreault et a l 1992), and a hypertensive rat model (Zhang et a l 1995) found 
no reduction in systolic Ca^  ^release, whereas peak Ca^  ^has been found to be 
reduced in cardiomyopathic hamsters (Kruger et al 1994), post-infarct rats (Capasso 
et a l 1993; Zhang et al 1995). This suggests that alterations in systolic Ca^  ^
handling may depend more on the pathological insult than the particular species, 
which may have implications for human study, given the broad range of aetiologies 
of heart failure in some series.
There is greater conflict in human and animal studies when sarcolemmal Ca^  ^
currents have been measured. Several studies have found reduced density of the L- 
type Ca^  ^current in animal models of cardiac hypertrophy and failure (Ming et al 
1994; Ouadid et a l 1995; De Brito Santos et a l 1995). In contrast, no reductions in 
Ca^ "^  current density have been found in myocytes isolated from failing human hearts
(Mewes & Ravens, 1994; Beuckelmann et a l 1992). There seems to be no consensus 
on changes in the activity of the Na' /^Ca '^  ^exchanger in either animal or human 
studies.
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Changes in expression of SERCA 2A in heart failure ai’e also controversial. 
Although mRNA for SERCA 2A has been found to be reduced in human heart 
failure, protein levels have been found to be normal by some groups (eg (Movsesian 
et a l 1994; Schwinger et a l 1995)), and reduced in others (eg (Meyer et a l 1995; 
Hasenfuss et a l 1994)). In contrast, the majority of investigators have found reduced 
protein expression of SERCA 2A in several animal models including the rabbit 
coronary artery ligation preparation(eg (Currie & Smith, 1999; Stein et a l 1996; 
Matsui et a l 1995; Kiss et a l 1995)).
In summary, it appears that evidence for the pathophysiological mechanisms of 
altered Ca^  ^ handling in human heart failure is less convincing than in animal 
models. However, clear evidence in human heart failure might best be described as 
lacking, rather than being in contradiction to animal studies. This may reflect the 
inherent difficulties in doing human research, or the possibility of some 
heterogeneity of mechanism depending upon the aetiology of heart failure, and it 
would be premature to conclude that there are major differences in the cellular 
pathophysiology of heart failure in humans and animal models.
6.2 Methods.
The purpose of these studies was to investigate methods for the dissociation of 
viable, single myocytes, and to assess the feasibility of applying the techniques for 
measuring Ca^  ^transients in intact and permeabilised myocytes described in earlier 
chapters.
6.2.1 Access to myocardial tissue.
Four possible sources of myocardial tissue were identified:
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reason patients were not consented for removal of atrial myocardium.
(i) Atrial myocardium taken during the placement of atrial cannulae at 
the time of cardiopulmonary bypass.
(ii) Epicardial ventricular biopsies during cardiac surgery.
(iii) Ventricular myocardial tissue removed during ventricular volume 
reduction surgery.
(iv) Ventricular myocardial tissue taken from explanted hearts.
Tliree cardiac surgeons agreed to collaborate and supply myocardial tissue for 
these studies. These were:
(i) Mr SK Naik (Glasgow Royal Infirmary).
(ii) Mr GA Berg (Western Infirmary Glasgow).
(iii) Mr K McArthur (Western Infirmary Glasgow).
." ' . i
Relatively large samples of atrial tissue were freely available from all procedures 
involving cardiopulmonary bypass. The teclinique of cardiopulmonary bypass 
involves placing two intravascular cannulae, one in the right atrial appendage and f t
one in the ascending aorta. This forms an extracorporeal bypass circuit where venous 
blood is removed from the right atrium, oxygenated at a controlled temperature and
pumped back into the ascending aorta. The bypass pump therefore performs the work
"ïï
necessary to maintain the circulation with oxygenated blood during cardioplegia and
cardiac surgery. The placement of the atrial cannulae opens the atrium and produces If
an flap of atrial tissue, samples of which can be safely removed. This tissue may be
redundant following bypass and can be considered a surgical by product. For this
"ÏI
I
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Atrial tissue was used in early experiments to explore methods for dissociation of 
myocytes, since relatively large samples were available. Since virtually all previous 
investigation of the pathophysiology of heart failure has studied ventricular 
myocardium, and changes in the function of atrial myocytes aie not well 
characterised, atrial myocytes were considered unsuitable for detailed experiments.
Most studies were carried out on epicardial biopsies taken from patients 
undergoing coronary artery bypass grafting. This procedure is undertaken on most 
days in both local hospitals used to provide tissue, and samples were therefore 
available as required. Since the removal of a ventricular biopsy was an additional 
procedure to routine cardiac suigery, all patients who donated samples were 
approached and gave written, informed consent. The patient information / consent 
form was designed in conjunction with the medical ethics committees at both 
hospitals. Two biopsy techniques were evaluated. The first teclmique used a “trucuf ’ 
needle. This needle removed a <lm m  diameter core of myocardium from the free 
wall of the left ventricle. The length of the core was up to 1cm depending upon the 
operator, thus the epicardial and mid-myocardial layers of the ventricle were 
sampled. The defect did not require suturing and no complications ensued. The 
second teclmique involved dissection of the pericardial fat from the free wall of the 
left ventricle and the removal of a small, superficial chunk of epicardial myocardium. 
The maximum dimensions of the sample were approximately 3mm^. The defect did 
not require to be sutured, and again no complications ensued.
More rarely, tissue was available fi’om ventricular volume reduction surgery, the 
Batista procedure (Batista et al. 1996). This procedure was carried by Mr Naik on 
patients with severe heart failure and dilated left ventricles. The basis of this
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procedure is that as the removal of a portion of the left ventricular wall causes a 
reduction in left ventricular dimensions. Applying the law of Laplace, this reduces 
the developed tension necessary for ventricular contraction and thus reduces 
myocardial work and energy consumption. The majority of the patients undergoing 
this type of surgery had ischaemic heart disease, with previous myocardial infarction. 
Although large sections of the left ventricle were removed during operation, the 
tissue removed tended to contain large quantities of scai" tissue, making myocyte 
dissociation more difficult. Since the myocardium was removed as part of the 
operation, patient consent was not sought for the use of part of the excised 
myocardium.
Finally, tissue was available from explanted hearts as part of the Scottish Cai’diac 
Transplantation program. Approximately 50 transplants per year are carried out at 
Glasgow Royal Infirmary, and myocardium was removed by dissection as soon as 
practicable following explantation. Consent was not sought from patients for the 
removal of this tissue.
6.2.2 Transport of myocardial tissue.
To maximise cardioprotection, epicardial biopsies were always taken following 
cardioplegic arrest of the heart. This ensured that all myocytes were quiescent, and 
energy stores were preserved as much as possible. Samples from patients undergoing 
volume reduction surgery were also removed after cardioplegia. Following removal, 
myocardial samples were immediately stored in oxygenated medium at 0° Celsius 
and transported to the laboratory as soon as possible. The transport medium 
composition was (in mM): 120 NaCl, 5.4 KCl, 0.5 MgSO^, 5.0 sodium pyruvate,
20 glucose, 20 taurine, 30 2,3-butanedione monoxime (BDM), 10 N-2-
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hydroxyethylpiperazine- N'-2~ethanesulphonic acid (HEPES) and 6 nitrilotriacetic 
acid (NT A) with pH adjusted to 7.0 with sodium hydroxide. NT A acted as a Ca^  ^
buffer, maintaining Ca^  ^concentration at sub-micromolar levels. BDM acts on the 
myofilaments to inliibit Ca^^-activated force production (Steele & Smith, 1993), and 
thus acts as a cardioprotective agent. Myocardial samples reached the laboratory in 
10-30 minutes depending upon which hospital surgery took place in.
6.2.3 Dissociation of myocytes.
Initial attempts to dissociate myocytes followed the methods of Peeters (Peeters et 
al. 1995). Biopsy material was cut into small fragments (~lmm^ ) with a scalpel 
under a lOx dissecting microscope. This procedure was done in the transport medium 
to prevent the tissue drying out, Peeters had used a mechanical tissue sheer to cut 
400pm slices, but epicardial biopsies in these experiments were too small to this to 
be technically feasible.
Tissue fragments were then transferred to conical flasks containing digestion 
medium. The composition of the digestion medium was the same HEPES buffered 
salt solution containing 0.2% bovine serum albumin. NT A was omitted fiom this 
solution and Ca^  ^concentration was raised to 50pM. This solution was maintained at 
35-37° Celsius.
Myocardial tissue was then digested in 3-4 stages. The first stage used collagenase 
and protease. The efficacy of two preparations of collagenase were assessed, 
collagenase type la  (Sigma pharmaceuticals, St Louis, MO) and collagenase type 1 
(Worthington Chemicals). Protease type XIV (Sigma) was used. The concentrations 
of both protease (0.5-1 mg / ml) and collagenase (l-4mg / ml) were varied. 
Myocardial tissue was gently agitated in this solution by continuous shaking and
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periodic tituration. The length of the first digestion was varied from 10-30 mins. No 
myocytes were successfully dissociated during the first stage of digestion. Tissue 
fragments were then transferred to a second flask containing identical digestion 
medium, but with collagenase and hyaluronidase (0.5 mg ml. Sigma). Again, 
incubation time varied from 10-30 mins. In some experiments, the effect of adding 
elastase (0.5 mg / ml, type IV, Sigma) was tested. Following this phase of digestion, 
myocytes had begun to dissociate from tissue fragments. Intact tissue fragments were 
then gently aspirated from the digestion medium and placed into a flask containing 
collagenase only, for the third stage of digestion. The supernatant from the second 
digestion was gently centrifuged at around lOOg for 2 mins. All enzyme solution was 
aspirated, and cells were resuspended in the HEPES buffered salt solution at room 
temperature. This process was repeated after the third stage of digestion, and in some 
experiments, an identical fourth digestion took place. Following each of the second, 
third and fourth digestions, a small sample of the resuspension was examined under a 
microscope for the presence of rod shaped myocytes. In early experiments, 
assessment of Ca^  ^tolerance of myocytes was made by gradually raising Ca^  ^
concentration in the HEPES buffered salt solution, initially to 250pM, and then in 
stages to 2mM. Unfortunately, most cells were found not to be Ca^  ^tolerant, and few 
myocytes remained rod shaped when extracellular Ca^  ^was raised.
6.2.4 Permeabilised myocyte experiments.
Since most cells were not Ca^  ^tolerant, analogous experiments to those in intact 
rabbit myocytes were not possible. It was therefore decided to assess whether human 
cells could be permeabilised and measurements made of SR load and spontaneous 
release. Similar protocols were used to those described in chapter 3.
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Briefly, myocytes were placed in a perfusion chamber on an inverted Nikon 
microscope and perfused at 1ml min  ^with O.IR containing lOpM Fura-2. 
Fluorescence was monitored using a Cairn spinning wheel spectrophotometer. Ca^ '^  
concentrations within the perfusate were the same as described in chapter 3, with 0, 
1,2,3 and 4pl of lOmM CaCl^ added per ml to produce solutions with a range o f 
Ca^  ^concentrations from approximately 50nM to 250nM. Myocytes were anchored 
using blunt, sealed microelectrodes, and permeabilised by brief exposure to 90nM (3- 
escin. SR Ca^  ^release was stimulated by microinjecting 2-3 pL of lOmM caffeine 
close to the cell at low bathing Ca^  ^concentration (solutions 0, 1 and 2). Spontaneous 
SR Ca^ "^  release was seen at higher Ca^ "^  concentrations.
6.3 Results.
6.3.1 Dissociation of atrial myocytes.
15 experiments were performed on the dissociation of human atrial myocytes. The 
mass of atrial tissue removed varied from 80-3 5Opg. Rod shaped myocytes were 
successfully dissociated from the second experiment onwards. In total dissociation 
successfully produced myocytes in 80% of experiments. Myocyte numbers varied 
following dissociation fiom 4-10 per high-power field.
Atrial myocytes showed reasonable Ca^  ^tolerance. Ca^  ^concentration was raised 
successfully to 2pM. Although numbers of rod shaped myocytes decreased in all 
experiments when Ca^  ^concentration was raised, around 50% of myocytes retained 
their shape and clear- cross striations when Ca^  ^was raised.
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6.3.2 Dissociation of ventricular myocytes from myoeardial biopsies.
30 experiments were undertaken to dissociate myocytes from epicardial 
ventricular biopsies. 10 of these were from trucut biopsies, and 20 from epicardial 
dissection biopsies. Trucut biopsies were of the order of 2mg, dissected biopsies 
ranged from 1-1 Omg in size. Biopsies were further dissected into smaller chunks 
using a dissecting microscope and scalpels. The biopsies were too small to have been 
mounted for preparation on a tissue sheer. Rod shaped myocytes were successfully 
dissociated in around 50% of experiments. This figure was similar’ for dissociations 
from both trucut and dissected biopsies. Maximum numbers of myocytes dissociated 
were 3-5 rods per high power field, and mean numbers in successful experiments 
were 1-3 rods per high power field.
6.3.3 Dissociation of ventricular myocytes from excised myocardium.
3 experiments were undertaken in myocardium taken from ventriculai’ volume
reduction surgery. Approximately 50-100g of ventricular myocardium was removed 
in each procedure. In all three cases, the myocai’dium removed was extremely 
fibrotic. Approximately 5 g of this tissue was removed for dissociation of cells.
Tissue with the lowest apparent scar content was selected. This tissue was then
!
dissected into small chunks. Myocardium from this source would have been suitable
for mormting on a tissue sheer if this had been available. Incubation times with 
digestive enzymes were increased to allow for the high content of fibrous tissue. 
Small numbers of rod shaped myocytes were dissociated in 2 of three experiments, 
with fewer than one myocyte per high-power field seen. In these experiments, the
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myocytes that were dissociated had a granular appearance. Cells from these 
dissociations were too few in number to proceed to further study.
6.3.4 Dissociation of ventricular myocytes from explanted hearts.
3 experiments were undertaken in myocai’dium taken from explanted hearts. In 
each case, the tissue was from terminally failing hearts, rather than unused donor 
hearts. Myocardium was taken from both the left and right ventricles. Tissue from the 
left ventricle tended to consist of more scar and fibrous tissue than the right. Sections 
of tissue of around 5g were taken. Myocytes were successfully dissociated from 2 of 
3 hearts. Maximum numbers of myocytes were 5-10 rods per high power field.
6.3.5 Permeabilisation of ventricular myocytes.
The limiting stage in experiments on permeabilised myocytes was the dissociation 
process. In addition there was a significant reduction in the numbers of rod shaped 
myocytes surviving both the dissociation process and storage mitil permeabilisation 
experiments could be undertaken. Although the number of experiments on 
permeabilised myocytes was small, the process of permeabilisation did not cause 
significant further attrition.
The most successful dissociation experiments were undertaken in myocardium 
from explanted hearts. Most successful experiments in permeabilised cells where 
therefore done on cells from this source. Some cells from epicardial biopsies were 
also successfully permeabilised, but cells fi’om venli’icular reduction surgery were of 
insufficient number and quality for this to be attempted. Atrial cells were also 
successfully dissociated, but permeabilisation was not attempted in these cells as 
protocols for permeabilisation had not been developed at this point.
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Permeabilised human myocytes behaved qualitatively like permeabilised rabbit 
myocytes. Cells contracted in response to injection of lOmmol caffeine and Ca^ ' 
transients could be recorded simultaneously. Raising cytosolic Ca^  ^to 150-200nM 
caused spontaneous oscillatory SR release. A typical record from a
permeabilised myocyte dissociated from an explanted heart is shown in figure 6.1.
6.4 Discussion.
These experiments show that investigation of SR function in human myocytes is 
practicable, though significantly more difficult than work on rabbit myocytes. The 
chief practical difficulty lies in the dissociation of rod shaped myocytes, rather than 
in applying methods for permeabilisation and study of SR function developed in 
rabbit myocytes. Current methods aie less successful in producing Ca^  ^tolerant cells 
where Ca^  ^homeostasis can be investigated at the whole cell level. Myocytes are not 
produced in sufficient numbers to make it feasible to measure oxalate supported SR 
Ca^  ^uptake without major adaptation to the protocol used in rabbit myocytes.
There are several possible reasons for the difficulties observed in dissociating 
human myocytes:
(i) Mass o f tissue. The size of ventricular biopsies taken for these experiments is at 
least an order of magnitude lower than that used by other groups working in 
this area (Sian Harding, personal communication). The most successful 
dissociations in these experiments were from explanted hearts where larger 
amounts of tissue were available. It would be possible to obtain larger biopsies
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Insufficient data were generated to make quantitative comparisons with rabbit 
myocytes possible.
■f.
from operative samples, though this would require further assessment from an 
ethics and safety perspective.
(ii) Enzymatic tissue access. Rabbit myocytes were dissociated using Langendorff 
perfusion of the whole heart with proteolytic enzymes. Digestive enzymes were 
therefore perfused tlirough the capillary network and thus had close access to 
all myocytes. Digestion of human myocytes was done using the chunk method, 
and therefore enzymes had to diffuse into the centre of the tissue to access all 
but the most superficial myocytes. Smaller tissue fragments would alleviate 
this problem, and thus there would be a clear theoretical advantage to the use of 
a tissue sheer, if the size of ventricular biopsy allowed this. Tissue slicing 
would maximise the surface area of tissue available to enzymes and minimise 
diffusion distances into the centre of tissue. This would allow for the use of 
shorter incubation times and lower concentrations of enzyme and minimise 
membrane damage caused by digestive enzymes. The partial success of pre­
incubating tissue with enzyme at low temperatuie (when enzyme will be 
inactive) suggests that improving tissue access would be beneficial.
(iii) Degree o f fihrosis. The fact that dissociation of myocytes from explanted 
hearts was more successful than from myocardial tissue taken during 
ventricular volume reduction surgery suggests that the degree of myocardial 
scarring / fibrosis affects the success of dissociation. This effect can also be 
seen in the fact that dissociation from explanted hearts was only marginally 
more successfi.il than dissociation from biopsies, despite the difference in mass 
of tissue of several orders of magnitude.
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This suggests that dissociation would be most successful in non-failing hearts 
without significant fibrosis, and the mass of tissue required for successful 
dissociation would be higher in failing hearts.
(iv) Ischaemic time. The mean time delay from taking the biopsy to the beginning 
of the dissociation process was in the order of 30mins. This compares with a 
delay of probably under 1 minute from sacrifice to Langendorff perfusion in 
the rabbit. The fact that successful cardioplegic protection of explanted hearts 
for transplantation is routine argues against this being a significant problem, 
but it remains possible that myocytes are more easily damaged by digestive ÿ
enzymes following an ischaemic period.
6.5 Future work.
These experiments have shown that the methods for studying SR function 
developed in rabbit single myocytes can be applied to human cells. As discussed in 
earlier chapters, experiments in rabbit tissue have characterised the abnormalities of 5
SR function in the coronary artery ligation model of hear t failure. The future 
direction of this work should therefore be concentrated on human tissue.
The first priority of any future work would be to improve techniques for 
dissociation of human myocytes. The most obvious changes in the technique would 
be to utilise larger biopsies and employ tissue slicing methods to maximise tissue 
access for the digestive enzymes. Once adequate numbers of myocytes could be 
dissociated, quantitative studies of SR function could be done to ascertain whether f
human SR behaves in the same manner to rabbit SR in this permeabilised 
preparation.
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Following these early experiments, SR function could be compared in failing and 
non-failing hearts. By utilising tissue from biopsies and from explanted hearts, 
changes in SR function in both mild and severe heart failure could be explored.
Material from explanted heaits and from ventricular volume reduction surgery could 
be used to ascertain whether changes in SR function in heart failure are seen in both 
endocardial and epicardial regions of the ventricular wall.
Finally, methods for measuring oxalate-supported SR Ca^  ^uptake could be |
developed for small masses of human ventricular tissue.
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Chapter 7: Summary.
Gwathmey showed in 1987 that Ca^  ^transients were prolonged in heart failure 
(Gwathmey et a l 1987). Evidence that myocyte contractile and lusitropic 
abnormalities contributes to mechanical dysfimction in heart failure was discussed in 
the introduction to this thesis. Following Gwatlimey’s initial findings, other groups 
have reported abnormalities in sarcolemmal Ca^  ^transport and in sarcoplasmie 
reticulum flmction. More recently abnormalities of expression of sarcoplasmic 
reticulum proteins have been described, which have been used to explain abnormal 
Ca^  ^handling in heart failure. Many of these findings remain controversial, and the 
both importance of abnormal Ca^  ^handling in the pathogenesis of heart failure and 
the exact mechanisms underlying it remain unresolved. Increasingly, manipulation of 
expression of SR proteins is being used to answer these questions and identify 
potential therapies.
The initial aim of the studies described in this thesis was to characterise 
abnormalities of Ca^  ^handling at the cellular level in the coronary artery ligation 
model of heart failui'e in the rabbit. Experiments in intact myocytes confirmed 
abnormal Ca^  ^handling in this model. The predominant abnormalities were slowing 
of diastolic Ca^  ^re-uptake, slowed systolic Ca^  ^release and reduced amplitude of 
systolic Ca^  ^release. These changes were more apparent in endocardial myocytes 
than epicardial cells, probably as a result of greater wall stress during ventricular 
remodelling.
Following this the permeabiiised single myocyte preparation was developed to 
assess the contribution of SR dysfunction to the changes seen in Ca^ "^  handling at the 
whole cell level. In these experiments, there was a significant reduction in the
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amplitude of caffeine-induced and spontaneous SR Ca^  ^release. The most likely 
explanation for these findings was a reduction in SR Ca^  ^content in heart failure 
cells, reflecting reduced activity of the SR Ca^  ^pump SERCA 2A.
Experiments were next designed to directly measure SERCA 2A mediated SR 
uptake to test the hypothesis that a reduction in SR Ca^  ^uptake underlay the 
reduced SR Ca^  ^content seen in studies of single permeabiiised myocytes. The main 
finding from these experiments measuring Ca  ^'' uptake in suspensions of 
permeabiiised myocytes confirmed that there was a reduction in the activity of 
SERCA 2A. In addition these experiments suggested that there was an increase in 
ryanodine-dependent SR Ca^  ^leak in myocytes from failing hearts.
The validity of these results was supported by pharmacological modelling o f SR 
function. Inhibition of SERCA 2A -mediated SR Ca^  ^uptake most closely mimicked 
the changes on amplitude and frequency of spontaneous SR Ca^  ^release seen in heart 
failure. This supported the hypothesis that a reduction in the activity of SERCA 2A 
underlies abnormal SR function in heart failuie, rather than changes in Ca^  ^release 
characteristics of the ryanodine receptor.
Differences in the actions of thapsigargin and ionomycin suggest that there are 
processes in the SR which regulate Ca^ "^  release independently of lumenal Ca^  ^
concentration. These regulatory processes may link the activity of SERCA 2A to the 
Ca^ "^  release characteristics of the ryanodine receptor. Wliether there is a bi­
directional effect can neither be confirmed or excluded. Tetracaine may have a direct 
action on SERCA 2A.
Finally some of the teclmiques developed for study of SR function in 
permeabiiised myocytes were applied successfully to myocytes isolated from human
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left ventricle. Future experimental work will be undertaken to establish whether the 
pathological mechanisms identified in the rabbit model of heart failure contribute to 
the pathogenesis of human heart failure.
188
References.
AFZAL, N. & DHALLA, N. S. (1992). Differential ehanges in left and right ventricular 
SR calcium transport in congestive heart failure. American Journal o f  Physiology ~ 
Heart and Circulatory Physiology 262, H868-H874.
ARAI, M., ALBERT, N. R., MACLENNAN, D. ,H., BARTON, P. & PERIASAMY, M. 
(1993). Alterations in sarcoplasmic reticulum gene expression in human heart failure. A 
possible mechanism for alterations in systolic and diastolic properties of the failing 
myocardium. Circulation Research 72, 463-469.
ARAI, M., MATSUI, H. & PERIASAMY, M. (1994). Sarcoplasmic reticulum gene 
expression in cardiac hypertrophy and heart failure. Circulation Research 74, 555-564.
ATAR, D., GAO, W. D. & MARBAN, E. (1995). Alterations of excitation-contraction 
coupling in stunned myocardium and in failing myocardium. Journal o f  Molecular and 
Cellular Cardiology 27, 783-791.
BARTEL, S., STEIN, B., ECSHENHAGEN, T., MENDE, U., NEUMANN, J., 
SCHMITZ, W., KRAUSE, E. G., KARCZEWSKI, P. & SCHOLZ, H. (1996). Protein 
phosphorylation in isolated trabeculae from non-failing and failing human hearts. 
Molecular and Cellular Biochemistry 157, 171-179.
BASSANI, J. W. M., YUAN, W. & BERS, D. M. (1995). Fractional SR Ca release is 
regulated by trigger Ca and SR Ca eontent in cardiac myocytes. American Journal o f  
Physiology 26^, C1313-C1329.
BASSANI, R. A. & BERS, D. M. (1995). Rate of diastolic Ca release from the 
sarcoplasmic reticulum of intact rabbit and rat ventricular myocytes. Biophysical 
Journal 68, 2015-2022.
BATISTA, R. J. V., SANTOS, J. L. V., TAKESHITA, N., BOCCHINO, L., LIMA, P. 
N. & CUNHA, M. A. (1996). Partial left ventrieulectomy to improve left ventricular 
function in end-stage heart disease. Journal o f  Cardiac Surgery 11, 96-97.
BERS, D. M. (1987). Ryanodine and the calcium content of cardiac SR assessed by 
caffeine and rapid cooling contractures. American Journal o f  Physiology 253, C408- 
C415.
BERS, D. M. (1991). Excitation-contraction coupling and cardiac contractile force. 
Dordrecht: Kluwer Academic Publishers.
BEUCKELMANN, D. J., NAB AUER, M. & ERDMANN, E. (1992). Intracellular 
calcium handling in isolated ventricular myocytes from patients with terminal heart 
failure. Circulation 85, 1046-1055.
189
BEUCKELMANN, D. J., LINDNER, M. & ERDMANN, E. (1994). Sarcoplasmic- 
reticuluiîi calcium content is altered in isolated ventricular myocytes from patients with 
heart-failure. Circulation 90, 216
BEUCKELMANN, D. J., NAB AUER, M., KRUGER, C. & ERDMANN, E. (1995). 
Altered diastolic [Ca^ ]^; handling in human ventricular myocytes from patients with 
terminal heart failure. American Heart Journal 129, 684-689.
BOHM, M., REIGER, B., SCHWINGER, R. H. G. & ERDMANN, E. (1994). cAMP 
concentrations, cAMP dependant protein kinase activity, and phospholamban in non­
failing and failing myocardium. Cardiovascular Research 28, 1713-1719.
BOLUYT, M. O., O'NEILL, L., MEREDITH, A. L., BING, O. H. L., BROOKS, W.
W., CONRAD, C. H., CROW, M. T. & LAKATTA, E. G. (1994). Alterations in cardiac 
gene expression during the transition from stable hypertrophy to heart failure. 
Circulation Research 75, 23-32.
BOWDITCH, H. P. (1871). Uber die Eigenthumlichkeiten der Reizbarkeit, welch die 
Muskeifasem des Herzens zeigen. Ber. Sachs. Ges. (Akad) Wiss. 652-689.
BRAUNWALD, E. & GROSSMAN, W. (1992). Heart Disease. Philadelphia: WB 
Saunders.
BRILLANTES, A., ALLEN, P., TAKAHASHI, T., IZUMO, S. & MARKS, A. R. 
(1992). Differences in cardiac calcium release channel (ryanodine receptor) expression 
in myocardium from patients with end-stage heart failure caused by ischemic versus 
dilated cardiomyopathy. Circulation Research 71, 18-26.
BUCKLEY, N. M., PENEFSKY, Z. J. & LITWAK, R. S. (1972). Comparative force- 
frequency relationships in human and other mammalian ventricular myocardium. 
Pflugers Arch. 332, 259-270.
CANNELL, M. B., SOELLER, C., SANTANA, L. F. & LEDERER, W. J. (1997). 
Regulation of SR calcium release by the local calcium current in cardiac myocytes. 
Journal o f  Molecular and Cellular Cardiology 28, A216
CAPAS SO, J. M., PENG, L. & ANVERS A, P. (1993). Cytosolic calcium transients in 
myocytes isolated from rats with ischemic heart failure. American Journal o f  
Physiology 265, H I953-H I964.
CARTER, L. F. & RUBIN, S. A. (1994). The molecular and cellular biology of heart 
failure. Current Opinion in Cardiology. 9, 264-271.
CLARKE, K. W., GRAY, D. & HAMPTON, J. R. (1995). How common is heart 
failure? Evidence from PACT (Prescribing Analysis and Cost) data in Nottingham. 
Journal o f  Public Health Medicine 17, 459-464.
190
COLYER, J. & WANG, J. H. (1991). Dependence of cardiac sarcoplasmic reticulum 
calcium pump activity on the phosphorylation status of phospholamban. Journal o f  
Biological Chemistry 266, 17486-17493.
CORNWELL, T. L., PRYZWANSKY, K. B., WYATT, T. & LINCOLN, T. M. (1991). 
Regulation of sarcoplasmic reticulum protein phosphorylation by localised cyclic GMP- 
dependent protein kinase in vascular smooth muscle cells. Molecular Pharmacology 40, 
923-931.
CORY, C. R., MCCUTCHEON, L. J., OGRADY, M., PANG, A. W., GEIGER, J. D. & 
O'BRIEN, P. J. (1993). Compensatory down-regulation of myocardial ca channel in SR 
from dogs with heart-failure. American Journal o f Physiology 264, H 926-H 937.
CORY, C. R., GRANGE, R. W. & HOUSTON, M. E. (1994). Role of sarcoplasmic 
reticulum in loss of load-sensitive relaxation in pressure overload cardiac hypertrophy. 
American Journal o f Physiology 266, H68-H78.
COWIE, M. R., MOSTERD, A., WOOD, D. A., DECKERS, J. W., POOLE-WILSON, 
P. A., SUTTON, G. C. & GROBBEE, D. E. (1997). The epidemiology of heart failure. 
European Heart Journal 18, 208-225.
CURRIE, S. & SMITH, G. L. (1996). Phosphorylation of phospholamban is altered 
after myocardial infarction. Journal o f  Molecular and Cellular Cardiology in press,
CURRIE, S. & SMITH, G. L. (1997). The rate of Ca^ "^  uptake is reduced in SR vesicles 
from coronary artery ligated rabbit hearts. Journal o f  Molecular and Cellular 
Cardiology 29, A96
CURRIE, S. & SMITH, G. L. (1999). Enlianced phosphorylation of phospholamban and 
downregulation of sarco / endoplasmic reticulum Ca^  ^ATPase type 2 (SERCA 2) in 
cardiac sarcoplasmie reticulum from rabbits with heart failure. Cardiovascular Research 
41, 135-146.
DARVISH, A. & MORAVEC, C. S. (1994). Decreased sarcoplasmic reticulum calcium 
content in the failing human heart is associated with a decrease in Ca^^-ATPase and 
phospholamban proteins. Circulation 90,1-217
DAVIES, C. H., DAVIA, K., BENNETT, J. G., PEPPER, J. R., POOLE-WILSON, P.
A. & HARDING, S. E. (1995). Reduced contraction and altered frequency response of 
isolated ventricular myocytes from patients with heart failure. Circulation 92, 2540- 
2549.
DAVIES, C. H., HARDING, S. E. & POOLE-WILSON, P. A. (1996). Cellular 
mechanisms of contractile dysfunction in human heail failure. European Heart Journal 
17, 189-198.
191
DE BRITO SANTOS, P. E., BARCELLOS, L. C , MILL, J. G. & MASUDO, M. O. 
(1995). Ventricular action potential and L-type calcium current in infarct-induced 
hypertrophy in rats. Journal o f  Cardiovascular Electrophysiology 6, 1004-1014.
DEL MONTE, F., O'GARA, P., POOLE-WILSON, P. A., YACOUB, M. &
HARDING, S. E. (1995). Cell geometry and contractile abnormalities of myocytes from 
failing human left ventricle. Cardiovascular Research 30, 281-290.
DENVIR, M. A., MACFARLANE, N. G., COBBE, S. M. & MILLER, D. J. (1995). 
Sarcoplasmic-reticulum and myofilament function in chemically-treated ventricular 
trabeculae from patients with heart-failure. Cardiovascular Research 30, 377-385.
DENVIR, M. A., MACFARLANE, N. G., MILLER, D. J. & COBBE, S. M. (1996). 
Enlianced SR function in saponin-treated ventricular trabeculae from rabbits with heart 
failure. American Journal o f  Physiology - Heart and Circulatory Physiology 271, H850- 
H859.
DIAZ, M. E., TRAFFORD, A. W., O'NEILL, S. C. & EISNER, D. A. (1997). 
Measui’ement of sarcoplasmic reticulum Ca^  ^content and sarcolemmal Ca^ "^  fluxes in 
isolated rat ventricular myocytes during spontaneous Ca^  ^release. Journal o f  Physiology 
501,3-16.
ENDO, M., YAGI, S. & UNO, M. (1982). Tension-pCa relation and sarcoplasmic 
reticulum responses in chemically skinned smooth muscle fibers. Federation 
Proceedings 41, 2245-2250.
192
DIXON, I. M., HATA, T. & DHALLA, N. S. (1992). Sarcolemmal calcium transport in 
congestive heart failure due to myocardial infarction in rats. American Journal o f  
Physiology 262, H1387-H1394.
DROUIN, E., CHARPENTIER, F., GAUTHIER, C., LAURENT, K. & LE MAREC, H. 
(1995). Electrophysiologic characteristics of cells spanning the left ventricular wall of 
human heart: evidence for presence of M cells. Journal o f the American College o f  
Cardiology 26, 185-192.
EISNER, D. A., TRAFFORD, A. W., DIAZ, M. E., OVEREND, C. L. & O'NEILL, S. 
C. (1998). The control of Ca release from the cardiac sarcoplasmic reticulum: regulation 
versus autoregulation. Cardiovascular Research
ERDAFIL, W. L., CHAPMAN, C. J., TAYLOR, R. W. & PFEIFFER, D. R. (1995). 
Effects of ph conditions on ca2+ transport catalyzed by ionophores a23187, 4-bra23187, 
and ionomycin suggest problems with common applications of these compounds in 
biological systems. Biophysical Journal 69, 2350-2363.
FABIATO, A. (1982). Calcium release in skinned cardiac cells: variations with species, 
tissues, and development. Federation Proceedings 41, 2238-2244.
Î
FELDMAN, A. M., WEINBERG, E. O. & RAY, P. E. (1993). Selective changes in 
cardiac gene expression during compensated hypertrophy and the transition to cardiac 
decompensation in rats with clironic aortic banding. Circulation Research 73, 184-192.
FIGUEREDO, V. M., BRANDES, R., WEINER, M. W., MASSIE, B. & CAMACHO, 
S. A. (1993). Endocardial versus epicardial differences of intracellular free calcium 
under normal and ischaemic conditions in perfused rat heart. Circulation Research 72, 
1082-1090.
FIGUEREDO, V. M, & CAMACHO, S. A. (1994). Basic mechanisms of myocardial 
dysfunction: cellular pathophysiology of heart failure. Current Opinion in Cardiology. 
9, 272-279.
FLESCH, M., SCHWINGER, R. H. G., SCHIFFER, F., FRANK, K., SUDKAMP, M., 
KUHN-REGNIER, F., ARNOLD, G. & BOFIM, M. (1996). Evidence for functional 
relevance of an enhanced expression of the Na -^Ca '^*' exchanger in failing human 
myocardium. Circulation 94, 992-1002.
GO, L. O., MOSCFIELLA, M. C., WATRAS, J., HAND A, K. K., FYFE, B. S. & 
MARKS, A. R, (1995). Differential regulation of two types of intracellular calcium 
release channels during end- stage heart failure. Journal o f  Clinical Investigation. 95, 
888-894.
GRYNKIEWICZ, G., POENIE, M. & TSIEN, R. Y. (1985). A new generation ofCa"+ 
indicators with greatly improved fluorescence properties. Journal o f  Biological 
Chemistry 6, 3440-3450.
GWATHMEY, J. K., COPELAS, L., MACKINNON, R., SCHOEN, F. J., FELDMAN, 
M. D., GROSSMAN, W. & MORGAN, J. P. (1987). Abnormal intracellular calcium 
handling in myocardium from patients with end-stage heart failure. Circulation 
Research 61, 70-76.
GWATHMEY, J. K., SLAWSKY, M. T., HAJJAR, R. J., BRIGGS, G. M. & 
MORGAN, J. P. (1990). Role of intracellular calcium handling in force-interval 
relationships of human ventricular myocardium. Journal o f  Clinical Investigation. 85, 
1599-1613.
GWATHMEY, J. K., WARREN, S. E., BRIGGS, G. M., COPELAS, L., FELDMAN, 
M. D., PHILLIPS, P. J., CALLAHAN, M., SCHOEN, F. J., GROSSMAN, W. & 
MORGAN, J. P. (1991). Diastolic dysfunction in hypertrophic cardiomyopathy. Effect 
on active force generation during systole. Journal o f Clinical Investigation. 87, 1023- 
1031.
GWATHMEY, J. K. & INGWALL, J. S. (1995). Basic pathophysiology of congestive 
heart failure. Cardiology Reviews 3, 282-291.
GYORKE, S., LUKYANENKO, V. & GYORKE, I. (1997a). Dual effects of tetracaine 
on spontaneous calcium release in ventricular myocytes. Biophysical Journal 72, A163
193 i
GYORKE, S., LUKYANENKO, V. & GYORKE, I. (1997b). Dual effects of tetracaine 
on spontaneous calcium release in rat ventricular myocytes. Journal O f Physiology- 
London 500, 297-309.
HAIN, J., ONOUE, H., MAYRLEITNER, M., FLEISCHER, S. & SCHINDLER, H. 
(1995). Phosphorylation modulates the function of the calcium release channel of 
sarcoplasmic reticulum from cardiac muscle. Journal o f Biological Chemistry 270, 
2074-2081.
HAJJAR, R. J„ KANG, J. X., GWATHMEY, J. K. & ROZENZWEIG, A. (1997a). 
Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum calcium 
ATPase in isolated rat myocytes. Circulation 95, 423-429.
HAJJAR, R. J., SCHMIDT, U., KANG, J. X., MATSUI, H. & ROZENZWEIG, A. 
(1997b). Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. 
Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca^  ^-ATPase. 
Circulation Research 81, 145-153.
HARDING, S. E., JONES, S. M., O'GARA, P., VESCOVO, G. & POOLE-WILSON, 
P. A. (1990). Reduced p-agonist sensitivity in single atrial cells from failing human 
hearts. American Journal o f  Physiology 259, H1009-H1014.
HARDING, S. E., MACLEOD, K. T., JONES, S. M., VESCOVO, G. & POOLE- 
WILSON, P. A. (1991). Contractile responses of myocytes isolated from patients with 
cardiomyopathy. European Heart Journal. 12, 44-48.
HARDING, S. E., JONES, S. M., O'GARA, P., DEL MONTE, F., VESCOVO, G. & 
POOLE-WILSON, P. A. (1992a). Isolated ventricular myocytes from failing and non­
failing human heart; the relation of age and clinical status of patients to isoproterenol 
response. Journal o f  Molecular and Cellular Cardiology 24, 549-564.
HARDING, S. E., JONES, S. M., VESCOVO, G., DEL MONTE, F. & POOLE- 
WILSON, P. A. (1992b). Reduced contractile responses to forskolin and a cyclic AMP 
analogue in myocytes from failing human ventricle. European Journal o f  
Pharmacology, 223, 39-48.
HASENFUSS, G., MULIERI, L. A., BLANCHARD, E. M., HOLUBARSCH, C., 
LEAVITT, B. R., ITTLEMAN, F. & ALPERT, N. R. (1990). Energetics of isometric 
force development in control and volume-overload human myocardium. Circulation 
Research 68, 836-846.
FIASENFUSS, G., MULIERI, L. A., LEAVITT, B. J., ALLEN, P. D., HAEBERLE, J. 
R. & ALPERT, N. R. (1992). Alteration of contractile function and excitation- 
contraction coupling in dilated cardiomyopathy. Circulation Research 70, 1225-1232.
HASENFUSS, G., REINECKE, H., STUDER, R., MEYER, M., PIESKE, B., HOLTZ, 
J., HOLUBARSCH, C., POSIVAL, H., JUST, H. & DREXLER, H. (1994). Relation
194
between myocai-dial function and expression of sarcoplasmic reticulum Ca2+-ATPase in 
failing and non-failing human myocardium. Circulation Research 75, 434-442.
HATEM, S. N., SHAM, J. S. K. & MORAD, M. (1994). Enhanced Na^ - Ca^ + exchange 
activity in cardiomyopathic Syrian hamster. Circulation Research 74, 253-261.
HE, H., GIORDANO, F. I., HILAL-DANDAN, R., CHOI, D., ROCKMAN, H. A., 
MCDONOUGH, P. M., BLUHM, W. F., MEYER, M., SAYEN, M. R., SWANSON, E. 
& DILLMAN, W. H. (1997). Overexpression of the rat sarcoplasmic reticulum Ca^ '*' 
ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac 
relaxation. Journal o f  Clinical Investigation. 100, 380-389.
HITTINGER, L„ MIRSKY, I., SHEN, Y. T., PATRICK, T. A., BISHOP, S. P. & 
VATNER, S. F. (1995). Hemodynamic mechanisms responsible for reduced 
subendocardial coronary reserve in dogs with severe left-ventricular hypertrophy. 
Circulation 92, 978-986.
HOLMBERG, S. R. M. & WILLIAMS, A. J. (1989). Single channel recordings from 
human cardiac sarcoplasmic-reticulum. Circulation Research 65, 1445-1449.
HOMCY, C. J., VATNER, S. F. & VATNER, D. E. (1991). P- adrenergic receptor 
regulation in the heart in pathophysiologic states: abnormal adrenergic responsiveness 
in cardiac disease. Annual Review o f  Physiology. 53, 137-159.
HOVE-MAD SEN, L. & BERS, D. M. (1993a). Passive Ca buffering and SR Ca uptake 
in permeabiiised rabbit ventricular myocytes. American Journal o f  Physiology 264, 
C677-C686.
HOVE-MADSEN, L. & BERS, D. M. (1993b). Sarcoplasmic reticulum Ca^  ^uptake and 
thapsigargin sensitivity in permeabiiised rabbit and rat ventricular myocytes.
Circulation Research 73, 820-828.
INESI, G. & DE MEIS, L. (1989). Regulation and steady-state filling in sarcoplasmic 
reticulum. Journal o f  Biological Chemistry 264, 5926-5936.
IS AC, M., MORANO, I. & RUEGG, J. C. (1988). Alteration of calcium sensitivity of 
skinned frog skeletal muscle fibres by inositol triphosphate and calmodulin antagonists.
Pflugers Arch. 412, 253-257.
ITOH, T., SUZUKI, S. & KURIYAMA, H. (1991). Effects of pinacidil on contractile 
proteins in high K+ -treated intact, and in b-escin-treated skinned smooth muscle of the 
rat mesenteric artery. British Journal o f Pharmacology 103, 1697-1702.
JANCZEWSKI, A. M., SPURGEON, H. A., STERN, M. D. & LAKATTA, E. G. 
(1995). Effects of sarcoplasmic reticulum Ca^  ^load on the gain function of Ca^  ^release 
by Ca^  ^current in single cells. American Journal o f Physiology 268, H916-H920.
195
KANNEL, W. B., HO, K. & THOM, T. (1994). Changing epidemiological features of 
cardiac failuie. British Heart Journal 72, S3-S9.
KANNEL, W. B. & BELANGER, A. J. (1991). Epidemiology of heart failure.
American Heart Journal 121, 951-957.
KIJIMA, Y., OGUNBUNMI, E. & FLEISCHER, S. (1991). Dmg action of thapsigargin 
on the Ca^'^pump protein of sarcoplasmic reticulum. Journal o f Biological Chemistry 
266, 22912-22918.
KIRBY, M. S., SAGARA, Y., GAA, S., INESI, G., LEDERER, W. J. & ROGERS, T.
B. (1992). Thapsigargin inhibits contraction and Ca^  ^transient in cardiac cells by 
specific inhibition of the sarcoplasmic reticulum Ca^  ^pump. Journal o f  Biological 
Chemistry 261, 12545-12551.
KIRK, E. S. & HONIG, C. R. (1964). An experimental and theoretical analysis of 
myocardial tissue pressure. American Journal o f  Physiology 207(2), 361-367.
KISS, E., BALL, N. A., KRANIAS, E. G. & WALSH, R. A. (1995). Differential 
changes in cardiac phospholamban and sarcoplasmic reticular Ca^^-atpase protein levels: 
effects on ca2+ transport and mechanics in compensated pressure-overload hypertrophy 
and eongestive heart failuie. Circulation Research 77, 759-764.
KOBAYASHI, S., KITAZAWA, T., SOMLYO, A. V. & SOMLYO, A. P. (1989). 
Cytosolic heparin inliibits muscarinic and a-adrenergic Ca^  ^release in smooth muscle. 
Physiological role of inositol 1,4,5-triphosphate in pharmacomechanical coupling. 
Journal o f  Biological Chemistry 264,, 17997-1804.
KONISHI, M. & WATAN ABE, M. (1995). Molecular size-dependant leakage of 
intracellular molecules from frog skeletal muscle fibers permeabilized with b-escin. 
Pflugers Archiv European Journal o f  Physiology 429, 598-600.
KRUGER, C., ERDMANN, E., NAB AUER, M. & BEUCKELMANN, D. J. (1994). 
Intracellular calcium handling in isolated ventricular myocytes from cardiomyopathic 
hamsters (strain bio 14.6) with congestive heart failure. Cell Calcium 16, 500-508.
LAKATTA, E. G. (1992). Functional implications of spontaneous sarcoplasmic 
reticulum release in the heart. Cardiovascular Research 26, 193-214.
LEHNART, S. E., SCHILLINGER, W., PIESKE, B., PRESTLE, J., JUST, H. & 
HASENFUSS, G. (1998). Sarcoplasmic reticulum proteins in heart failure. Annals o f  the 
New York Academy o f Sciences 853, 220-230.
LIU, C. & HERMANN, T. E. (1978). Characterization of ionomycin as a calcium 
ionophore. Journal o f  Biological Chemistry 253, 5892-5894.
196
LOKUTA, A. J., ROGERS, T. B. & LEDERER, W. J. (1995a). Modulation of cardiac 
ryanodine receptors of swine and rabbit by a phosphorylation-déphosphorylation 
method. Journal o f  Physiology 487, 609-622.
LOKUTA, A. L, ROGERS, T. B., LEDERER, W. J. & VALDIVIA, H. H. (1995b). 
Modulation of cardiac ryanodine receptors of swine and rabbit by a phosphorylation- 
déphosphorylation mechanism. Journal o f  Physiology 487, 609-622.
MA, J. (1993). Block by ruthenium red of the ryanodine-activated calcium release 
channel of skeletal muscle. Journal o f General Physiology 102, 1031-1056.
MARBAN, E., ROBINSON, S. W. & WEIR, W. G. (1986). Mechanisms of 
airhythmogenic delayed and early afterdepolarisations in ferret ventricular muscle. 
Journal o f  Clinical Investigation. 78, 1185-1192.
MATSUI, H., MACLENNAN, D. ,H. & ALPERT, N. R. (1995). Sarcoplasmic 
reticulum gene expression in pressure overload-induced cardiac hypertrophy in rabbit. 
American Journal o f  Physiology 268, C252-C258.
MCDONAGH, T. A., MORRISON, C. E., LAWRENCE, A., FORD, L, TUNSTALL- 
PEDOE, H., McMURRAY, J. J. V. & DARGIE, H. J. (1997). Symptomatic and 
asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 350, 
829-833.
McMURRAY, J. & DAVIE, A. (1996). The phaimacoeconomics of ACE iidiibitors in 
chronic heart failure. Pharmacoeconomics 9, 188-197.
MERCADIER, J., LOMPRE, A., DUC, P., BOHELER, K. R., FRAYSSE, J., 
WISNEWSKY, C., ALLEN, P. D., KOMAJDA, M. & SCHWARTZ, K. (1990).
Altered sarcoplasmic reticulum Ca^'^-ATPase gene expression in the human ventricle 
during end-stage heart failure. Journal o f  Clinical Investigation. 85, 305-309.
ME WES, T. & RAVENS, U. (1994). L-type calcium currents of human myocytes from 
ventricle of non-failing and failing hearts and from atrium. Journal o f  Molecular and 
Cellular Cardiology 26, 1307-1320.
MEYER, M., SCHILLINGER, W., PIESKE, B., HOLUBARSCH, C., HEILMANN, C., 
POSIVAL, H., KUWAJIMA, G., MIKOSHIBA, K., JUST, H. & HASENFUSS, G. 
(1995). Alterations of sarcoplasmic-reticulum proteins in failing human dilated 
cardiomyopathy. Circulation 92, 778-784.
MING, Z., NORDIN, C., SIRI, F. & ARONSON, R. S. (1994). Reduced calcium 
cuirent-density in single myocytes isolated from hypertrophied failing guinea-pig 
hearts. Journal o f Molecular and Cellular Cardiology 26, 1133-1143.
MOISESCU, D. G. & PUSCH, H. (1975). A pH metric method for the determination of 
the relative concentration of calcium to EGTA. Pfugers Archives 355, 243
197
MOVSESIAN, M. A., BRISTOW, M. R. & KRALL, J. (1989). uptake by cardiac 
sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy.
Circulation Research 65, 1141-1144.
MOVSESIAN, M. A., KARIMI, M., GREEN, K. & JONES, L. R. (1994). Ca^N 
transporting ATPase, phospholamban, and calsequestrin levels in non-failing and failing 
human myocardium. Circulation 90, 653-657.
MULIERI, L. A., HASENFUSS, G., LEAVITT, B., ALLEN, P. A. & ALPERT, N. R.
(1992). Altered myocardial force-frequency relation in human heart failure. Circulation 
85, 1743-1750.
NAQVI, R. & MACLEOD, K. T. (1994). Effect of hypertrophy on mechanisms of 
relaxation in isolated cai’diac myocytes from guinea pig. American Journal o f  
Physiology - Heart and Circulatory Physiology 267, HI 851 -HI 861.
NG, G. A., COBBE, S. M. & SMITH, G. L. (1998). Non-uniform prolongation of 
intracellular Ca^  ^transients recorded from the epicardial surface of isolated hearts from 
rabbits with heart failure. Cardiovascular Research 37, 489-502.
i
O'BRIEN, P. J. & GWATHMEY, J. K. (1995). Myocardial Ca^L and ATP-cycling 
imbalances in end-stage dilated and ischemic cardiomyopathies. Cardiovascular 
Research 30, 394-404.
human cardiac cells. Journal o f  cardiovascular pharmacology 25, 282-291.
NIMER, L. R., NEEDLEMAN, D. H., HAMILTON, S. L., KRALL, J. & 
MOVSESIAN, M. A. (1995). Effect of ryanodine on sarcoplasmic-reticulum ca2+ 
accumulation in non-failing and failing human myocardium. Circulation 92, 2504-2510.
OHKUSA, T., HISAMATSU, Y., YANO, M., KOBAYASHI, S., TATSUNO, H., 
SAIKI, Y., KOHNO, M. & MATSUZAKI, M. (1997). Altered cardiac mechanism and 
sarcoplasmic reticulum function in pressure overload-induced cardiac hypertrophy in 
rats. Journal o f Molecular and Cellular Cardiology 29, 45-54. I
OUADID, H., ALBAT, B. & NARGEOT, J. (1995). Calcium currents in diseased
OVEREND, C. L., EISNER, D. A. & O'NEILL, S. C. (1997). The effect of tetracaine 
on spontaneous Ca^  ^release and sarcoplasmic reticulum calcium content in rat 
ventricular* myocytes. Journal o f  Physiology 502, 471-479.
PEETERS, G. A., SANGUINETTI, M. C., EKI, Y., KONARZEWSKA, H., 
RENLUND, D. G., KARWANDE, S. V. & BARRY, W. H. (1995). Method foi- 
isolation of human ventricular myocytes from single endocardial and epicardial 
biopsies. American Journal o f  Physiology 268, H1757-H1764.
PERREAULT, C. L., SHANNON, R. P., KOMAMURA, K. & MORGAN, J. P. (1992). 
Abnormalities in intracellular calcium regulation and contractile function in
198
myocai'dium from dogs with pacing-induced heart failure. Journal o f  Clinical 
Investigation. 89, 932-938.
PHILLIPPE, M., CHIEN, E. M., FREIJ, M. & SAUNDERS, T, (1995). lonomycin- 
stimulated phasic myométrial contractions. American Journal O f Physiology- 
Endocrinology And Metabolism 32, E779-E785.
PIESKE, B., KRETSCHMANN, B., MEYER, M„ HOLUBARSCH, C., WEIRICH, L, 
POSIVAL, H., MINAMI, K., JUST, H. & HASENFUSS, G. (1995). Alterations in 
intracellular calcium handling associated with the inverse force-frequency relation in 
human dilated cardiomyopathy. Circulation 92, 1169-1178.
PYE, M. P., BLACK, M. & COBBE, S. M. (1996). Comparison of in vivo and in vitro 
haemodynamic function in experimental heart failure: use of echocardiography. 
Cardiovascular Research 31, 873-881.
ROCKMAN, H. A., ONO, S. & ROSS, R. S. (1994). Molecular and physiological 
alterations in murine ventricular dysfunction. Proceedings o f  the National Academy o f  
Sciences 91, 2694-2698.
ROE, M. W., LEMASTERS, J. J. & HERMAN, B. (1990). Assessment of Fura-2 for 
measurements of cytosolic free calcium. Cell Calcium 11, 63-73.
SAGARA, Y. & INESI, G. (1991). Inhibition of the sarcoplasmie reticulum Ca^ "* 
transport ATPase by thapsigargin at sub-nanomolar concentrations. Journal o f  
Biological Chemistry 266, 13503-13506.
SCHMIDT, U., SCHWINGER, R. H. G., BOHM, M. & ERDMANN, E. (1994). 
Alterations of the force-frequency relation depending on stages of heart failure in 
humans. The American Journal o f  Cardiology. 74, 1066-1068.
SCHWINGER, R. H. G., BOHM, M. & ERDMANN, E. (1992). Inotropic and lusitropic 
dysfunction in myocardium from patients with dilated cardiomyopathy. American Heart 
Journal 123, 116-128.
SCHWINGER, R. H. G., BOHM, M., MULLER-EHMSEN, J., UHLMANN, R., 
SCHMIDT, U., STABLEIN, A., UBERFUHR, P., KREUZER, E., REICHART, B., 
EISSNER, H. & ERDMANN, E. (1993), Effect of inotropic stimulation on the negative 
force-frequency relationship in the failing human heart. Circulation 88, 2267-2276.
SCHWINGER, R, H. G., BOHM, M., SCHMIDT, U., KARCZEWSKI, P., 
BAVENDICK, U., FLESCH, M., KRAUSE, E. G. & ERDMANN, E. (1995). 
Unchanged protein levels of SERCA ii and phospholamban but reduced Ca^  ^uptake and 
Ca^  ^-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy 
patients compared with patients with non-failing hearts. Circulation 92, 3220-3228.
199
SITS APES AN, R. & WILLIAMS, A. J. (1990). Mechanisms of caffeine activation of 
single calcium-release channels of sheep cai'diac sarcoplasmic reticulum. Journal o f  
Physiology 423, 425-439.
SMITH, G. L., DUNCAN, A. M., BRUCE, L. & NEARY, P. (1998). Inhibition of Ca"+ 
uptake by inorganic phosphate is accompanied by increased Ca^  ^leak from the 
sarcoplasmic reticulum in permeabilized cardiac myocytes from rabbit. Journal o f  
Physiology
SMITH, G. L. & STEELE, D. S. (1992). Inorganic phosphate decreases the Ca^  ^content 
of the sarcoplasmic reticulum in saponin-treated rat cardiac trabeculae. Journal o f  
Physiology 458, 457-473.
SMITH, G. L. & STEELE, D. S. (1998). Measurement of SR Ca2+ content in the 
presence of caffeine in permeabiiised rat cardiac trabeculae. Pflugers Archiv European 
Journal o f  Physiology
SMITH, J. B., ZHENG, T. & LYU, R. M. (1989). Ionomycin releases calcium from the 
sarcoplasmic-reticulum and activates Na^ / Ca^ "^  exchange in vascular smooth-muscle 
cells. Cell Calcium 10, 125-134.
STEELE, D. S. & SMITH, G. L. (1993). Effects of 2,3-butanedione monoxime on 
sarcoplasmic reticulum of saponin-treated rat cardiac muscle. American Journal o f  
Physiology - Heart and Circulatory Physiology 265, H I493-HI 500.
STEIN, B., BARTEL, S. & KIRCHHEFER, U. (1996). Relation between contractile 
function and regulatory cardiac proteins in hypertrophied hearts. American Journal o f  
Physiology 270, H2021-H2028.
STERN, M. D., CAPOGROSSI, M. C. & LAKATTA, E. G. (1988). Spontaneous
calcium release from the sarcoplasmic reticulum in myocardial cells: mechanisms and 
consequences. Cell Calcium 9, 247-256.
STEVENSON, W. G., STEVENSON, L. W., MIDDLEKAUF, H. R., FONAROW, G.
C., HAMILTON, M. A., WOO, M. A., SAXON, L. A., NATTERSON, P. D., 
STEIMLE, A., WALDEN, J. A. & TILLISCH, J. H. (1995). Improving survival for 
patients witli advanced heart failure; a study of 737 consecutive patients. Journal o f  the 
American College o f  Cardiology 26, 1417-1423.
STUDER, R., REINECKE, H., BILGER, J., ESCHENHAGEN, T., BOHM, M., 
HASENFUSS, G., JUST, H. & DREXLER, H. (1994). Gene expression of the cardiac
Na^-Ca^ exchanger in end-stage human heart failure. Circulation Research 75, 443-453.
SUKO, J., WINKLER, F., SCHARINGER, B. & HELLMANN, G. (1976). Aspects of 
the mechanism of action of local anesthetics on the sarcoplasmic reticulum of skeletal 
muscle. Biochem Biophysica Acta 443, 571-586.
3J
■I
200
TAD A, M. & KADOMA, M. (1997). Uptake of calcium by sarcoplasmic reticulum and 
its regulation and functional consequences. In Physiology and pathophysiology o f  the 
heart, ed. SPERELAKIS, N. pp. 333-353. Boston: Kluwer Academic Publishers.
THE SOLVD INVESTIGATORS (1991). Effect of enalapril on survival in patients 
with reduced left ventricular ejection fractions and congestive heart failure. The New 
England Journal o f Medicine. 325, 293-302.
TIMMERMAN, M. & ASHLEY, C. C. (1986). Fura-2 diffusion and its use as an 
indicator of transient free calcium changes in single striated muscle cells. FEES 
209,No.l, 1-8.
TINKER, A. & WILLIAMS, A. J. (1993). Charged local anaesthetics block ionic 
conduction in the sheep cardiac sarcoplasmic reticulum calcium release channel. 
Biophysical Journal 65, 852-864.
TRAFFORD, A. W., DIAZ, M. E. & EISNER, D. A. (1998). Stimulation ofCa"^ - 
induced Ca^ "^  release only transiently increases the systolic Ca^ "'^  transient: measurement 
of Ca^  ^fluxes and sarcoplasmic reticulum Ca^ "^ . Cardiovascular Research 37, 710-717.
VAHL, C. F., BONZ, A., TIMEK, T. & HAGL, S. (1994). Intracellular calcium 
transient of working human myocardium of seven patients transplanted for congestive 
heart failure. Circulation Research 74, 952-958.
VARRO, A., NEGRETTI, N., HESTER, S. B. & EISNER, D. A. (1993). An estimate of 
the calcium content of the sarcoplasmic reticulum in rat ventricular myocytes. Pflugers 
Arch. 423, 158-160.
VERMEULEN, J. T., MCGUIRE, M. A., OPTHOF, T., CORONEL, R., DE BAKKER,
J. M. T., KLOPPING, C. & JANSE, M. J. (1994). Triggered activity and automaticity in 
ventricular trabeculae of failing human and rabbit hearts. Cardiovascular Research 28, 
1547-1554.
VOLPE, P., PALADE, P., COSTELLO, B„ MITCHELL, R. D. & FLEISCHER, S.
(1983). Spontaneous Calcium release from sarcoplasmic reticulum. Effect of local 
anaesthetics. Journal o f  Biological Chemistry 258, 12434-12442.
WANG, E., TAYLOR, R. W. & PFEIFFER, D. R. (1998). Mechanism and specificity 
of lanthanide series cation transport by ionophores a23187, 4-bra23187, and ionomycin. I:
Biophysical Journal 75, 1244-1254.
WONG, A. Y. K. & RAUTAHARJU, P. M. (1968). Stress distribution within the left 
ventricular wall approximated as a thick ellipsoidal shell. American Heart Journal 75, 
649-662.
XU, L., JONES, R. & MEISSNER, G. (1993). Effects of local anaesthetics on single 
channel behaviom* of skeletal muscle calcium release channel. Journal o f  General 
Physiology 101, 207-233.
201
YOSHIDA, A., TAKAHASHI, M., IMAGAWA, T., SHIGEKAWA, M., TAKISAWA, 
H. & NAKAMURA, T. (1992). Phosphorylation of ryanodine receptors in rat myocytes 
during b-adrenergic stimulation. Journal o f  Biochemistry 111, 186-190.
ZHANG, X., MOORE, R. L., TENHAVE, T. & CHEUNG, J. Y. (1995). [Ca"*],
transients in hypertensive and post-infarction myocytes. American Journal o f  
Physiology 269, C632-C640.
202
Appendix 1: Solutions.
Ringer pH 7.4 37 "C
NaCl 150mM
KCl 5mM
CaClz 2mM
MgCl2 ImM
HEPES 5mM
glucose lOmM
Relaxing Solution (O.IR) pH 7.0 20 °C
EGTA OTmM
ATP 5mM
PCR 15mM
HEPES 25mM
KCl 120mM
MgCl^ 6mM
95 Relaxing Solution (0.05R) pH 7.0 20 '
EGTA O.OSmM
ATP 5mM
PCR 15mM
HEPES 25mM
KCl 120mM
MgCl2 6mM
(iv) Transport solution for human biopsies pH 7.4 0
NaCl
KCl
MgS04
sodium pyruvate
glucose
taurine
BDM
HEPES
NTA
120mM
5.4mM
0.5mM
5mM
20mM
20mM
30mM
lOmM
6mM
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